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Abstract 
 
This thesis presents research work conducted in the field of knowledge discovery. It 
presents an integrated trend-mining framework and SOMA, which is the application of 
the trend-mining framework in diabetic retinopathy data. Trend mining is the process of 
identifying and analysing trends in the context of the variation of support of the 
association/classification rules that have been extracted from longitudinal datasets. 
 The integrated framework concerns all major processes from data preparation to the 
extraction of knowledge. At the pre-process stage, data are cleaned, transformed if 
necessary, and sorted into time-stamped datasets using logic rules. At the next stage, 
time-stamp datasets are passed through the main processing, in which the ARM 
technique of matrix algorithm is applied to identify frequent rules with acceptable 
confidence. Mathematical conditions are applied to classify the sequences of support 
values into trends. Afterwards, interestingness criteria are applied to obtain interesting 
knowledge, and a visualization technique is proposed that maps how objects are moving 
from the previous to the next time stamp.  
A validation and verification (external and internal validation) framework is described 
that aims to ensure that the results at the intermediate stages of the framework are 
correct and that the framework as a whole can yield results that demonstrate causality. 
To evaluate the thesis, SOMA was developed. 
 The dataset is, in itself, also of interest, as it is very noisy (in common with other similar 
medical datasets) and does not feature a clear association between specific time stamps 
and subsets of the data. The Royal Liverpool University Hospital has been a major centre 
for retinopathy research since 1991. Retinopathy is a generic term used to describe 
damage to the retina of the eye, which can, in the long term, lead to visual loss. 
 Diabetic retinopathy is used to evaluate the framework, to determine whether SOMA 
can extract knowledge that is already known to the medics. The results show that those 
datasets can be used to extract knowledge that can show causality between patients’ 
characteristics such as the age of patient at diagnosis, type of diabetes, duration of 
diabetes, and diabetic retinopathy. 
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Chapter 1 Introduction 
 
Ignorance is the curse of God, knowledge the wing wherewith we fly to heaven— 
William Shakespeare 
 
We now live in the information age. “Data owners” such as scientists, businesses, and 
medical researchers, are able to gather, store, and manage previously unimaginable 
quantities of data owing to technological advances and economic sciences in sensors, digital 
memory, and data-management techniques. In 1991, it was proposed that the amount of 
data stored in the world doubles every 20 months (Piatetsky-Shapiro and Frawley, 1991). 
At the same time, there is a growing realization and expectation that data, intelligently 
analysed and presented, will be a valuable resource to gain a competitive advantage. 
 
Knowledge Discovery (KD) is a non-trivial process of identifying valid, novel, potentially 
useful, and ultimately understandable patterns from large collections of data (Fayyad et al., 
1996). One of the steps KD is Data Mining (DM). DM is concerned with the actual extraction 
of knowledge from data, in contrast to the KD process, which is concerned with many other 
things such as understanding and preparation of the data, verification, and application of 
the discovered knowledge. In practice, however, people use terms DM, KD, and DMKD 
synonymously (Cios et al., 2002). The design of a framework for a KD process is an 
important issue. Several researchers have described a series of steps that constitute the KD 
process, ranging from very simple models, incorporating few steps that usually include data 
collection and understanding, DM, and implementation, to more sophisticated models such 
as the nine-step model proposed by Fayyad et al. (1996) or the six-step DMKD process 
model proposed by Cios et al. (2000) and Cios and Moore (2000). Cios et al. (2000) applied 
the model to several medical problem domains (Sacha et al., 2000; Kurgan et al., 2001, 
2003). 
To bridge the growing gap between data generation and data understanding, there is an 
urgent need for new computational theories and tools to assist humans in extracting useful 
knowledge from the huge volumes of data. These theories and tools are the subject of the 
emerging field of Knowledge Discovery in Databases (KDD), or DM, which sits at the 
common frontiers of several attributes including Database Management, Artificial 
Intelligence, Machine Learning, Pattern Recognition, and Data Visualization (Hand, 1994). 
 
DM is a multidisciplinary field, drawing work from areas including database technology, 
machine learning, statistics, pattern recognition, information retrieval, neural networks, 
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knowledge-based systems, artificial intelligence, high performance computing, and data 
visualization” (Han and Kamber, 2006). 
 
In the past decade, DM techniques have been widely applied in bioinformatics (Wang et al., 
2005), e-commerce (Raghavan, 2005), financial studies (Kovalerchun and Vityaev, 2000), 
geography (Miller and Han, 2001), marketing and sales studies (Berry and Linoff, 1997; 
Rypielski et al., 2002), etc. 
 
Most DM applications routinely require datasets that are considerably larger than those that 
have been addressed by traditional statistical procedures. The size of the datasets often 
means that traditional statistical algorithms are too slow for DM problems, and alternatives 
have to be devised. The volume of the data is probably not very important: the number of 
variables or attributes often is much more important. The analysis of the way in which data 
change with time is an important mechanism for providing information for decision-makers, 
policy-makers and other “stakeholders”. One way of conducting such an analysis is by 
considering data trends. 
 
Trends can be defined and generated in a number of ways. One mechanism, and the focus 
of the work to be undertaken here, is to define trends in terms of the way that the 
frequency of occurrence of patterns changes with time and to employ DM techniques to 
identify such trends. In this work, the term “trend mining” has been adopted to describe 
this discovery process. 
 
Trend mining is the process of identifying and analysing trends in the context of the 
variation of the support of the association rules that have been extracted from longitudinal 
datasets. The proposed trend-mining mechanism is founded on an Association Rule Mining 
(ARM) approach whereby an ARM technique is applied to a sequence of time-stamped data 
sets. This approach is both efficient and effective in finding trends. 
 
The temporal data to which trend mining can be applied can take many forms; one common 
form of data is longitudinal data. One application domain that features data sets that are 
both large and temporal is medical records or, more specifically, patient records. Many 
branches of medicine have collected large longitudinal data sets spanning many years. 
These data sets in themselves constitute a wealth of information. 
This type of data is of particular interest, in the context of trend mining, as the “time 
stamps” are defined in terms of patient visit number, as opposed to more traditional forms 
of temporal data. The data are also extremely noisy. 
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The field of medical informatics has evolved around structuring, processing, storing, and 
transmitting medical information for a variety of purposes (Shortliffe, 1990). One of these 
purposes is to develop decision-support systems that enhance the human ability to 
diagnose, treat, and assess prognoses of pathological conditions. Even if disease processes 
were fully understood, population variability would still make individualized diagnosis, 
treatment, and prognosis— all essential parts of good health care—difficult classification 
tasks. The reality is, however, that diseases are not fully understood; nor is population 
variability fully taken into account in many decision-making situations. Sometimes it is not 
possible for a clinician to employ the principles learned in the basic and clinical sciences to 
determine whether a patient has a given disease, whether he or she should be given a 
certain treatment, and how long he or she will survive. 
 
Trends across time-stamped data sets can therefore be identified by observing the change 
in the support values of items sets across the data set. Trend mining is a branch of DM that 
focuses on the process of identifying and analysing hidden trends in temporal data. The 
study described in this work is directed towards longitudinal patient data (longitudinal data 
are data collected using the same set of attributes at a series of points over time), more 
specifically diabetic retinopathy screening data collected by St. Paul’s Eye Unit, Royal 
Liverpool University. Diabetic retinopathy (DR) is a common complication of diabetes, the 
most common cause of blindness in working-age people in the UK. DR is a chronic disease 
affecting patients with diabetes mellitus and causes damage to the retina (Kanski, 2007). 
Over 3,000,000 people suffer from diabetes, at least 750,000 people are registered blind or 
partially sighted in the UK, and the remainder are at risk of blindness. Consequently, it is 
important that DR be diagnosed at an early stage, and accurately. 
 
The research objective of the work is to investigate and identify a mechanism or 
mechanisms, whereby longitudinal data trends can be mined and the results presented in 
such a way that informed decisions can be made by policy-makers, etc. Broadly, this entails 
a number of issues:  The mechanism for the pre-processing of the longitudinal data required to permit the 
desired trend mining.  The nature of the trend mining mechanisms to be employed.  The identification of the process to be used to present the results in a meaningful 
way. Longitudinal data thus provide a record of the “progress” of some set of 
features associated with the subjects. Medical longitudinal data, such as DR data, 
typically plot the progress of a medical condition.  Longitudinal data thus implicitly contain information concerning trends. 
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This work has resulted in a novel trend mining framework along with a validation and 
verification framework, and also resulted with an evaluation application called “SOMA”, 
which not only enables trend mining but also supports the validation of discovered trends. 
This validation is based upon the selection of certain attributes for which there are known 
associations. Having known these associations as well as the patterns they change, trends 
can be identified using mathematical conditions. Hence, the main purpose of this research is 
to develop a novel trend-mining framework for extracting trends from longitudinal data 
while emphasizing the validation of those trends. 
 
This thesis introduces the described method as a general framework for trend-mining 
validation and verification that can be applied generally to most trend procedures and types 
of data. The work also introduces trend mining, provides a description of the validation 
framework, and includes the experimental evaluation of the application. 
 
1.1 Contribution and research questions 
 
Trend mining remains an open challenge in the field of knowledge discovery in data (KDD). 
This can be attributed partly to the lack of a clear definition of what we mean by a “trend” 
(it is very much an application-dependent definition), and partly to issues associated with 
the modelling of time-stamped (longitudinal) data. This research addresses the 
development of a trend-mining framework for knowledge discovery from large databases, 
the development of a validation framework for trend mining, and the application of trend 
mining in medical data (SOMA). The trend-mining framework is an integrated platform 
which can be used for knowledge discovery in databases starting from the pre-processing of 
data and ending with the extraction of useful information. 
The research questions which arise from this research work are: 
• What is the most appropriate mechanism to identify, analyse and validate trends in 
real, noisy and longitudinal data and in particular when the input time stamped data 
denote patients' progress? 
• Can this mechanism produce trends that may be employed for prediction purposes? 
• Can trend mining be applied on medical applications? 
More detailed, this thesis examines the following issues: 
• How can frequent patterns and trends be discovered to facilitate the desired trend 
mining? 
•  How can changes be detected in the identified trends?  
•  How the large numbers of generated trends are handled? How can the 
interestingness of these trends be measured? 
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• Can be applied constraints to the data in order to anticipate interesting, desirable 
and useful trends? 
• How can different types of trends be interpreted to the users?  
• What criteria can be used to validate and verify the framework? 
 
In the pre-processing stage the framework directed to solve issues that they arise after 
bringing together data from various sources such as missing values, heterogeneity of data 
(combination of numerical with discrete or continuous values and or categorical data) and 
creation of time stamps. The creation of time stamped data is very important issue for the 
framework. The data do not feature a clear association between specific time stamps and 
subsets of data. These include any time-stamped subset of data comprising data collected 
at different dates and stored in different locations. As a result, the creation of time-stamped 
subsets for analysis is not straightforward and they form quasi-longitudinal data. 
 
At the processing stage, the framework, through the combination of association rule mining 
(ARM) and prototype mathematical conditions, deals with the following challenges:  identifying temporal patterns (associations) that commonly occur in the input data;  working on distinguish interesting knowledge through a large amount of temporal 
patterns  identifying change points of state changes in temporal sequences or, alternatively, 
the lack of such state changes;  the grouping (clustering) of data according to some temporal change;  the classification of temporal data sequences.  The knowledge that is extracted from trend mining depicts how the initial conditions 
(that describe a situation) of a group (e.g. patients) change over time. This type of 
change is called a state change. To visualize any possible state stage, a colourful 
representation scheme is used to interpret the results. 
This thesis also aims to produce a consistent framework for validation of trend mining. The 
trend-mining method essentially performs “learning by discovery”, and so it cannot be 
trained; rather, the user has to have confidence in the results it gives, that is, it should be 
validated. To perform validation and verification of the trend-mining framework, two 
complementary approaches are advocated here: 
Validation: This method tests the outputs of the framework and also checks the consistency 
in the application that experts already know and expect. The methods include: confirmation 
of the framework that uncovers known causal connections in the application and 
confirmation of the framework that uncovers known trends in the application. 
Verification: This type of validation tests whether the intermediate results and/or outputs of 
the framework are self-consistent. At each of the intermediate stages, a language for a set 
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of declarative validation rules are set up, and a systematic process of validation of each set 
of input data is created. 
For the development and application of both the trend-mining framework and its validation 
framework, real world medical data are used in this research. Data came from the Diabetic 
Retinopathy databases maintained by the Royal Liverpool University Hospital, and these 
data are an example of an irregular database in that they contain 150,000 records 
comprising 450 attributes distributed over two databases, each composed of a number of 
tables. 
 
SOMA, the application of the framework over those data, consists of three steps:  Pre-processing: data from different sources are brought together after applying logic 
rules to deal with problems arising from the nature of data and to create a time-
stamped subset for analysis.  ARM stage where, for each time-stamped subset, the matrix algorithm technique is 
used to identify the rules, which are determined by the user specifying which are 
“variable attributes”, or the left-hand side of the rule, and which are the key 
attributes, or the right-hand side of the rule, whose support and confidence exceeds 
the user’s specified threshold values. Matrix algorithm (Yuan and Huang, 2005) it is 
a novel algorithm for the identification of frequent item sets based on the creation of 
a matrix with binary entries and its main advantage is that only one passing it is 
needed.  The trend mining taking information from the ARM stage creates trends using 
prototypes (mathematical conditions), which show the attitude of the rules over 
time. Beyond this, trend mining creates a colourful representation that shows how a 
group of patients moving from one time-stamp to another either remain with the 
same rule or may move to another rule owing to changes in some of their 
characteristics. 
A novel algorithm was created to implement the above trend mining framework.  The 
algorithm consists of 3 parts: the first part implements pre-processing, the 2nd part is the 
main processing and the last part is the post-processing and outputting the results. 
In order to minimize as much as possible the interaction between the user and the process, 
the novelty of the script is the transformation of the input attribute names and their values 
into a numerical language which is recognized from all parts of the algorithm without the 
need of any action required by the user when the algorithm proceeds from one stage to the 
next. The problem with existing algorithms found in the literature was that each one has its 
own way of reading data and as a result more work was required to prepare the data, 
especially to go from the pre-processing stage to the main processing stage. 
 
22 
 
 
1.2 Thesis Structure 
 
The rest of this thesis is organised as follows: 
Chapter 2 presents the literature review which describes the background of current 
KDD research with respect to a variety of methodologies in both data mining in general and 
trend mining in particular. Also Review of Association Rule Mining, review of trend mining 
(similar approaches for identifying change, such as Emerging Patterns and Jumping EPs, to 
which the work can be compared), review of the nature of longitudinal data. 
Chapter 3 presents the Medical overview of Diabetic retinopathy and review of the data 
used and the challenging aspects of these data, the warehouse, logic rules, and the pre-
processing. Draw out the fact that the data being used is different to more standard 
temporal data sets in terms of the concept of episodes. Include description of methods 
including definitions and schemas.  
Chapter 4 introduces the Trend mining framework and description. An approach to 
trend mining is to use the concept of user defined temporal prototypes to define the nature 
of the trends of interests. The trends are defined in terms of sequences of support values 
associated with identified frequent patterns. The prototypes are defined mathematically so 
that they can be mapped onto the temporal patterns. A process to validate the intermediate 
data sets and the results of the trend mining process is presented. This is about how to deal 
with the main challenge of the framework which is how to evaluate the results of trend 
mining. The primary information that is required for the validation stage is a set of 
"expected" associations between features, given that all these features have been 
represented as inputs. These associations represent actual known relationships between 
features. The purpose is to produce a consistent framework for validation: 
at each of the intermediate stages; a language for a set of declarative validation rules will 
be set up, and a systematic process of validation for each set of input data will be created.     
at the end of the data mining pipeline, a process for testing for   known associations (the 
expected outputs) will be created. Thus, it  may use invariants and characteristics of the 
data to prune and/or synthesise output rules to fit the associations being looked for. Such 
complex “pipelines” of processes are fraught with various kinds of errors and biases that can 
creep into the process at each stage. When the process is for use as a research aid applied 
to sets of patient data, then the integrity of the data and the reliability of the results are 
particularly important. To promote the quality of the data mining process, and the outputs 
of the whole process, we propose to extend the current framework to one that incorporates 
a systematic method for validation: that is to check that the results obtained accord with 
the domain (in this case the domain of diabetes retinopathy). At the same time we will 
investigate the scope and value of incorporating verification checks: that is to check that the 
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sequence of processes are working correctly. The trend mining framework application 
SOMA, and Aretaeus, the associated trend mining algorithm have been developed. The 
application is used to detect different kinds of trends across longitudinal medical datasets. 
Chapter 5 details the evaluation of research work on trend mining. The aim is to 
evaluate the approach for the development of the advocated trend mining framework. The 
goal of evaluation process described here is to judge the usefulness of the discovered 
knowledge and the process of trend mining itself.  On the one hand the evaluation of the 
produced rules is straightforward by using criteria evaluating novelty action ability 
unexpectedness reliability etc, on the other hand evaluating the processes of the framework 
is based on quantitative criteria which measure the performance. The evaluation by 
applying the framework to the DR data examines if the validation and verification are 
effective as part of the framework. 
Chapter 6 conclude the thesis and present a summary of research work along with main 
findings and future work. 
Finally, the Appendices present information on the data used (schemas), tables and 
figures from evaluation experiments. 
1.3 Publications 
 
The following papers were produced as part of the research described in this thesis: 
Somaraki V., Broadbent D., Harding P.S., Coenen F. (2010). Finding temporal 
patterns in noisy longitudinal data: A study in diabetic retinopathy. Perner, Petra 
(ed.), Advances in Data Mining. Applications and Theoretical Aspects. 10th 
Industrial Conference, ICDM 2010, Berlin, Germany, July 12-14, 2010. 
Proceedings. Berlin: Springer. Lecture Notes in Computer Science 6171. Lecture 
Notes in Artificial Intelligence, 418–431. 
This paper describes an approach to temporal pattern mining using the concept of user 
defined temporal prototypes to define the nature of the trends of interests. The temporal 
patterns are defined in terms of sequences of support values associated with identified 
frequent patterns. The prototypes are defined mathematically so that they can be mapped 
onto the temporal patterns. The focus for the advocated temporal pattern mining process is 
a large longitudinal patient database collected as part of a diabetic retinopathy screening 
programme, The data set is, in itself, also of interest as it is very noisy (in common with 
other similar medical datasets) and does not feature a clear association between specific 
time stamps and subsets of the data. The diabetic retinopathy application, the data 
warehousing and cleaning process, and the frequent pattern mining procedure (together 
with the application of the prototype concept) are all described in the paper. An evaluation 
of the frequent pattern mining process is also presented. 
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Somaraki V., Harding P.S., Broadbent D., Coenen F. (2010).SOMA: A Proposed 
Framework for Trend Mining in Large UK Diabetic Retinopathy Temporal 
Databases. Research and Development in Intelligent Systems XXVII Proceedings 
of AI-2010, The Thirtieth SGAI International Conference on Innovative Techniques 
and Applications of Artificial Intelligence Bramer, Max; Petridis, Miltos; Hopgood, 
Adrian (Eds.) 
This paper is a continuation and extension of the previous paper and how the proposed 
framework is able to detect different kinds of trends within the SOMA application and how 
the proposed framework is able to detect different kinds of trends within longitudinal 
datasets. To evaluate the proposed framework the process was applied to a large collection 
of medical records, forming part of the diabetic retinopathy screening programme at the 
Royal Liverpool University Hospital. 
 
Somaraki V., McCluskey L. (2012). Robust Validation Framework for Trend Mining. 
Diamond Jubilee Annual Researchers' Conference, University of Huddersfield. 
An extended framework for Validation of trend mining framework is described in this paper. 
To validate the framework in the analysis of the generated trends a mechanism is also 
proposed. The framework is evaluated using longitudinal Diabetic Retinopathy screening 
data. 
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Chapter 2 Literature review 
 
2.1 Introduction 
 
This thesis describes an approach to finding temporal patterns in noisy longitudinal 
patient data and an extended internal and external validation (validation and 
verification) process to validate the framework. The identification of patterns in such 
data has many applications. One common example is the analysis of questionnaire 
returns collated over a number of years, for example Kimm et al.,(2000) studied the 
nature of physical activity in groups of adolescents and Skinner et al. studied children's 
food eating habits (Skinner et.al,2002).Another example of the application of 
longitudinal studies is in the analysis of statistical trends; an early reported example is 
that of Wagner (1992),who performed an extensive longitudinal study of children with 
special educational needs". Longitudinal studies particularly lend themselves to the 
analysis of patient data in medical environments where records of a series of 
“consultations" are available. For example Yamaguchi et. al., (2001) studied the effect of 
treatments for shoulder injuries, and (Levy et, al., 1996) studied the long term effects of 
Alzheimer's disease. 
In this chapter a literature review is presented on topics that are related to the 
development of the trend mining framework. Firstly, is given an overview of data mining 
and also the following aspects are covered:  Association Rule Mining (ARM): they are presented as algorithms for the 
discovery of association rules in datasets and a set of criteria for the 
definition of what is an interesting rule.  Associative Classification (AC): how ARM can be used to build a classifier.  Data mining in medical applications or Medical Data Mining(MDM): here it 
is presented how data mining techniques are applied to extract knowledge 
from medical data  Trend Mining(TM): here is presented the definition of trend mining and the 
work on emerging and jumping patterns which are the cornerstone on 
which a new trend mining algorithm is built.  Verification and validation: in this part the difference between internal and 
external validation is given what other researchers did in that field and 
what strategy will be implemented here. 
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2.2 Knowledge discovery in databases process 
 
Knowledge discovery in databases (KDD) has been attracting a huge amount of 
research, for business, media, social network, health care, etc. As data volumes have 
grown dramatically, manual analysis and interpretation of data have become impractical 
for many domains. KDD is the overall process of discovery of novel, potentially useful, 
and ultimately understandable patterns in data (Fayyad, Piatetsky-Shapiro, and Smyth 
1996a). 
 
The KDD process consists of several steps (Fayyad, Piatetsky-Shapiro, and Smyth 
1996b), which are shown in Figure 2.1. 
 
 
           Figure 2.1 :Overview of the KDD process (Fayyad, Piatetsky-Shapiro, and Smyth 1996a) 
 
1. Developing an understanding of the application domain and the relevant 
prior knowledge and identifying the goal of the KDD process from the 
user’s viewpoint. 
2. Creating a target data set: selecting a data set, or focusing on a subset of 
variables or data samples, on which discovery is to be performed. 
3. Cleaning and pre-processing. Basic operations include removing noise if 
appropriate, collecting the necessary information to model or account for 
noise, deciding on strategies for handling missing data attributes, and 
accounting for time-sequence information and known changes. 
4. Data reduction and projection: finding useful features to represent the 
data depending on the goal of the task. With dimensionality reduction or 
transformation. 
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5. Matching the goals of the KDD process (step 1) to a particular data-mining 
method. For example, summarization, classification, regression, clustering, 
and so on. 
6. Exploratory analysis and model and hypothesis selection: choosing the 
data mining algorithm(s) and selecting method(s) to be used for searching 
for data patterns. This process includes deciding which models and 
parameters might be appropriate and matching a particular data-mining 
method with the overall criteria of the KDD process (for example, the end 
user might be more interested in understanding the model than its 
predictive capabilities). 
7. Data mining: searching for patterns of interest in a particular 
representational form or a set of such representations, including 
classification rules or trees, regression, and clustering. The user can 
significantly aid the data-mining method by correctly performing the 
preceding steps. 
8. Interpreting mined patterns: possibly returning to any of steps 1 through 
7 for further iteration. This step can also involve visualization of the 
extracted patterns and models or visualization of the data given the 
extracted models. 
9. Acting on the discovered knowledge: using the knowledge directly, 
incorporating the knowledge into another system for further action, or 
simply documenting it and reporting it to interested parties. This process 
also includes checking for and resolving potential conflicts with previously 
believed (or extracted) knowledge. 
 
2.3 Data Mining methods 
 
As noted above, data mining (DM) is part of the KDD process, and it is the stage where 
knowledge discovery takes place. As a highly application driven-domain, DM has 
incorporated many techniques from other domains such as statistics, machine learning, 
pattern recognition, visualization, algorithms, and many more (Figure 2). The overall 
goal of the DM process is to extract information from a data set and transform it into an 
understandable structure for further use. As a general technology, DM can be applied in 
many forms of data such as: database data, warehouse data, transactional data, medical 
data, data streams, sequence data, multimedia data, text data, spatial data, and web 
data. 
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                     Figure 2.2 : Techniques for DM (Han et al., 2011) 
 
Two high-level primary goals of DM in practice tend to be prediction and description. 
Prediction involves using some variables or attributes in the database to predict 
unknown or future values of other variables of interest, and description focuses on 
finding human-interpretable patterns describing the data. Although the boundaries 
between prediction and description are not always distinct (some of the predictive 
models can be descriptive to the extent that they are understandable, and vice versa), 
the distinction is useful for understanding the overall discovery goal. The relative 
importance of prediction and description for particular DM applications can vary 
considerably. The goals of prediction and description can be achieved using a variety of 
particular DM methods. Some of the methods for DM are described below (Witten and 
Frank, 2005; Han et al., 2011):  Regression is learning a function that maps a data item to a real-valued 
prediction variable. There are many regression applications, such as 
predicting the amount of biomass present in a forest given remotely 
sensed microwave measurements, estimating the probability that a patient 
will survive given the results of a set of diagnostic tests, predicting 
consumer demand for a new product as a function of advertising 
expenditure, and predicting time series where the input variables can be 
time-lagged versions of the prediction variable.  Classification is learning a function that maps (classifies) a data item into 
one of several predefined classes (Weiss and Kulikowski, 1991; Hand, 
1981). Examples of classification methods used as part of knowledge 
discovery applications include the classifying of trends in financial markets 
(Apte and Hong, 1996) and the automated identification of objects of 
interest in large image databases (Fayyad, Djorgovski, and Weir, 1996). 
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The classifiers used are generated using what are called supervised 
learning methods in that they require pre-labelled training data.  Clustering is a common descriptive task where one seeks to identify a 
finite set of categories or clusters to describe the data (Jain and Dubes, 
1988; Titterington, Smith, and Makov, 1985). The categories can be 
mutually exclusive and exhaustive, or consist of a richer representation, 
such as hierarchical or overlapping categories. Examples of clustering 
applications in a knowledge discovery context include discovering 
homogeneous subpopulations for consumers in marketing databases and 
identifying subcategories of spectra from infrared sky measurements. 
Closely related to clustering is the task of probability-density estimation, 
which consists of techniques for estimating from data the joint multivariate 
probability density function of all the variables or attributes in the 
database (Silverman, 1986).  Summarization involves methods for finding a compact description for a 
subset of data. A simple example would be tabulating the mean and 
standard deviations for all attributes. More sophisticated methods involve 
the derivation of summary rules (Agrawal et al., 1996), multivariate 
visualization techniques, and the discovery of functional relationships 
between variables (Zembowicz and Zytkow, 1996). Summarization 
techniques are often applied to interactive exploratory data analysis and 
automated report generation.  Dependency modelling consists of finding a model that describes 
significant dependencies between variables. Dependency models exist at 
two levels: (1) the structural level of the model specifies (often in graphic 
form) which variables are locally dependent on each other, and (2) the 
quantitative level of the model specifies the strengths of the dependencies 
using a numeric scale. For example, probabilistic dependency networks 
use conditional independence to specify the structural aspect of the model 
and probabilities or correlations to specify the strengths of the 
dependencies (Glymour et al., 1987; Heckerman, 1996). Probabilistic 
dependency networks are increasingly finding applications in areas as 
diverse as the development of probabilistic medical expert systems from 
databases, information retrieval, and modelling of the human genome.  Decision trees and rules that use univariate splits have a simple 
representational form, making the inferred model relatively easy for the 
user to comprehend. However, the restriction to a particular tree or rule 
representation can significantly restrict the functional form (and, thus, the 
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approximation power) of the model. A large number of decision tree and 
rule-induction algorithms are described in the machine learning and 
applied statistics literature (Quinlan, 1992; Breiman et al., 1984). To a 
large extent, they depend on likelihood-based model-evaluation methods, 
with varying degrees of sophistication in terms of penalizing model 
complexity. Greedy search methods, which involve growing and pruning 
rule and tree structures, are typically used to explore the super-
exponential space of possible models. Trees and rules are primarily used 
for predictive modelling, both for classification (Apte and Hong, 1996; 
Fayyad, Djorgovski, and Weir, 1996) and for regression, although they can 
also be applied to summary descriptive modelling (Agrawal et al., 1996). 
 
2.4 Association Rule Mining 
 
Association Rule Mining (ARM) consists of first finding frequent item sets (set of items A 
and B) from which strong association rules in the form A=>B are generated. ARM was 
first proposed by Agrawal, Imielinski and Swami (1993). It is an important task in DM 
that finds correlations between items in a database. ARM is an unsupervised DM method. 
The classic application for ARM is market basket analysis (Agrawal et al., 1993; Agrawal 
and Srikant, 1994), in which business experts aim to investigate the shopping behaviour 
of customers in an attempt to discover regularities. In finding association rules, one tries 
to find groups of items that are frequently sold together in order to infer certain items 
from the presence of other items in the customer’s shopping cart. 
 
Agrawal and Srikant (1994) defined the task of association rule discovery as follows: Let 
D be a database of sales transactions, and I = {i1, i2, …, im} be a set of binary literals 
called items. A transaction T in D contains a set of non-empty items called an item set, 
such that T  I. The support of an item set is defined as the proportion of transactions in 
D that contain that item set. An association rule is an expression YX  , where X, Y  I 
and YX . The confidence of an association rule is defined as the probability that a 
transaction contains Y given that it contains X, and given as support (XY)/support(X). 
Given a transactional database D, the association rule problem is to find all rules that 
have supports and confidences greater than certain user-specified thresholds, denoted 
by minsupp and minconf, respectively. 
 
The problem of producing all association rules from a transactional database can be 
decomposed into two sub-problems according to (Agrawal and Srikant, 1994): 
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 Step 1. The generation of all item sets with support greater than the 
minsupp threshold. These item sets are called frequent item sets. All other 
item sets are called infrequent.  Step 2. For each frequent item set generated in Step1, produce all rules 
that pass the minconf threshold. For example if item XYZ is frequent, then 
we might evaluate the confidence of rules ZXY , YXZ  and XYZ  . 
While the second step that involves generating the rules from the set of discovered 
frequent item sets is straightforward, given that frequent item sets and their supports 
are known (Han et al., 2000; Lim et al., 2000), the first step of finding frequent item 
sets is a relatively harder problem that requires extensive computation and storage (Zaki 
et al., 1997; Cheung et al., 1997; Lin and Dunham, 1998; Lim et al., 2000). If we 
consider a database that contains 1500 different distinct items, there are 21500 possible 
different combinations of candidate item sets, most of which do not appear even once in 
the database. Only a small subset of this large number of candidate item sets are 
frequent. Many researchers have extensively investigated the problem of finding 
frequent item sets in association rule discovery in the last decade for the purpose of 
improving its efficiency (Park et al., 1995; Liu et al., 1999; Li et al., 1999; Zaki, 2000; 
Bayardo and Agrawal, 1999; Baralis et al., 2004). 
 
2.4.1 Apriori algorithm 
 
Apriori is an algorithm that has been proposed in Agrawal and Srikant (1994), and its 
name is based on the fact that it uses prior knowledge of frequent item sets. As 
mentioned earlier, the discovery of frequent item sets is accomplished in a stepwise 
fashion, where, in each iteration, a full pass over the training data is required to 
generate new candidate item sets from frequent item sets already found in the previous 
step. Apriori uses the “downward-closure” property, aiming to improve the efficiency of 
the search process by reducing the size of the candidate item sets list during each 
iteration.  
 
The Apriori algorithm for finding frequent item sets is shown in Figure 2-3, where the 
generate candidate function shown in Figure 2-4, is used to produce Cn from Fn-1 by 
merging Fn-1 with Fn-1, and discarding all item sets in Cn that do not pass the support 
threshold.  
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1. DB : Transactional database 
2. Fn: Set of n-items that pass the 
minsupp threshold (frequent 
item sets) 
3. Cn : Set of n-candidate item 
sets that are possibly frequent 
4. F1={frequent 1-item sets}; 
5. for (n=2; Fn-1≠Ø; n++) Do 
6. Cn=generate_candidates(Fn-1);  
7. for each transaction TDB  Do 
8. Pt = subset(Cn, t) 
9. for each candidate cPt  
10. c.count++; 
11. end //for 
12. Fn={cCn| c.count≥ minsupp} 
13. 10. end// for 
14. output = nn
F
 
 
1. Function 
Generate_candidate(Fk) 
2. begin 
3. C :=0;  
4. for all k
Fff 21,   
5. with 
},,...,{ 111 kk iiif     
6. and  
},,...,{ 112 kk iiif    
7. and  kk
ii 
Do 
8. 
,,,...,,{: 12121 kkk iiiiifff  
 
9. if ki
Fiff  }{:
 
10.  
};{: fCC 
 
11. end if 
12. end   
13. return C  
14. end 
Figure 2.3 Apriori Algorithm 
The subset function (line 5) finds the subset of candidate item sets contained in the 
current database transactional (t). Once these candidate item sets are identified from Cn, 
their supports are incremented (line 6-7). The algorithm terminates whenever there are 
no frequent item sets Fn in the nth iteration.  
Figure 2.4 Apriori Generate_Candidate function 
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To illustrate the discovery of frequent item sets in Apriori, consider Figure 2-5, which 
shows the steps of Apriori’s candidate generation described in Figure 2-4 on a database 
using a minsupp of 2. As shown in Figure 2-5, Apriori scans the database to find 
candidate item sets of length 1, and from which it determines those that pass the 
support threshold (F1). In the second level, the algorithm generates candidate item set 
of size two 2 (C2) and scans the database to determine which subset of them is frequent 
(F2). The algorithm finally terminates after discovering frequent item sets of length three 
(F3). For the database shown in Figure 2-5, Apriori requires three passes over the 
database in order to discover the complete set of frequent item sets. 
 
 
                Figure 2.5 :Apriori candidate generation example 
2.4.2 Dynamic item-set counting 
 
To speed up the discovery of frequent item sets in a database, a new ARM algorithm 
called Dynamic Item set Counting (DIC) was developed in Brin et al. (1997). DIC splits 
the database into several partitions marked by start points. Then, it calculates the 
supports of all item sets counted so far, dynamically adding new candidate item sets 
whenever their subsets are determined to be frequent, even if their subsets have not yet 
been seen at all transactions. The main difference between DIC and Apriori is that 
whenever a candidate item set reaches the support during a particular scan, DIC starts 
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producing additional candidate item sets based on it, without waiting to complete the 
scan as Apriori does. 
 
To accomplish the dynamic candidate item sets generation, DIC employs a prefix tree 
where each item counted so far is associated with a node. One of the drawbacks of DIC 
algorithm is its sensitivity to how homogeneous the data are. Particularly, if the 
database to be mined is correlated, DIC cannot recognnise that an item set is frequent 
unless it has been seen in most transactions.  
Experimental results using census and synthetic data sets (Agrawal and Srikant, 1994) 
indicated that DIC is faster by 30.00% than Apriori at a support threshold of 0.5% on 
the synthetic database. On the large and highly correlated census database, DIC 
outperformed Apriori at a support threshold of 36.00%. Both algorithms require a long 
period of training when the support is lowered, since the items in the census database 
occur frequently 95% of the time and thus yielding a very large number of candidate 
item sets. 
2.4.3 Partition 
 
An ARM approach that minimizes the I/O time by reducing the number of database scans 
to two has been proposed in Savasere et al. (1995). The algorithm divides the database 
into small partitions such that each partition can fit in the main memory and discovers 
frequent item sets locally using a stepwise approach, e.g. Apriori, in the first pass. A tid-
list structure for each item set in a partition is then constructed. The tid-list of an item 
set identifies rows in a partition that contain that item set. The cardinality of an item set 
tid-list divided by the total number of the transactions in a partition gives the support of 
that item set. 
 
In the second pass, the algorithm performs union operations on local frequent item sets 
found in each partition to discover frequent item sets in the database as whole. One of 
the drawbacks of the partitioning algorithm is that it prefers a uniform data distribution 
in which, if the count of an item set is evenly distributed in each part, the vast majority 
of the item sets to be counted in the second pass are frequent. However, for an 
unevenly distributed database, the majority of item sets in the second pass may be 
infrequent, causing extra I/O overhead (Lin and Dunham, 2000). Furthermore, when the 
number of partitions increases, the number of local frequent item sets also increases, 
consuming processing time and increasing redundant computation, especially when 
these partitions overlap in several frequent item sets (Zaki et al., 1997).  
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A comparison of performance between Apriori and the partitioning algorithm using six 
market basket analysis data sets (Agrawal and Srikant, 1994) revealed that the 
execution times of both algorithms increase when the support is reduced. A comparison 
using different number of partitions against the six benchmark problems indicates that 
the execution time decreases when fewer partitions are used, because the candidate set 
normally becomes smaller. 
2.4.4 Frequent pattern growth 
 
Apriori-like techniques use a candidate generation step to find frequent item sets during 
each iteration, and so these techniques require significant processing time and memory. 
Han et al. (2000) presented a new ARM approach, called FP-growth, that generates a 
highly condensed frequent pattern tree (FP-tree) representation of the transactional 
database. Each database transaction is represented in the tree by at most one path, and 
the length of each path is equal to the number of frequent items in the transaction 
representing that path. The FP-tree is a useful data representation because (1) all of the 
frequent item sets in each transaction of the original database are given by the FP-tree, 
and since there is a lot of sharing between frequent items, the FP-tree is smaller in size 
than the original database; and (2) the FP-tree construction requires only two database 
scans, whereby, in the first scan, frequent item sets along with their support in each 
transaction are produced, and in the second scan, the FP-tree is constructed.  
 
Once the FP-tree is built, a pattern growth method is used to mine association rules by 
using patterns of length 1 in the FP-tree. For each frequent pattern, all possible other 
frequent patterns co-occurring with it in the FP-tree (using the pattern links) are 
generated and stored in a conditional FP-tree. The mining process is performed by 
concatenating the pattern with those produced from the conditional FP-tree. The mining 
process used by the FP-growth algorithm is not Apriori-like in that there is no candidate 
rule generation. One primary weakness of the FP-growth method is that there is no 
guarantee that the FP-tree will always fit in main memory, especially in cases where the 
mined database is dimensionally large.  
 
A performance comparison between FP-growth and Apriori on two 10,000 record data 
sets (Han et al., 2000) indicates that FP-growth is at least an order of magnitude faster 
than Apriori, since the candidate sets that Apriori must maintain become extremely 
large. Also, the searching process through the database transactions to update candidate 
item set support counts at any level becomes very expensive for Apriori, especially when 
the support threshold is set to a small value. As the number of transactions grows, the 
difference in processing time between the two techniques increases further. Yildiz et.al. 
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(2010) compared matrix algorithm with FP growth algorithm using two case studies, the 
first one with 10000 items and 30000 transactions and the second with 30000 items and 
30000 transactions. They concluded that the performances of the two algorithms are 
related to the characteristics of the given datasets and the minimum support threshold. 
Also, they concluded that the matrix algorithm performs better than the FP-Growth and 
their difference in the performance is more noticeable as the minimum support threshold 
decreases. For minimum threshold less than 10% the matrix algorithm is more efficient 
by up to 230%. 
2.4.5 Confidence-based approach 
 
Another possible solution to the problem of discarding rules with high confidence and low 
support, which abandons the support threshold and mines only top confidence rules, has 
been proposed (Li et al., 1999). Given a database, the end-user has to set an item set 
target, which represents the consequent of the desired outcome (rules). The problem of 
mining high confidence rules is to find all association rules where the target is the 
consequent. In doing that, the algorithm divides the problem of mining confidence rules 
into two steps. Step 1 involves splitting the original database into two sets, one set that 
holds transactions containing the target item set, T1, and the other holds the rest of the 
transactions, T2. The algorithm discards all items of the target from transactions in T1 
and T2, therefore, the set of items in the original database I, becomes I   = I – target. 
In the second step, all item sets, X, which appear in T1 but do not appear in T2 are 
discovered, and rules such as tgX  , is produced, where tg is the target consequent. 
These item sets have a zero support in T2 but non-zero support in T1 and are called 
Jumping Emerging Patterns (JEP). The authors of (Li et al., 1999) have adopted two 
border methods from (Dong, 1999) to discover item sets whose support is zero in one 
sub-set, but non-zero in the other sub-set. The first border algorithm finds all item sets 
with non-zero support in a data set and names them horizontal borders. When taking 
two horizontal borders produced from two sets of data, as an input, the second border 
algorithm can derive all item sets whose support in one is zero, but non-zero in the other 
one.  
 
Experimental studies using three data sets showed that this confidence-based approach 
can produce high confidence rules that cannot be found by traditional association rule 
approaches. However, the candidate item sets generated are much larger than in the 
original database. Therefore, a disk-based implementation is often preferred when 
pruning the search space using only the confidence threshold (Wang et al., 2001). 
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2.4.6 Matrix algorithm 
 
In 2005, Yuan and Huang presented a novel algorithm for generation of association 
rules. The algorithm is called a matrix algorithm, and it creates a binary matrix with 
entries 0, 1 passing over the database only once creating a set of candidate items from 
which association rules are produced. The process of generating the matrix is the 
following: first the items in I are set as columns and the transactions D as rows in the 
matrix. 
 Let I={i1,i2,...,in} be the set of items and D = {t1,t2,...,tm} be the set of transactions.  
Then, the matrix G={gij} for i=1,...n and j=1,...m is generated using the following rule: 
1,
0,
j i
ij
j i
if i t
g
if i t
    
Using this generated matrix association rules are produced using the matrix algorithm: 
The 1-item set C1 consists of the sets which are subsets of single item in I , that is, 
C1 = {{i1},{i2},…,{in}}. In order to compute the support number for each set in C1, we 
express every set in C1 as a row vector in R
n, that is, we express {i1} as 11 {1,0,...,0}S 
and {ik} as: 
1 {0,0,...,1,...0}kS   
where the kth element is 1 and others are 0. Then the support number of the set {ik} is 
calculated by:    1
1
,
m
k j k
j
supp i g S  
Where <,> is the dot product of two row vectors and gj j=1,…,m are the rows of matrix 
G. 
Then the set of all the frequent 1-item sets, L1, is generated from C1. If the support 
number of {ik} is beyond the user-specified support threshold Minsupport, that is,   ksupp i Minsupp  
Then {ik} L1 . 
The set of candidate 2-item sets C2 is the joint set of L1 with itself. Each subset in C2 
consists of two items and has the form {ik, ij}, k < j. Similarly, we specify each set in C2 
a row vector in Rn. For example, for the set {ik, ij}, the specified vector is: 
2
,
{0,...,0,0,1,...,0,0,1,...,0}k jS   
Where the kth and jth elements are 1 and others are 0. The support number of the set 
{ik, ij} is : 
   2,
1
,
int
2
m
s i k
k
j
g S
supp i 
       
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where int[・] is the integrating function that changes a real number to integer by 
discarding the number after decimal point. 
The frequent item set L2 is generated from C2 with the set whose support number is 
beyond the user specified support threshold Minsupport, that is:   ,k jsupp i i Minsupp
 
then {ik, ij} ∈ L2. 
After the frequent 2-item sets L2 is obtained, it can be used to generate C3.  
The process is repeated with successively increasing number k until either Ck or Lk is 
empty, where each subset in Ck has the form {il1, il2 , ・ ・ ・ , ilk} 
including k items, and is generated from the frequent (k − 1)−item sets Lk−1, and Lk is 
the frequent k−item sets generated from Ck with the set whose support number is 
beyond the user specified threshold. 
At the end of procedure, we can get the all frequent item sets by the following formula. 
Let the procedure is terminated after step k, then: 
1
1
k
i
i
L L

  
2.4.7 Multiple supports Apriori 
 
The support constraint is the most important factor that controls the number of 
association rules produced (Agrawal et al., 1993; Bayardo and Agrawal, 1999; Zaki, 
2000). Almost all current ARM algorithms use a single support, but setting the support to 
a high value results in disposal of some useful, rare items in the database. Furthermore, 
to capture such rare items, one has to set the support to a very small value, which can 
lead to the generation of many useless rules (Liu et al., 1999, Li et al., 1999).  
 
To overcome such a problem, Liu et al. (1999) proposed a multiple-support Apriori-like 
approach, called MSapriori, which assigns different support values for each item in the 
database. This enables users to express different support requirements for different 
rules. The support for a particular rule in MSapriori is the lowest minsupp value among 
the items in that rule. The candidate generation step in MSapriori is similar to the 
generate function in the Apriori algorithm. 
 
An evaluation study comparing the MSapriori against real data from Agrawal and Srikant 
(1994) reveals that MSapriori generates a smaller number of candidate item sets than 
that of Apriori for real-world data sets. In particular, when the support threshold is set to 
0.2%, the number of frequent item sets found by MSapriori is 61% lower than that of 
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Apriori. However, the execution time spent to find frequent item sets for both algorithms 
is roughly the same.  
 
2.4.8 Hash-based technique and pruning 
 
Generally, the computational cost of ARM is largely determined by the speed of the 
discovery of frequent one- and two-item sets. Empirical results from Agrawal and Srikant 
(1994) suggest that the computational cost in the initial iterations dominates most of the 
execution time for the candidate generation phase. When the number of frequent item 
sets during iteration 1 is large, the expected number of candidate item sets at iteration 2 
is also large, and so reducing the size of the candidate item sets in the early iterations 
may result in huge savings in processing time and memory. A hash-based technique, 
called Direct Hashing and Pruning (DHP), has been proposed in Park et al. (1995) to 
efficiently reduce the size of candidate item sets in early iterations. 
 
DHP works as follows. While scanning the database to find frequent one-item sets, a 
hash tree, H1, is built for candidate one-item sets to facilitate the search. The algorithm 
evaluates during the scan whether an item exists in the hash table, and if so, the count 
of the item is incremented by 1; otherwise, the item is inserted into the hash table and 
is given a count of 1. Also, when the occurrences of all one-item sets are counted for 
each transaction, all two-item sets are produced and hashed into another hash table, H2, 
where a count is initialized to 1 for each item set. Once the database is scanned, we can 
obtain the possible candidate two-item sets from H2. 
 
Pruning occurs to reduce the database size during the scan in which not only a 
transaction is trimmed but also some of the transactions are removed. DHP trims an 
item in a transaction t if it does not have a certain number of occurrences in t’s 
candidate item sets. For example, If the support is set to 2, t = XYZWP and four two-
subsets, (XZ, XW, XP, WP), exist in the hash tree constructed for candidate two-item 
sets, H2, the number of frequencies according to each item in t is 3, 0, 1, 2, 2, 
respectively. For frequent three-item sets, only three items in t, e.g. (X, W, P), have 
occurrences above the support threshold. Consequently, these three items are kept in t 
and items Y and Z are removed. 
 
Empirical studies indicate that DHP reduces the execution times not only in the second 
iteration, when the hash table is employed by DHP to facilitate the production of 
candidate two-item sets, but also in later iterations (Park et al., 1995). In particular, the 
execution time required to produce candidate two-item sets by DHP is several orders of 
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magnitude smaller than that of Apriori, but the execution time of DHP is slightly larger 
than that of Apriori in the first iteration, owing to time required for building the hash 
table for candidate two-item sets. 
 
2.4.9 Eclat algorithm 
 
To minimize the number of passes over the input database, the Eclat algorithm was 
presented in Zaki et al. (1997). It requires only one database scan, thus addressing the 
question of whether all frequent item sets can be derived in a single pass. Eclat uses a 
vertical database transaction layout, where frequent item sets are obtained by applying 
simple tid-list intersections, without the need for complex data structures.  
 
A recent variation of the Eclat algorithm, called dEclat, has been proposed in (Zaki and 
Gouda, 2003). The dEclat algorithm uses a new vertical layout representation approach 
called a diffset, which only stores the differences in the transactions identifiers (tids) of a 
candidate item set from its generating frequent item sets. This considerably reduces the 
size of the memory required to store the tids. The diffset approach avoids storing the 
complete tids of each item set; rather the difference between the class and its member 
item sets are stored. Two item sets share the same class if they share a common prefix. 
A class represents items that the prefix can be extended with to obtain new class. For 
instance, for a class of item sets with prefix x, [x] = {a1, a2, a3, a4}, one can perform the 
intersection of xai with all xaj with j>i to get the new classes. From [x], we can obtain 
classes [xa1] = {a2, a3, a4}, [xa2] = {a3, a4}, [xa3] = {a4}. 
Experimental results on real world data and synthetic data (Zaki and Gouda, 2003) 
revealed that dEclat and other vertical techniques like Eclat usually outperform 
horizontal algorithms like Apriori and FP-growth with regards to processing time and 
memory usage. Furthermore, dEclat outperforms Eclat on dense data, whereas the size 
of the data stored by dEclat for sparse databases grows faster than that of Eclat. 
Consequently, the authors concluded that for dense databases, it is better to start with a 
diffset representation, but for sparse databases, it is better to start with a tid-list 
representation and then switch to a diffset at later iterations. 
 
2.4.10 Sampling technique 
 
Another technique to solve Apriori’s slow counting and Eclat’s large memory 
requirements is to use sampling as proposed by Toivonen (1996). The presented 
sampling algorithm picks a random sample from the database, finds all relatively 
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frequent patterns in that sample, and then verifies the results with the rest of the 
database. In cases where the sampling method does not produce all frequent sets, the 
missing sets can be found by generating all remaining potentially frequent sets and 
verifying their supports during a second pass through the database. The probability of 
such a failure can be kept small by using a lower support threshold than the minimum 
support value. 
 
2.4.11 Measuring interestingness of rules 
 
ARM has the potential to produce a large number of patterns as the size and 
dimensionality of databases increase. Most ARM algorithms employ a support–confidence 
threshold framework. 
 
Let I = {i1,i2,…,in} be a set of items and D = {t1,t2,…,tm} be a set of transactions. A rule 
is defined as an implication X=> Y where X,Y ⊆ I and XຕY=0. 
 Item set X is called antecedent of the rule and Y is called the consequent of the rule. 
The support of the rule support(X=>Y) is the number of occurrences of X and Y, P(XຖY).  
The confidence of the rule confidence(X=>Y) is defined as conditional probability P(Y|X) 
which is the percentage of transactions on D containing X that also containing Y: 
 
 
The candidate rules must have both confidence and support at least equal with the 
threshold values that are given by the users. 
 
The issue that arises is that using the framework of support and confidence only cannot 
guarantee that a strong rule is necessarily interesting. The pitfall of confidence can be 
traced to the fact that its definition ignores the support of the item set Y, support(Y). 
Han et al. (2011) and Pong-Ning et al. (2000) described other measures that are used to 
measure the interestingness of a rule. 
 
One measure of interestingness is the lift. Lift is defined as the ratio of the confidence of 
the rule X=> Y over the support of Y. Lift is used to filter misleading strong association: 
  If lift equals 1 X,Y are independent  
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 If lift is less that 1 X,Y are negatively correlated 
The following four measures:  all confidence,  max_confidence,   Kulczynski and   Cosine, have the following property: each value is only influenced by the 
supports of X, Y and XUY or more exactly, by the conditional probabilities 
of P(X|Y) and P(Y|X), but not by the total number of transactions. 
 Another common property of these four measures is that the value they take ranges 
from 0 to 1, and the higher the value, the higher is the relationship between X, Y.  
 
The definitions of these measures are: 
All confidence: 
 
Max confidence: 
 
Kulczynski: 
 
Cosine: 
 
 
2.5 Associative classification 
 
Associative classification has been proposed from Liu et al., 1998. In associative 
classification the right side of a rule  is considered to be class attribute. 
Associative classification builds rules based on conjunctions of attribute–value pairs that 
occur frequently in data. The steps of Associative Classification are:  Mine the data for frequent item sets, that is, find commonly occurring 
attribute–value pairs in the data.  Analyze the frequent item sets to generate association rules per class, 
which satisfy confidence and support criteria.  Organize the rules to form a rule-based classifier. 
In order to rank the strength of each rule parameters such as support of the rule, 
confidence of the rule, length of the antecedent part of the rule and the generation time 
of the rule. 
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In (Liu et al., 1998) (Yin et al., 2003) (Thabtah et al., 2005), (Thabtah et al., 2010) it is 
stated that removing redundant and misleading rules often lead to wrong classification 
might enhance model efficiency as well as effectiveness. 
Also one of the main drawbacks of AC mining is that it often generates large 
number of rules since AC extract all the correlations among the items and the class are 
discovered as rules. Finally, the use of large number of rules necessitates high 
computation cost and often degrades the accuracy rates.  
2.6 Temporal Pattern Mining 
 
The objective of Temporal Pattern Mining(TPM) is to discover temporal patterns in time 
stamped data. However, the identification of known patterns is also seen as important as 
this would provide a means of validating the adopted approach. The process of frequent 
pattern mining in static data tables is well established within the Knowledge Discovery in 
Data (KDD) community and can be traced back to early work on Association Rule Mining 
(ARM) as first espoused by Agrawal and Srikant (1994).Less attention has been applied 
to temporal pattern mining. There has been reported work on Temporal ARM (TARM) 
where association rules are mined from time stamped data. 
The TPM process described in this paper operates on binary value data sets (thus, where 
necessary, data must be transformed into this format using a process of normalisation 
and discretisation). The research described in this work also borrows from the field of 
Jumping and Emerging Patten (JEP) mining as first introduced by Dong and Li (1999). 
The distinction between the work on JEPs, and that described in this paper, is that JEPs 
are patterns whose frequency increases (typically) between two data sets (although 
some work has been done on identifying JEPs across multiple data sets, for 
example Khan et al. (2010). JEP mining is usually also conducted in the context of 
classification (see for example Fan and Kotagiri, 2003). The distinction between JEPs and 
the work described here is that the work is directed at patterns that change in a variety 
of pre-described ways over a sequence of data sets. To the best knowledge of the 
authors there is little reported work on temporal pattern mining or trend mining as 
defined above. 
Zhu et al. [18], in the context of data stream mining, identify three processing models 
for temporal pattern mining:  Landmark  Damped and  Sliding Windows. 
The Landmark model discovers all frequent patterns over the entire history of the data 
from a particular point in time called the “landmark". The Damped model, also known as 
the Time-Fading model, finds frequent patterns in which each time stamp is assigned a 
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weight that decreases with “age" so that older records contribute less than more recent 
records. In the Sliding Window model the data is mined by sliding a “window" through 
the temporal dimension. A similar categorisation may be adopted with respect to 
temporal pattern mining. The work described in this work adopts the Landmark model. 
This thesis addresses a number of aspects of the ﬁeld of temporal data mining (TDM) 
(Lin et al., 2002; Roddick and Spiliopoulou, 2002), with the central goal being the 
identification of interesting temporal rules between patterns in time-stamped data. 
Several authors have previously identified a number of such temporal rules. Agrawal and 
Srikant (1995) originally used an a priori-like technique to extract sequential patterns; 
this was then extended by Mannila and Toivonen (1996) to address the existence of 
frequent episodes and episode rules. Subsequently, a number of authors published 
extensions to the extraction of temporal association rules and inter-transactional 
association rules (Chen et al., 1998; Li et al., 2003; Tung et al., 2003). 
Several authors have mined temporal rules in interval-based data. Having provided a 
definition of temporal patterns based on temporal relationships between interval-based 
events, Kam and Fu (2000) proposed an a priori-like strategy for the efficient detection 
of such patterns. A general methodology for the process of knowledge discovery in time 
series databases, addressing both the pre-processing and the rule mining step, was 
presented by Last et al. (2001). Cohen (2001) introduced the theory of ﬂuent learning in 
order to extract common patterns in time series data and described the ‘shape’ of 
episodes using a statistical technique; this was well suited for multivariate time series 
data with binary variables. 
A mining technique to discover containment relationships in series of interval events was 
proposed by Villafane et al. (2000) (Sacchi et al., 2004); such events are derived from 
numerical time series through a quantisation step. 
The newly discovered rules between temporal patterns were applied in unsupervised 
neural networks to detect complex temporal patterns and to generate temporal 
grammatical rules for a symbolic knowledge representation (Guimaraes and Ultsch, 
1999; Guimarães et al., 2001), thus highlighting the benefits of using prior knowledge to 
improve algorithm performance. 
Höppner and Klawonn (2002b) and Höppner (2003) developed informative temporal 
rules on a given sequence of labelled intervals, thus improving the flexibility of the 
temporal pattern previously defined by Kam and Fu (2000). Using the work of Höppner 
and an algorithm for the discovery of temporal patterns from interval-based data 
proposed by Lin and Lee (2005), Winarko and Roddick recently proposed a new method 
to extract frequent temporal patterns and then to infer temporal rules from such 
patterns (Winarko and Roddick, 2005). Papapetrou et al. (2005) developed a novel 
formalisation of the problem of mining frequent arrangements of temporal intervals, 
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wherein the method acts on a database of sequences of events each of which occur 
during a defined time interval. Of the aforementioned publications, the method that is 
closest to the one that will be described in this thesis is that of Höppner (2003), who 
suggests a formulation of the problem of extracting rules from temporal. In particular, 
Höppner proposes qualitative features by which the time series can be divided into 
segments, as well as a method for mining temporal patterns from which informative 
rules are derived. Höppner (2003) provides an introduction to how to learn qualitative 
labels (usually trends) from time stamped data, mentioning techniques such as 
clustering and smoothing, and wavelets. 
Following the ideas of Bellazzi et al. (2005), Sacchi et al. (2007) presented raw time 
series introducing a step for the extraction of an interval-based representation based on 
the formalism of TAs . In previous proposals, even when a qualitative representation of 
the time series is suggested (Höppner and Klawonn, 2002b) or achieved through TAs 
(Bellazzi et al., 2005), the representation that is considered is always of a basic nature 
(e.g., intervals of increasing, decreasing or stationary trends for a single time series) 
and the temporal rules are always extracted between such simple patterns. 
Bellazzi et al. (2005) aimed at interpreting and performing data analysis in real time, 
with the difference that they wished to evaluate knowledge discovery of data in batch 
mode. Thus it can be seen that the field of temporal data mining is rich and varied. 
2.7 Temporal Logic 
 
Temporal logic aims on extracting knowledge on sequential and complicatedly 
changeable. This method is an extension of the classical propositional logic where an 
event is true (1) or false (0). Temporal logic tries to answer what to do with the fact that 
true or false value of a statement changes from time to time. Temporal logic associates 
each point of a given flow time with a separate evaluation about an event.  
The basic idea of temporal logic is to make the evaluations (true or false) time 
dependent. The second fundamental idea of the temporal logic is the use of distinct time 
point, e.g. future, past which is interpreted for a case   as: at some time in the future 
the case is   or at some time in the past   holds. 
In the work presented here the time is not used in the form of distinct points but time is 
used in form of time stamps which are synthesised from distinct points. The total 
number of time stamps forms a time interval where the knowledge is extracted not as 
event (true or false) but as an association between attributes which may or may not be 
strong and interesting within this time interval.    
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2.8 Longitudinal data mining 
 
Longitudinal data are information comprising values for a set of data attributes that are 
repeatedly collected for the same object over a sequence of sample points, and as such 
it can be said to track the progress of the object in some context (Singer and Willett, 
2003).  
The exemplar longitudinal data set is patient data, where information concerning a 
patient's condition is repeatedly collected so as to track a patient's progress. 
 
Longitudinal data may be categorized in a number of ways: one suggested categorization 
is that of (Singer and Willet, 2003) who identified person-level and person-period data 
sets. In a person-level data set, each person (subject) has one record and multiple 
variables containing the data from each sampling. In a person-period data set, each 
person (subject) has multiple records, one for each measurement occasion. Thus, a 
person-level data set has as many records as there are subjects in the sample, while a 
person-period data set has many more records (one for each subject sampling event). 
The former is sometimes referred to as a broad data structure, and the latter as a long 
data structure (Twisk, 2003). Longitudinal studies vary with regard to sample size, 
number of variables, and number of time stamps. Broadly speaking, there are five main 
types of longitudinal study based on these characteristics (Kamp and Bijleveld, 1988):  simultaneous cross-sectional studies,  trend studies,  times series studies,  intervention studies and  Panel studies. 
2.9 Data mining for medical applications 
 
Modern medicine generates a great deal of information stored in medical databases, and 
it has become increasingly necessary to extract useful knowledge and provide scientific 
decision-making for the diagnosis and treatment of disease from the database. Because 
the medical information is characteristic of redundancy, multi-attribution, incompletion 
and closely related with time, the medical DM differs from others. 
 
Many factors affect the success of DM on medical datasets, such as the quality of the 
data. If the information is irrelevant or redundant, or the data are noisy and unreliable, 
knowledge discovery during training is more difficult. Zhao and Wang (2010) refer to the 
four characteristics of medical data: 
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  Redundancy: The medical database is a huge data resource, and a large 
number of records are stored in the database every day. It may contain 
repeated, irrelevant, and even contradictory records. For example, for one 
disease, patients' symptoms, test results, and treatment measures may be 
the same. In addition, the medical data are also a feature of time.  Complexity: Complexity is a remarkable feature of medical data. As the 
medical data obtained from medical imaging, laboratory data and the 
exchange between doctors and patients, they are in various forms. These 
include images (SPECT), signals (ECG), pure data (the signs of 
parameters, test results), and text (such as the identity of the patient 
records, descriptions of the symptoms, detection and diagnosis of the 
textual representation).  Privacy: Privacy is different from security and confidentiality, in that when 
individuals or organizations access private information without 
authorization, this creates a safety issue. While researchers share private 
information with unauthorized individuals or institutions, this exposes the 
issue of confidentiality. Medical DM scientists are obliged to carry out 
research on the premise to protect patients' privacy.  Missing values: Medical data collection is always out of line with the stage 
of processing. The main purpose of medical data collection is to cure 
sickness and save patients’ lives. However, the purpose of medical data 
processing is to determine regular patterns in certain diseases. In this 
case, the collected data may not meet the need to cover all the 
information. In addition, human factors may lead to errors and incomplete 
information in patients' records and the expression of many medical data 
is uncertain and fuzzy. 
 
In their work, Robu and Hora (2012) described the main DM techniques used in medical 
applications:  Classification – in order to predict a nominal value  Regression - estimation of an output value based on input values  Time series analysis - is the value of an attribute examined over a time 
period usually at evenly spaced time intervals.  Clustering – is a descriptive technique which consists of identifying classes 
or groups in sets of unclassified data. Clustering is often one of the first 
steps in data mining analysis. It identifies groups of related records that 
can be used as a starting point for exploring further relationships. 
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 Association rules – discovering that a set of symptoms often occur 
together with another set of symptoms 
Delen et al. (2005) used two popular DM algorithms (artificial neural networks and 
decision trees) along with the most commonly used statistical method (logistic 
regression) to develop prediction models using a large dataset to predict breast-cancer 
survivability (more than 200 000 cases). They also used 10-fold cross-validation 
methods to measure the unbiased estimate of the three prediction models for 
performance-comparison purposes. 
 
Srinivas et al. (2010), in their study in health care and prediction of heart attacks, 
examined the potential use of classification based DM techniques such as rule-based, 
decision tree, Naïve Bayes, and artificial neural networks for massive volumes of data. 
The health-care industry collects huge amounts of health-care data, which, 
unfortunately, are not “mined” to discover hidden information. They are used for data 
preprocessing and effective decision-making for the One Dependency Augmented Naïve 
Bayes classifier (ODANB) and Naïve Credal Classifier 2 (NCC2). This is an extension of 
Naïve Bayes to imprecise probabilities aimed at delivering robust classifications when 
dealing with small or incomplete data sets.  
 
Lavrac (1999), in his paper, reviewed several DM methods for intelligent data analysis in 
medicine, in particular machine-learning methods. Machine-learning methods can be 
classified into three major groups: inductive learning of symbolic rules (such as induction 
of rules, decision trees, and logic programs), statistical or pattern-recognition methods 
(such as k-nearest neighbours or instance-based learning, discriminate analysis, and 
Bayesian classifiers), and artificial neural networks (such as networks with back-
propagation learning, Kohonen’s self-organizing network, and Hopfield’s associative 
memory). 
 
Breault et al. (2002), in their study on diabetic data warehouse, used a classification tree 
approach as standardized in the CART software by Salford Systems. 
 
Li et al. (2004), in their study on DM techniques for cancer detection using serum 
proteomic profiling, used a support vector machine-based method as applied in this 
study, in which statistical testing and genetic algorithm-based methods are used for 
feature selection respectively. Leave-one-out cross-validation with a receiver operating 
characteristic (ROC) curve is used to evaluate and compare cancer-detection 
performance. 
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Silva et al. (2008), in their study on rating organ failure via adverse events, compared 
two DM methods: multinomial logistic regression (MLR) and artificial neural networks 
(ANNs). These methods were tested in the R statistical environment, using 20 runs of a 
fivefold cross-validation scheme. The area under the ROC curve and Brier score were 
used as the discrimination and calibration measures. 
 
Srimani and Koti (2011), in their study on difference medical databases, examined the 
performance of different classification methods:  Decision Trees: Decision trees are a way of representing a series of rules 
that lead to a class or value. Therefore, they are used for directed DM, 
particularly classification. One of the important advantages of decision 
trees is that the model is quite explainable, since it takes the form of 
explicit rules.  Bayesian Network: A Bayesian Network (BN) is a graphical model for 
probability relationships among a set of variable features. The most 
interesting feature of BNs, compared with decision trees or neural 
networks, is the possibility of taking into account the prior information 
about a given problem, in terms of structural relationships among its 
features.  Naïve Bayes: The Naïve Bayes classifier [8] uses the Bayes rule to 
compute the conditional probability of each possible class by assuming the 
input features to be conditionally independent, given the target feature.  Ripper: Ripper is a rule-based learner that builds a set of rules to identify 
the classes while minimizing the amount of error. The error is defined by 
the number of training examples misclassified by the rules.  Nearest Neighbour: Nearest Neighbour, instead of determining the tables 
global majority, based on the same set of features, determines the class 
for each instance that is not covered by a decision table entry.  Bagging: Bagging bags a classifier to reduce variance. This works for both 
classification and regression, depending on the base learner. In the case of 
classification, predictions are generated only by averaging the probability 
estimates, not by voting.  Decision stump: Decision stump builds one-level binary decision trees for 
datasets with a categorical or numeric class, by dealing with missing 
values and by treating them as a separate value and extending a third 
branch from the stump.  Dagging: Dagging creates a number of disjointed, stratified folds out of 
the data and feeds each chunk of data to a copy of the supplied base 
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classifier. Predictions are made by majority vote, since all the generated 
base classifiers are put into the vote meta classifier. 
 
The rapid growth of digitalized medical records presents new opportunities for mining 
large (terra-bytes) amounts of data, when the structure of the text record is very loose 
without any rules. Term mining technique can led to the identification of keywords with a 
significant value within the narratives of medical records. Term mining can help to 
convert unstructured text into structured content. Term mining can be applied in textual 
data (literature, admission notes, reports and summaries) and yields precise knowledge 
nuggets from a sea of information. 
Claster et.al., (2008) presented an unsupervised neural network text-mining technique 
for the analysis of computed tomography scanning. Using the notes of physicians 
identified keywords and correlated them with either negative or positive outcome. 
Ananiadou et.al.(2012) applied semantic text mining techniques in diabetes databases. 
Semantic text mining techniques can be customized to extract semantic types, relations 
and associations with multifactorial diseases such as diabetes. Currently, such extraction 
is being manually conducted by a large group of scientists, and therefore it is anticipated 
that text mining will contribute to the automation of this work. 
Wu et.al. (2007) they used text mining on clinical records for cancer diagnosis. In this 
work, they proposed a framework for discovering the relationships between cancer 
diseases and potential patterns from clinical medical records. They applied a text mining 
process on a corpus of clinical records to extract the potential patterns. First, they 
utilized to the Cancer Ontology & Thesaurus for extracting and weighting the key terms 
from clinical records and tag various cancer-specific concepts. Second, they applied the 
SOM algorithm to perform a clustering process and extracting the relationships between 
cancer diseases and potential factors from clinical medical records. Third, they developed 
an approach applying a SVM method to supporting acquisition of relatedness among 
texts and clinical records. The results show that the integration of cancer ontology and 
this approach can extract the potential patterns and re-categorize clinical records. 
Furthermore, the system also allow combine microarray data-mining methods into the 
framework to find the relationships between cancer diseases and specific genes. 
 
2.10 Trend mining 
 
Trend mining is the process of identifying and analysing trends in the context of the 
variation of the support of the association rules that have been extracted from 
longitudinal datasets.  
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The identification and the analysis of trends are performed using mathematical 
conditions (prototypes). The aim of these identities is to separate into groups the large 
amount of knowledge that is hidden in the datasets. A longitudinal data is a set of finite 
variables that are revealingly measured. The repeated measurements create a class of 
multidimensional time series. The application of trend mining for the discovery of trends 
requires the following steps/procedure:  Understanding the domain: In real-life applications, data are complex, and 
often the user must deal with problems such as missing records, 
conflicting values, and double records. The success of trend mining is 
highly related to the clarity of the input data.  Association rule mining: After data preparation the next step is to discover 
useful knowledge through the application of ARM. This process is repeated 
as many times as the number of datasets with different time stamps.  Trend mining algorithm: The mathematical conditions  are applied in order 
to determine the evolution of the support of the interesting rules and 
create different categories of trends, depicted using a colourful 
representation. 
Dong and Li (1999) introduced the idea of emerging patterns in order to describe the 
change of the support of a frequent item set from a Dataset D1 to a dataset D2. Let I be 
an item set {i1, i2, ..., iN}and X be a subset of I. A transaction T contains X if . The 
support of item set X in a dataset D is denoted as suppD(X) which is the number of 
transactions in D that contain X. Assume two datasets D1 and D2 and supp1(X), supp2(X) 
the support of X in D1 and D2 respectively, then the Growth Rate(X) is defined as: 
 
 
 
Given ρ>1 as a growth rate threshold an item set X is said to be an ρ-emerging pattern 
from database D1 to D2 if GrowthRate(X)≥ρ. 
Li et.al, (2000 and 2001) presented the concept of jumping emerging patterns (JEP). 
 A jumping emerging pattern from D1 to D2 is an item set X that satisfies 
 with î a minimum support threshold. 
Dong et al., (1999) proposed new classifier called CAEP (classification by aggregating 
emerging patterns) based on the definitions of emerging patterns proposed by Dong and 
Li (1999) using the following fundamental ideas: 
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 i) Each emerging patterns can sharply differentiate the class membership of a fraction of 
instances containing the emerging patterns due to the big difference between its 
supports in the opposing classes. They defined the differentiating power of the emerging 
patterns in terms of the support and their ratio on instances containing the emerging 
patterns.  
ii) for each instance t, by aggregating the differencing power of a fixed automatically 
selected set of EPs a score is obtained for each class. The scores of all classes are 
normalized and the largest score determines t’s classes. 
 
Terlecki and Walczak (2007) proposed the concept of JEP with negation (JEPNs) based 
on the concept of JEPs. They defined negation as a transaction that does not contain an 
item but  it contains the respective negated item. 
 
Soulet et al. (2004) proposed a new kind of emerging pattern that they termed “strong 
emerging patterns” (SEPs) as the emerging patterns with the best possible growth rates. 
In order to calculate the growth rate, they divided the database D into as many datasets 
as the number of different values of an item C, where C1, C2 represent two different 
classes. 
 
Fan and Ramamohanarao (2006) proposed the generalised noise-tolerant emerging 
patterns (GNEPs). They defined the generalised growth rate of an item set from dataset 
D1 to D2 as: GrowthRate(X)=       
     
 
 
Where f1(x) and f2(x) are two monotone function and  x≥0, f1(x)≥0, f2(x)≥0. 
 Given two thresholds δ1 >0 and δ2 >0 with δ2  δ1. 
 An item set X is GNEP from D2 and D1 if: 
 
 
 
Zhu et al. (2002), in the context of data stream mining, identify three processing models 
temporal pattern mining:  Landmark, 
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 Damped and  Sliding Windows. 
The Landmark model discovers all frequent patterns over the entire history of the data 
from a particular point in time called the “landmark”. The Damped model, also known as 
the Time-Fading model, finds frequent patterns in which each time stamp is assigned a 
weight that decreases with “age” so that older records contribute less than more recent 
records. In the Sliding Window model, the data are mined by sliding a "window" through 
the temporal dimension. A similar categorization may be adopted with respect to 
temporal pattern mining. 
 
Kohavi et al. (2002) defined trend-mining techniques to extract trends from time-
stamped data collections, and Nohuddin et al. (2012) used SOM to identify trends using 
cattle-movement data. Other related work by Streibel (2008) used quantitative numeric 
financial data, and qualitative text corpi data extracted from business news articles, to 
forecast financial market trends. Google provides Google Trends, a public web facility 
that supports the identification of trends associated with keyword search volume. Raza 
and Liyanage (2008) introduced a trend-analysis approach to mine and monitor data for 
abnormalities and faults in industrial production processes. 
 
The major difference of the proposed trend mining algorithm is that it examines any 
number of datasets, and the identities that determine the trends must be valid across all 
datasets. 
2.11 Validation and verification 
 
Verifying and validating a system are very important processes in the development of a 
knowledge-based system. Verification tests examine whether the system is built 
correctly. Thus, verification examines the internal procedures and that is why here it is 
called “internal”. Validation tests are aimed at building the right system, and so 
validation needs to ensure that the system produces the right output. 
 
Verification was defined by Branstad and Cherniavsky (1982) as "the demonstration of 
the consistency, completeness and correctness of the software". 
 
O’Leary (1993) presented a review of case-based systems and concluded that the 
validation of each system has used the comparison of the system with human experts or 
machine learning. Murrel and Plant (1997) examined 33 tools of validation and 
verification with 145 testing techniques, and these techniques were categorized into 
three categories: requirements/design methods, static testing, and dynamic testing.  
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O’Keele and Preece (1996) noted that the verification of a system can be achieved using 
three measures: conflict, redundancy, and deficiency. Conflict refers to the ability of the 
system to arrive at logically inconsistent conclusions from consistent input; redundancy 
refers to the presence within the system of logically unnecessary structures that never 
affect the relationship between the input and output of the system; and deficiency refers 
to the absence of structures that should be present, logically, for the system to arrive at 
conclusions for all valid input cases. They worked on verifying their system attempting to 
detect anomalies. Thus, an anomaly could indicate any of the above measures. Anomaly 
detection is focused on the usage of rules. In terms of validation, O’Keele and Preece 
presented a list of methods used for calibration of knowledge-based systems (rules, 
heuristic, case testing) and also suggested that a strategy should be implemented for 
validation and verification of a knowledge-based system. They suggested the following 
guidelines for the development of a strategy:  choice and specification of the criteria of validation and verification;  development of a list of methods for validation and verification;  mapping of validation and verification methods into the life cycle of the 
system. 
Liu et al. (2010) presented a comparison of 11 validation measures for five clustering 
aspects: monotonicity, noise, density, subclusters, and skewed distribution. They defined 
internal validation as the process that relies on information in data, and external 
validation as the process based on external information not contained in data. External 
validation measures know the “true” cluster number in advance, so they are mainly used 
to choose an optimal clustering algorithm on a specific data set. On the other hand, 
internal validation measures can be used to choose the best clustering algorithm as well 
as the optimal cluster number without any additional information. 
 
Theodoridis and Koutroubas (1999) identified three approaches to validate clustering 
results. The first approach is based on external criteria. This implies that we evaluate the 
results of a clustering algorithm based on a pre-specified structure, which is imposed on 
a data set and reflects our intuition about the clustering structure of the data set. The 
second approach is based on internal criteria. We may evaluate the results of a 
clustering algorithm in terms of quantities that involve the vectors of the data set 
themselves (e.g. proximity matrix). The third approach of clustering validity is based on 
relative criteria. Here, the basic idea is to evaluate a clustering structure by comparing it 
with other clustering schemes, resulting in the same algorithm but with different 
parameter values. 
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There are existing examples of DM process models that incorporate the notion of 
validation, such as CRISP-DM, but these tend to be very general models and do not 
relate to a specific framework. The central idea of validation in the DM community is one 
of checking the results by “cross-validation”, where the data are split into a training set 
and a testing set, and the results of the data mining applied to the testing set are 
compared with the training set. This kind of statistical validation, of course, is not 
possible when the goal of the system is to discover trends. In this case, a more 
application-specific method has to be adopted, so the following strategy has been 
developed here for the verification and validation of the trend-mining framework:  At the beginning and end of the constituent processes, a language for a 
set of declarative validation rules will be established, and a systematic 
process of validation of each set of input data will be created.  At the end of the DM pipeline, a process for testing for known associations 
(the expected outputs) will be created. This involves using invariants and 
characteristics of the data to prune and/or synthesize output rules to fit 
the associations being sought. 
 
2.12 Conclusion 
 
An overview of various aspects of DM has been presented in this chapter. ARM plays a 
vital role in the trend-mining framework, which is presented in this research. The matrix 
algorithm was selected, owing to its ability to scan a dataset only once, which is very 
important when a large number of time stamps are present. The trend-mining definition 
has been given in order to clarify the term trend, and the strategy of the validation has 
been given, as it is crucial to prove that the framework has been built appropriately and 
provides the right output.
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Chapter 3 Medical Overview and Data Description  
 
3.1 Introduction 
 
In the UK, about 3,000,000 people are diabetic and one third of them have signs of 
diabetic retinopathy. This disease has many side effects, such as a higher risk of eye 
disease, a higher risk of kidney failure, and other complications. However, early 
detection of the disease and proper care management can make a difference. To combat 
this disease, a national scheme in England introduced a regular screening programme for 
diabetic patients. The application domain, with respect to this study, is diabetic data. 
 
Patient information, clinical symptoms, eye-disease diagnosis, and treatments are 
routinely recorded in these databases, and medical longitudinal data are used to plot the 
progress of a medical condition and implicitly provide information about various trends. 
After 20 years of data collection from the diabetic-retinopathy (DR) screening process, a 
wealth of information has been gathered, and this naturally this has led to the 
application of knowledge-discovery and data-mining techniques to discover interesting 
patterns in the data. 
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DR is the most common cause of blindness in working-age people in the UK. It is a 
chronic multifactorial disease affecting patients with diabetes mellitus and causes 
damage to the retina. About 750,000 are registered blind or partially sighted in the UK, 
and the remainder are at risk of blindness. 
 
 
The RLUH screening programme currently deals with some 17,000 people with diabetes 
registered with GP1  within the Liverpool Primary Care Trust2 per year. Consequently, a 
substantial amount of data is available for analysis, and further details on the data 
collection are presented in the next subsection. 
 
The objective is to find rules that can be used by medical doctors to improve their daily 
tasks, that is, to understand more about diabetes or to discover something special about 
the treatment, patient management, and also to stop the progress of DR. Although 
knowledge discovery in databases has reportedly been very successful in domains such 
                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 In the UK GP stands for "General Practitioner", essentially a family doctor 
2 Primary Care Trusts are organizational units established to manage local health 
services in the UK. 
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as fraud detection, targeted marketing, etc., we found in comparison that there have 
been relatively few applications of data-mining techniques to the health sector. This is 
important for two reasons. First, the data obtained by health clinics are typically very 
noisy. Many of the patient records contain typographical errors, missing values, or 
incorrect data on details such as street names date of birth, etc.; worse, many records 
are in fact duplicate records. Cleaning these data takes a tremendous amount of effort 
and time. In addition, many of the data collected are not in the forms that are suitable 
for data mining. They need to be transformed to more meaningful attributes before 
mining can proceed. Second, health doctors are usually too busy to see patients every 
day, and medics cannot afford the time or energy to sieve through the thousands of 
rules generated by state-of-the-art mining techniques in the diabetic patient database. 
Thus, it is important to present the discovered rules in an easy-to-understand way for 
interpretation. 
 
These concerns are addressed in the validation chapter. To overcome the problem of 
noisy data, a semi-automatic data-cleaning system based on logic rules has been 
developed. The system reconciles database format differences by allowing doctors to 
specify the mapping between attributes in different format styles and in the encoding 
schemes used. To resolve the problem of too many rules being generated by the state-
of-the-art mining techniques, a user-orientated approach is applied to provide a step-by-
step exploration of the data to better understand the discovered patterns. 
 
3.2 Diabetes overview  
 
Diabetes mellitus is the most common metabolic disease worldwide. Quality and 
Outcomes Framework data suggest that there are 1,766,391 patients registered as 
diabetic in England, a prevalence of 3.55%. DR is a frequent complication of both types 
of diabetes and represents the most common cause of blind registration in the working-
age population in the Western world (Harding S.P., Broadband B.D., 2009). 
 
Diabetes is a chronic disease that occurs either when the pancreas does not produce 
enough insulin or when the body cannot effectively use the insulin it produces. Insulin is 
a hormone that regulates blood sugar. Hyperglycaemia, or raised blood sugar, is a 
common effect of uncontrolled diabetes and over time leads to serious damage to many 
of the body's systems, especially the nerves and blood vessels. Worldwide, 347 million 
people have diabetes. In 2004, an estimated 3.4 million people died from consequences 
of fasting high blood sugar. A similar number of deaths has been estimated for 2010. 
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More than 80% of diabetes deaths occur in low- and middle-income countries (WHO, 
2013). 
 
Type 1 diabetes (previously known as insulin-dependent, juvenile, or childhood-onset 
diabetes) is characterized by deficient insulin production and requires daily 
administration of insulin. The cause of type 1 diabetes is not known, and it is not 
preventable with current knowledge. Symptoms include excessive excretion of urine, 
thirst, constant hunger, weight loss, vision changes, and fatigue. These symptoms may 
occur suddenly. 
 
Type 2 diabetes (formerly non-insulin-dependent or adult-onset diabetes) results from 
the body’s ineffective use of insulin. Type 2 diabetes comprises 90% of people with 
diabetes around the world (World Health Organization, 2011) and is primarily the result 
of excess body weight and physical inactivity. Symptoms may be similar to those of type 
1 diabetes, but are often less marked, and so the disease may be diagnosed several 
years after the onset, once complications have already arisen. Until recently, this type of 
diabetes was seen only in adults, but it is now also occurring in children. 
The most common effects of diabetes are as follows: 
Over time, diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves. 
Diabetes increases the risk of heart disease and stroke: 50% of people with diabetes die 
of cardiovascular disease (primarily heart disease and stroke) (Morrish et al., 2001) 
Combined with reduced blood flow, neuropathy (nerve damage) in the feet increases the 
chance of foot ulcers, infection, and eventual need for limb amputation. 
Diabetes is among the leading causes of kidney failure (World Health Organization, 
2011). 
The overall risk of dying among people with diabetes is at least double the risk of their 
peers without diabetes (Roglic, et al.,2005) 
The DR focused on in this study is an important cause of blindness, occurring as a result 
of long-term accumulated damage to the small blood vessels in the retina. One per cent 
of blindness globally can be attributed to diabetes (World Health Organization, 2012). 
3.3 Diabetic Retinopathy overview 
 
DR is the leading cause of blindness in people of working age in industrialized countries 
and accounts for 1.8 million of the 37 million cases of blindness throughout the world. 
The total number of people with diabetes is projected to rise from 285 million in 2010 to 
439 million in 2030. DR is a chronic multi-factorial disease affecting patients with 
diabetes mellitus and causes damage to the retina (Stangos, 2009). Patients with 
diabetes are more likely to develop eye problems such as cataracts and glaucoma, but 
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the disease’s effect on the retina is the main threat to vision. It occurs when high blood 
sugar damages small blood vessels at the back of the eye, called the retina. All people 
with diabetes are at risk from this disease. There are things that can be done to reduce 
one’s risk and prevent or slow vision loss. DR can affect both eyes, and there may not be 
any signs at first. As the condition worsens, blood vessels weaken and leak blood and 
fluid. As new blood vessels grow, they also leak, causing blocks in vision. 
 
 
                                               Figure 3.1: Circulatory system of the retina 
Over time, diabetes affects the circulatory system of the retina. The earliest phase of the 
disease is known as background DR. In this phase, the arteries in the retina become 
weakened and leak, forming small, dot-like hemorrhages. These leaking vessels often 
lead to swelling, or oedema, in the retina and decreased vision (Figure 3.1). The next 
stage is known as proliferative DR. In this stage, circulation problems cause areas of the 
retina to become oxygen-deprived or ischemic. New, fragile vessels develop as the 
circulatory system attempts to maintain adequate oxygen levels within the retina. This 
process is called neovascularization. Unfortunately, these delicate vessels hemorrhage 
easily, and blood may leak into the retina and vitreous, causing spots or floaters, along 
with decreased vision. In the later phases of the disease, continued abnormal vessel 
growth and scar tissue may cause serious problems such as retinal detachment and 
glaucoma. 
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                                               Figure 3.2 :Mechanism of DR development 
The effect of DR on vision varies widely, depending on the stage of the disease (Figure 
3.2). Some of the common symptoms of DR are listed below, but diabetes may cause 
other eye symptoms such as blurred vision (this is often linked to blood sugar level, 
floaters, flashes, and sudden loss of vision).Diabetic patients require routine eye 
examinations so that related eye problems can be detected and treated as early as 
possible. Most diabetic patients are frequently examined by an internist or 
endocrinologist, who in turn works closely with the ophthalmologist. The diagnosis of DR 
is made following a detailed examination of the retina with an ophthalmoscope, and the 
prognosis for visual recovery is dependent on the severity of the detachment. 
Researchers have found that diabetic patients who are able to maintain appropriate 
blood sugar levels have fewer eye problems than those with poor control. Diet and 
exercise also play important roles in the overall health of those with diabetes. 
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Figure 3.3: Photograph of a normal eye   Figure 3.4 : Photograph of a DR eye  
Diabetic macular oedema is the leading cause of legal blindness in diabetics and can be 
present at any stage of the disease but is more common in patients with proliferative DR 
(Figures 3.3 and 3.4) 
3.4 Epidemiology 
 
The best predictor of DR is the duration of the disease. After 20 years of diabetes, nearly 
99% of patients with type 1 diabetes and 60% with type 2 have some stage of DR, and 
33% of patients with diabetes have signs of DR. People with diabetes are 25 times more 
likely to become blind than the general population (Yanoff and Duker, 2008). 
 
Some important points in Research strategy for Diabetes:  Diabetes occurs in men, women, the young and old and in all races. No 
group is spared.  There is no known cure for diabetes and available treatments have limited 
success in controlling the devastating consequences of the condition.  Diabetes affects 5 per cent of the world’s population and its prevalence is 
doubling every generation.  The International Diabetes Federation estimates that in 2005 around 333 
million1 people in the world aged 20–79 had diabetes.  More than two million people in the UK have been diagnosed with 
diabetes. This number is predicted to reach three million by 2010. 
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 It is estimated that around another 750,000 people in the UK have 
diabetes but do not know they have it.  There are over 250,000 people in the UK with Type 1 diabetes. This is 
caused by an absolute lack of the hormone insulin, resulting from 
autoimmune destruction of the body’s pancreatic islet beta cells.  Around 1.8 million people have Type 2 diabetes, 2, 3 representing about 
90 per cent of diabetes cases. Type 2diabetes is due to varying 
combinations of insulin deficiency and insulin resistance.  The incidence of Type 1 diabetes in children is rising at a rate of 3–4 per 
cent a year. 4 We do not know why.  The increase in Type 2 diabetes is closely linked to an aging population 
and rapidly rising numbers of obese or overweight people.  Diabetes is the leading cause of kidney failure, blindness in adults, and 
amputations. It can lead to impotence, can affect mental health and 
wellbeing, and is a major risk factor for heart disease, stroke and birth 
defects.  On average, life expectancy is reduced by 20 years in people with Type 1 
diabetes and by 10 years in people with Type 2 diabetes. In the next 10 
years there will be a 25 per cent increase in the number of diabetes-
related deaths.  The clinical supervision and care of people with diabetes currently 
consumes 5 per cent of the NHS budget (about £10 million a day) and 10 
per cent of hospital in-patient resources. The NHS spend on diabetes will 
rise to around 10 per cent of the NHS budget by 2011.  Various national plans outlining the standards of care that should be 
expected by people with diabetes exists but its full implementation across 
the NHS has yet to be achieved.  People with diabetes (or their carers) are responsible for the day-to-day 
management of their condition.  
3.5 Symptoms 
 
DR is asymptomatic in the early stages of the disease, but as the disease progresses, 
the symptoms may include: blurred vision, floaters, fluctuating vision, distorted vision, 
dark areas in the vision, poor night vision, impaired color vision, and partial or total loss 
of vision. Known risk factors include: duration of diabetes, poor blood sugar control, HTN 
and hyperlipidaemia. The effect of intensive diabetes treatment on the progression of DR 
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in insulin-dependent diabetes mellitus reduced the risk of developing retinopathy by 
76% and slowed the progression of retinopathy by 54%. 
 
3.6 Data collection and pre-processing 
 
The ophthalmologist is in a unique position to collect information on sight loss. Without 
the collection and analysis of this type of data, it is not possible to understand the 
changing epidemiology of DR as well as other important conditions leading to sight loss 
and blindness. Collection of outcome data is essential for a screening programme to:  undertake audit to ensure that systems are working effectively;  demonstrate cost-effectiveness of screening as an intervention;  understand inequalities in access to services;  use the information to improve services for the future. 
The Royal Liverpool University Hospital (RLUH) has been a major centre for retinopathy 
research since 1991. Retinopathy is a generic term used to describe damage to the 
retina of the eye which can, in the long term, lead to visual loss. Retinopathy can result 
from a number of causes, for example: diabetes, age- related macular degeneration 
(AMD), high blood pressure and various genetic conditions. In diabetes the retinopathy 
progresses over a number of years through well characterized stages. Treatment 
comprises the application of laser to the retina and is most effective during the stages 
before vision is affected. Screening Programmes for people with diabetes have recently 
been established in all four UK nations to detect retinopathy and refer for prompt 
treatment.  
RLUH has collected a substantial amount of data over a considerable period of time as 
part of its diabetic retinopathy research and screening programme. 
Screening takes place within the community and is conducted by technicians who 
perform photography and record data images on “lap-tops" which are then down-loaded 
(typically) at the end of each day. Retinal images are graded at a central grading facility 
at a separate time within a few weeks with results recorded onto a database. If disease 
is detected on the retinal photographs worse than a predetermined level or if 
photographs are upgradable or unobtainable then patients are invited to a dedicated 
hospital outpatient clinic for further examination by an ophthalmologist using more 
specialized slit lamp biomicroscopy (A high intensity light source instrument to facilitate 
examination of the human eye). Data on retinal findings are entered into the database. 
This clinical assessment can occur several months after the initial photographic 
screening. 
 Four types of data associated with a single screening sequence are collected: 
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1. General demographic data. 
2. Data on visual acuity (clarity of vision). 
3. Data from grading of retinal images. 
4. Data from biomicroscopy of the retina. 
The full screening sequence is referred to as a “screening episode". 
People with diabetes are usually screened once a year with the option to rescreen early 
(typically 6 months) depending on presence of intermediate levels of disease indicating 
greater risk of progression. The RLUH screening programme currently deals with some 
17,000 people with diabetes registered with general practices within Liverpool Primary 
Care Trust per year. Overall details of some 20,000 patients have been recorded. 
Consequently a substantial amount of data is available for analysis. Some further details 
of the data collection are presented in the following sub-section. 
 
3.6.1 Diabetic retinopathy Databases 
 
Longitudinal data is data that is repeatedly sampled and collected over a period of time 
with respect to some set of subjects. Typically values for the same set of attributes are 
collected at each sample points. The sample points are not necessarily evenly spaced. 
Similarly the data collection process for each subject need not necessarily be 
commenced at the same time. A regular longitudinal data set is one where data at each 
sample point is collected simultaneously for all subjects. Most longitudinal data sets are 
not regular. The most common example of irregular longitudinal data sets are patient 
medical records where patients enter and leave the “system” continuously and data is 
collected during consultations which occur at irregular intervals (episodes/time stamps). 
One example of an irregular longitudinal database, and the focus of the research 
described here, is the Diabetic Retinopathy screening dataset maintained by The Royal 
Liverpool University Hospital (RLUH). 
Longitudinal data thus provides a record of the “progress” of some set of features 
associated with the subjects. Medical longitudinal data, such as the Diabetic Retinopathy 
data, typical plots the progress of some medical condition.  
St Paul’s Eye Unit is a major referral centre for patients with diabetic retinopathy. 
Recruitment will be run from established NHS services and referrals. 
Baseline screening takes place in diabetic retinopathy assessment clinic, medical retina 
clinic and general ophthalmology clinic of St. Paul’s Eye Unit at Royal Liverpool University 
Hospital. Data are collected and stored on the encrypted disk in accordance with Data 
Protection Act and Caldicott guidelines. 
The data which are collected for a warehouse with 22,000 patients, 150,000 episodes, at 
least 1200 values of attributes, include demographic details, visual acuity data, 
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photographic grading results, data from biomicroscopy of the retina and results from 
biochemistry investigations. One challenging task is the application of logic rules either 
to address the missing value problem or to retrieve knowledge from existing information.  
One of the major challenge of the work described, is that the data collection is extremely 
large and complex; comprising about 450 attributes (of various types: categorical, 
quantitative, text, etc.), distributed over two databases each composed of a number of 
datasets. Another challenge represented by the data, was that unlike more standard 
longitudinal data sets, there was no clear association between specific time stamps and 
subsets of the data. The data warehousing process established to prepare the data for 
mining is therefore also described. 
The datasets, contained in the RLUH database and used to construct the warehouse in 
this research work, are: 
1. Patient Details. Table containing background information regarding individual patients.  
2. General. Demographic patient details and visual acuity data. 
3. Photodetails. Results from the photographic grading. 
4. Biomicroscopy. Results from the slit lamp biomicroscopy in cases where this has been 
conducted. 
5. Risk Factors. Results from blood pressure and biochemistry investigations known to be 
associated with an increased risk of progression of retinopathy. 
 
The Diab database contains paper work and film photos from 1991 – 2005. This 
database consists of several datasets:  TbDiabEyePatient (8437×17)  Dead (Yes or No)  Sex (M or F)  Age (number)  Personal Details  tbDiabRetinPhotDetails (63110×141)  Examination Details for both eyes. The vast majority of the columns are 
numerical data. There are few columns with string data.  tbDiabRetinBiomicDetails (15070×171)  Details of exam date,grading for both eyes. Both string and numerical 
data.  tbEyeGeneral (62875×52)  Age of exam, eye conditions (cataract, glaucoma, family history glaucoma, 
weak/lazy eye etc). Both string and numerical data. 
The RAD is the risk assessment database. It consists of two tables: one contains the risk 
factors and the other demographic data. The risk factors table contains medical 
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information regarding the patient e.g. diastolic pressure, systolic pressure, range 
random cholesterol, urea, creatine etc. The table with the demographic data contains 
personal details of the patients and details of diabetes (type, year of diagnosis, diabetes 
carer)  All databases contain both numerical and string values. Also, all of them 
have missing values.  Some medical characteristics have numerical values. The following 
schemas show the maximum and the minimum values that these 
characteristics can take (Appendix 1).  
Data collected from the diabetic retinopathy screening process described above is stored 
in a number of databases. The structure (tables) of Diab database reflects the 
mechanism whereby patients are processed and includes historical changes in the 
process. Screening commenced in 1991 when data was recorded in a bespoke database 
system called Epi-Info. The number of records in the Epi-Info database is small and for 
this reason it is not considered appropriate with respect to the intended temporal pattern 
mining study described here. Epi-Info was replaced with a more sophisticated system, 
Diab, in 1991, which describes the data used in this study. Diab, in turn, was replaced 
with a national database system, Orion, in 2005. The design and implementation of 
Orion does not lend itself to simple extraction of data for temporal pattern mining 
purposes and thus the data contained in this latest database system also does not form 
part of the current study. Thus the study described here deals with data collected from 
1995 to 2005. 
The RLUH, as opposed to the screening programme, also maintains a clinical 
investigations database called Ice. This database includes information about biochemical  
“risk factors" that are known to be associated with progression of diabetic retinopathy. 
Not all patients included in the screening programme have records on ICE. The screening 
programme has its own Risk Factors database, maintained by the programme team, 
containing data mostly extracted from ICE. 
 An additional complication was that the data, in common with similar patient datasets, 
was very noisy in that it contained much missing and anomalous data. 
This issue was addressed by defining a set of logic rules. In the context of missing data 
the logic rules were used to derive appropriate values. In the case of anomalous data, 
the logic rules were used to derive additional attributes to formulate consensus values. 
   The nature of the longitudinal data is of interest because it does not fit into any 
standard categorization of such data, in that the “time stamp” used is the sequential 
patient consultation event number. The duration between consultations is also variable. 
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3.6.2 Data warehousing and cleaning 
 
For the study described in this thesis, before any investigation of trend mining could 
commence the five database tables identified in the above subsection (Patient, General, 
Photodetails, Biomicroscopy and Risk factors) were combined into a single warehouse 
(i.e. a static data repository specifically intended for the application data mining and 
data analysis tools). The creation of the data warehouse required data anonymization 
and data cleaning. 
The anonymisation of the data tables was initiated by removing patient names. Although 
this was straightforward, this presented a second problem as in many cases the patient 
name was the common "key" linking database tables. 
An obvious candidate for a universal common key was patient NHS (National Health 
Service) numbers; however this was missing with respect to some 8000 records and 
consequently had to be added manually. The NHS number was then used for the 
construction of the data warehouse; on completion the NHS number was replaced by a 
sequential record number so that individual records could not be traced back to 
individual patients. 
The next step after anonymisation was data cleaning. There were three principal issues 
to be addressed: 
1. Missing values 
2. Contradictory values (conflict) 
3. Duplicate records 
The first two issues were addressed by developing a set of logic rules.  
The problem of missing attribute values is well established in the context of data mining. 
In any large database, we encounter a problem of missing values. A missing value may 
have been accidentally not entered, or purposely not obtained for technical, economic, 
or ethical reasons. 
The missing value problem is widely encountered in medical databases, since most 
medical data are collected as a by-product of patient-care activities, rather than for 
organized research protocols, where exhaustive data collection can be enforced. In the 
emerging federal paradigm of minimal risk investigations, there is preference for data 
mining solely from by-product data. Thus, in a large medical database, almost every 
patient-record is lacking values for some feature, and almost every feature is lacking 
values for some patient-record. 
 
One approach to address this problem is to substitute missing values with most likely 
values; another approach is to replace the missing value with all possible values for that 
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attribute. Still another approach is intermediate: specify a likely range of values, instead 
of only one most likely. The difficulty is how to specify the range in an unbiased manner. 
The generally agreed view is that removing records with missing data is the least 
favoured option as this may introduce bias. The reduction of the overall data set size, by 
removing records that contain missing values, is not considered to be critical. There is 
significant scientific work to support this view. Approaches to the imputation of missing 
values have been extensively researched from a statistical perspective (Kalton, 
Kasprzyk,1986),(Little, Rubin, 2002)( Mumoz, Rueda,2009) .Example imputation 
methods include: nearest neighbour imputation, mean imputation, ratio imputation and 
regression imputation.  
 
The approach to missing data advocated in this study is to define and implement a set of 
logical rules to address the missing value problem; this is discussed further in the 
following section, 3.6.3. 
In this study we define 2 different types of missing data: the data that is not entered 
because there is no meaning in some cases (not applicable) and the data that is 
accidentally not entered (not recordable). 
With respect to missing values the evidence of such a missing value could be interpreted 
in three ways:  The value was either unknown or mistakenly omitted at time of collection.  The missing value indicated a negative response to a question suggested 
by the field.  The clinician considered the field to be inapplicable for the given case.  
For example some attributes indicated responses to question such as “does the patient 
have one weak eye", to which, in many cases, the clinician had inserted a “yes" if the 
answer to the question was an affirmative and left the field blank otherwise (the latter 
can thus be interpreted as either a "no", or a "don't know". 
 A set of “if . . . then . . . “logical rules were therefore developed to address this issue.  
The logic rules were written in such a way that they could also be used for data 
validation purposes. The operation of these rules is best illustrated using some examples 
(See Appendix 1 for all rules).  
Consider the field SeeGPRegulary featured in the Diab General dataset. 
This field can have three possible values: 1 ("No"), 2 ("Yes") and 9 ("Don't know"). 
 In the event of a missing value for this field it can be derived from another field, in the 
set of database tables, LastSeeGP; asking when the patient last saw their GP for 
anything.  
The LastSeeGP field can have the following values:   1 ("Within last 6 months") 
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 2 ("Within last 6 to 12 months")  3 ("More than a year ago")   9 ("Don't know") 
The logic rule is then as shown below (the null value indicates a missing field). The rule 
states that if the value for SeeGPRegulary is missing and the value for LastSeeGP is also 
missing, or set to 9 ("Don't know"), we set the value for SeeGPRegulary to 9. If the 
patient has seen their GP with the last 12 months (LastSeeGP field set to 1 or 2) we set 
the value for SeeGPRegulary to 9 ("Yes"). 
 Otherwise we set the value of SeeGPRegulary to 1:  if (SeeGPRegulary == null)   if (LastSeeGP == 9) or (LastSeeGP == null) then (SeeGPRegulary = 9)  if (LastSeeGP == 1) or (LastSeeGP == 2) then (SeeGPRegulary = 2)  if (LastSeeGP == 3) then (SeeGPRegulary = 1) 
With respect to contradictory/anomalous values this issue can be exemplified by the 
diAgeDiag field, the age of the patient when diabetes was first diagnosed. Within the 
application domain this has been recognised as a question patients find very difficult to 
answer, and consequently clinicians responsible for gathering data often leave this field 
blank if they feel that a patient is unable to give a definitive answer. In addition it was 
found that patients may give a different answer over different consultations, hence it 
was believed to get less accurate with the passing of time. The rule adopted in this case 
was to take the first recorded value of the field as this was likely to be the most 
accurate. 
 
3.6.3 Issues and challenges of medical data 
 
The field of medical informatics has evolved around structuring, processing, storing and 
transmitting medical information for a variety of purposes (Shortliffe, 1990). One such 
purposes is to develop decision-support systems that enhance the clinician’s ability to 
diagnose, treat and assess prognoses of pathological conditions. Even if disease 
processes were fully understood, population variability would still make individualised 
diagnosis, treatment and prognosis, all essential parts of good health care, difficult 
classification tasks. The reality is, however, that diseases are not fully understood, nor is 
population variability fully taken into account in many decision-making situations. 
Sometimes it is not possible for a clinician to employ the principles learned in the basic 
and clinical sciences to determine whether a patient has a given disease, whether the 
patient should be given a certain treatment or how long the patient will survive. 
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Medical informatics has been an important area for the application of computing and 
database technology for at least four decades and this thesis presents a number of new 
research challenges in this area. These include the need for complex-data modelling 
features, advanced temporal support, advanced classification structures, continuously 
valued data, dimensionally reduced data and the integration of very complex data. In 
addition, the support for clinical treatment protocols and medical research is an 
interesting area for research. 
It is extremely important to have a good understanding of the data when embarking on 
a data mining project and this is facilitated by considering the following questions:  What data is available?  What available data is actually relevant or useful?  Can the data be enriched from other sources?  Are there historical datasets available?  Who is the real expert on the data to whom questions can be addressed?  Are the results at all sensible?   
Cios et al. (2002) refer to a number of important issues and challenges that were also 
encountered in the work of this thesis, and which will now be described. 
Medical datasets often contain insignificant, redundant or inconsistent data objects or 
attributes that present a number of issues and challenges such as:  Dimensionality reduction. The large volume and heterogeneity of medical 
databases makes it unlikely that any data-mining tool can succeed with 
raw data (Cios and Moore, 2000). The tools may require that a sample is 
extracted from the database in the hope that results obtained in this 
manner are representative of the entire database. Dimensionality 
reduction can be achieved in two ways:   Updating. Medical databases are constantly updated by, say, adding 
records (for an existing or new patient), or by replacement of the existing 
records. This requires methods that are able to incrementally update the 
knowledge learned so far.   Missing values. The medical information collected in a database is often 
incomplete and it is very difficult to avoid the problem of missing values. 
This happens either because some values were accidentally not entered or 
not obtained for technical or ethical reasons. Sometimes the patients 
themselves are unsure of the answers to some of the questions they are 
asked. Therefore, databases typically contain significant levels of noise. 
For data mining purposes it is important to eliminate this noise in order to 
achieve accuracy in the results. There are several ways to address the 
problem of missing values. For example, it might be possible to substitute 
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missing values with the most likely values; another approach is to replace 
the missing value with all possible values (Cios et al., 1998). Another 
approach is to use the experience of clinicians in order to create logic rules 
to replace missing values. One of the major concerns in large longitudinal 
medical datasets is how to find natural groupings (clusters); objects are 
clustered together if they are similar to one another and at the same time 
are not similar with objects from other groups. Without at least partial 
human supervision (Cios, 2001), it is easy to end up with results that do 
not make sense.  This thesis will use a variety of methods to investigate 
and treat the missing values problem: (i) to assign cell averages, (ii) to 
use the frequency distribution of every field to decide whether or not to 
include that field in the analysis, (iii) to replace empty attributes with a 
global constant value, (iv) to use logic rules based on the experience and 
human knowledge of the domain.  Data ownership. Data ownership is a topic of debate in the field of medical 
data mining. Legally, ownership is determined by who is entitled to sell a 
particular item of property (Moore and Berman, 2000). The corpus of 
human medical data potentially available for data mining is enormous, 
with thousands of terabytes being generated annually in UK.   Privacy and security of human data. Privacy and security are areas of 
concern with medical data. UK law includes guidelines for the concealment 
of individual patient identifiers. At stake is not only a potential breach of 
patient confidentiality, with the possibility of ensuing legal action, but also 
erosion of the physician–patient relationship, in which the patient is often 
candid with the physician in the expectation that such private information 
will never be made public. Under some guidelines concealment of 
identifiers must be irreversible.   While it is possible for these special requirements to be managed by 
appropriate regulatory agencies, this is not possible in the case of totally 
anonymised data. There are four forms of patient data:  Anonymous data. Data where the patient identification was removed at 
the time the data was collected. For example, a block of tissue may be 
taken from an autopsy on a patient with a certain disease to serve as a 
control tissue block in the histology laboratory. The patient’s identifiers are 
not recorded at the time of specimen collection and thus can never be 
recovered.  Anonymised data. Data that are collected initially with the patient 
identifiers, which are subsequently and irrevocably removed. That is, there 
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can never be a possibility of returning to the patient’s record and obtaining 
additional information. While this practice was common in the past, it is no 
longer used as standard since accidental duplication is possible and such 
data is thus difficult to verify for corrections or additional data.  De-identified data. Data that are collected initially with the patient-
identifiers and are subsequently encoded or encrypted.   Identified data. Fully identifiable data which can only be collected under 
significant review by the institution, federal guidelines, etc. with the 
patient giving written informed consent. 
If one employs only data that are collected as part of the ordinary diagnosis and 
treatment of patients, so that there is no change in patient management (course of 
treatment) as a result of the research, such as pressure on the patient to accept or 
refuse certain management or call-back for additional data that might upset the patient 
or next of kin, then the only risk of using such data is the loss of confidentiality to the 
patient.   Administrative issues. Emerging guidelines for patient privacy specify a 
number of administrative policies and procedures that would not ordinarily 
be required for non-medical data mining (Saul, 2000). Such policies are 
required to evaluate and certify that appropriate security measures are in 
place in the place of research. There must be legal contracts between the 
organisation and any outside parties given access to individually 
identifiable health information that require the outside parties to protect 
the data.  Security issues. There must be security training for all staff accessing 
computer-based databases, including awareness training for all personnel, 
periodic security reminders, user education concerning virus protection, 
user education in the importance of monitoring login failures, password 
management, and how to report discrepancies. These and many other 
rules impose constraints upon medical data miners that other academic 
researchers may regard as burdensome and stifling to the creativity of 
scientific research. Researchers must carefully assess the perceived need 
for information such as postcodes (which might be necessary for 
epidemiological studies), that have the potential to also render the data 
re-identifiable in combination with other information (Sweeney, 2001).  Statistical philosophy. There is an emerging doctrine that data mining 
methods themselves, especially statistical methods, and the basic 
assumptions underlying these methods, may be fundamentally different 
for medical data. Human medicine is primarily a patient-care activity and 
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has only a secondary role as a research resource. Generally, the only 
justification for collecting data in medicine, or the refusal to collect certain 
data, is to benefit the individual patient. Some patients might consent to 
be involved in research projects that do not benefit them directly, but such 
data collection is typically very small-scale, narrowly focused, and highly 
regulated by legal and ethical considerations. The major points of 
statistical philosophy in medicine may be organised under these general 
headings: 
o Ambush in statistics 
o Data mining as a superset of statistics 
o Data mining and knowledge discovery process  Importance of physician’s interpretation: The physician’s interpretation of 
images, signals or any other clinical data is normally written in 
unstructured free-text English that is very difficult to standardise and thus 
difficult to mine. Even specialists from the same discipline very often 
cannot agree on unambiguous terms to be used in describing a patient’s 
condition.  Volume and complexity of medical data: Raw medical data are voluminous 
and heterogeneous. Medical data may be collected from various sources 
including images, patient interviews and physician’s notes. All data-
elements may influence diagnosis, prognosis and treatment plan and must 
be taken into account in data mining research. 
3.7 Conclusion 
 
This chapter gives a quick overview of diabetic retinopathy and continues with the issues 
of pre-processing and post-processing (before and after rule generation) that have 
largely been ignored by the data mining research community. Yet these issues are 
critical to the success of any real-life applications to deal with these issues, we have 
proposed the use of a semi-automatic data cleaning system for cleaning the noisy data 
and an exploration mining strategy for easy understanding of the rules generated by the 
state-of-the-art data mining techniques. 
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Chapter 4 Trend-mining framework description 
 
4.1 Introduction 
 
In modern applications data from different sources that vary after some time must come 
together and be transformed into a dataset from which the user can extract knowledge. 
That kind of knowledge should show causality between the data attributes. This means 
that any discovered rule of the form     should show a relationship between the 
attributes in X and the attributes in Y. However, when the amount of data is huge the 
data must be filtered out from noise, identify frequent item sets and distinguish which of 
them are interesting or not. Moreover, when data change in time it is important to know 
how relation between attribute changes and how causality is affected. The trend mining 
framework that is proposed in this thesis forms a part of the investigation of how to deal 
with large noisy and time varying data. 
 
This chapter provides a description of the trend-mining framework, detailing all major 
steps of the framework: pre-processing, main processing association rule mining (ARM) 
and trend generation, and output production. Moreover, this chapter provides the main 
aspects of verification and validation. The fundamental idea of verification is to test 
whether the intermediate results and/or outputs of the framework are self-consistent 
and the main idea of validation is to test the outputs of the framework and also check 
the consistency of them in respect of what experts already know.  
The chapter contains the following parts: firstly it provides a generic description of the 
trend-mining framework, and continues with the aspects of verifying and validating the 
framework and finally provides a description of SOMA which is the application of trend 
mining in the area of diabetic retinopathy. 
SOMA starts with the pre-processing of data, continues with the Association Rule Mining 
algorithm, continues with the new trend generation algorithm Aretaeus, and ends with 
the (colourful) visualization of trends producing a mosaic-based representation of 
knowledge.  Pre-processing includes the preparation of time-stamped datasets through 
the application of logic rules both for the creation of time stamps and for the band 
creation of continuous variables, for the transformation of the continuous variables into 
categorical using bands: for example the age of patient is a continues variable and it’s 
become categorical using bands; so if age is between 0 and 12 the categorical value is 1, 
if age is between 12 and 20 then the categorical value is 2 and so on, as well as to 
correct errors in the datasets. The Association Rule Mining algorithm, that is described 
here, is used for the discovery of ‘interesting’ rules. The trend-mining algorithm, 
76 
 
Aretaeus, uses mathematical conditions to produce trends, based on the changes of the 
support count of an association rule and then it classifies them into groups based on how 
the support count of a rule changes in each time stamp, and finally a description of the 
concept behind the visualization technique is given.  
 
4.2 Trend mining framework 
 
As stated earlier, this section describes the trend mining framework. More specifically, it 
outlines the fundamental principles behind each element of the trend mining.
Figure 4.1: Trend mining framework representation 
 
Figure 4.1 shows the stages of trend mining framework. Data from different sources 
bring into pre-processing and they are transformed into time – stamped datasets which 
then enter the main processing stage where ARM first and trend mining algorithm 
subsequently aims to identify frequent and interesting rules and then to create trends. 
The final stage is to output the discovered knowledge. The output has two forms; one is 
text which reports analytically the trends and how their characteristics change at every 
time stamp (support, confidence, and lift) and the second form aims to represent using 
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colours how a group of objects ,which initially have the same attributes values, appear 
from one trend to another at each time stamp.  
 
4.2.1 Pre-processing  
 
Pre-processing is the first step of the framework where data from different sources come 
together. Data may have several forms, discrete, continues, numerical, text or 
combinations of these. Real data come with several problems such as missing values, 
duplicated records, values entered by mistake and so on. Another issue, which is related 
to discovery of frequent item sets at the next stage of the framework, is how to treat 
continuous values. The reason is that the presence of continuous values makes it difficult 
to identify frequent item set and therefore the amount of extracted knowledge might 
become huge. The framework deals with this problem by sorting the continuous values 
into bands. Depending on the data, bands represent equal intervals or not. 
Another important function of the pre-processing stage is the application of logic rules to 
reduce noise from data and to ensure that data are consistent with the domain that they 
describe. To replace missing values several methods can be used either the averaged 
observed value or the most frequent observed value or to use the knowledge of an 
expert who for example can combine values of other attributes to determine how to 
replace the missing value. 
After the application of logic rules, sorting and cleansing, pre-processing performs the 
task of creating time stamped datasets.  Each dataset contains data under certain time 
conditions and thus all datasets show how data evolve with time. However, when there 
are data from different sources and data are not collected with the same frequency or 
when different data collection takes place on different dates then it is complicated to 
define a clear association of how to define a time stamp. The solution of this problem lies 
solely on the knowledge of the domain in order to define the time window between each 
time stamp. 
 
4.2.2 Main processing  
 
The main processing stage of the framework consists of two processes:  The association rule mining (ARM) process.  The trend generation and categorization process. 
The mechanisms behind each process are totally different and a detailed description is 
given in the following subsections. Another difference is that the ARM – process is 
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repeated for every time stamp while the trend generation and categorization takes place 
only once after all time stamped datasets have passed through the ARM – process. 
The ARM –process performs the following tasks: firstly to indentify the frequent item sets 
and create rules of the following form    . Y is the consequent of the rule and it is the 
subset that contains attribute(s) that describe a class or a transaction. X is the 
antecedent of the rule and it is a subset that contains attributes which may or not be 
related with subset Y. Then it keeps the frequent item sets and calculates characteristics 
that measure interestingness confidence, lift and confidence of the inverse rule. Thus the 
filtering process is twofold; one part is to measure frequency of existence and the other 
is to measure interestingness.  
4.2.2.1 Association rule mining 
 
The ARM process is the stage where the data are filtered by the identification of rules X-
> Y which are frequent and interesting. The support threshold and the confidence 
threshold are determined by the user of the framework and they are used in the filtering 
process. The number of occurrences of the item that contains subsets X and Y must be 
greater or equal to the support threshold. In addition, the confidence of the rule X->Y 
must be greater or equal to the confidence threshold. The threshold is chosen by the 
user depending on the amount of knowledge (number of discovered rules) the user 
wants to reveal. 
 
In large datasets time is an important factor and in this thesis where the ARM – process 
is repeated in every time stamp the mechanism of identifying frequent and interesting 
item sets must be capable to perform those tasks with the least passes through data. 
The matrix algorithm has been chosen for its ability to identify which item sets are 
frequent with one pass through of the dataset. Below, the major steps of the algorithm 
are described. 
 
The first thing that the algorithm does is to look for all the single items (attribute values) 
from all datasets. These items form I, where:  
I = {i1, i2, i3... iN}.  
 
The next step is the formation of the generating matrix G = {gij}. If M is the number of 
patients, then i = 1, 2... M and j = 1, 2... N. If D is the set of transactions, then D = {t1, 
t2, t3 ,..., tM}. In this study, the term transaction refers to each line of each time 
stamped dataset which is created from pre-processing.  Therefore, the generating matrix 
G is a M × N, where: 
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Then, using I, the algorithm produces all candidate k-item sets, using combinations of 
items in I, C. 
 
C= {{C1}, {C2}... {CN}}, 
 
Where C1 contains all candidate one-item sets, C2 contains all candidates two-item sets, 
and so on. 
Then, for each candidate item set in Ci (i=1, 2, 3... N), the vector S is produced.  
Vector S is a binary vector and has space equal to the number N. 
Let C be a candidate item set: 
1
1
2
2
3
3
,
,
,
if c C then S has only one unite element S
if c C then S has only two unite elements S
if c C then S has only three unite elements S
 
and so on. 
Then, for each candidate, c creates its feature vector from the following equation for 
every time stamp (episode): 
 

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Generally, if l=1, 2, 3, ..., N, the support of each candidate l-item set would be given by 
 

     1 ,sup({ }) int lM jj g Sc l  
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The sign <> denotes the inner product of two vectors, and the sign int[.] denotes a 
function that changes a real number into an integer, e.g. int[0.8] =0.0. 
The minimum support value MinSup works as a threshold that determines which item set 
is frequent or not. If sup({c}) is less than the MinSup, then it is assigned the value 0. 
Let SUPP  be the feature vector of a candidate item set; if the sum of the vector 
components equals zero, this means that across all datasets, this item set has support 
count less than the threshold, and so it is discarded from the model for further analysis. 
The candidate item sets whose vector SUPP  has at least one non-zero element are 
those that undergo further analysis. The next pseudo-code describes how the association 
rule mining algorithm works. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above description to can be understood the importance of the prepossessing 
stage which takes as impute heterogeneous data and transforms them into files written 
with the same manner, binary datasets. 
After the discovery of frequent item sets is completed the ARM- processes is looking for 
rules X->Y whose confidences equal or exceed the confidence threshold. However, unlike 
1. Set E to the total number of time stamps 
2. Set P to the number of objects 
3. Set I to the number of all 1-item sets 
4. Set C to the number of all candidates 
5. For k=1 to E 
6. Set G
k
 to the matrix algorithm for time stamp k  
7. For kk=1 to C 
8. For ii=1 to P 
9.  
 ( ,:),
sup sup int
k lG i S kk
l
        
10. End 
1. For kk=1 to C 
2. If sum { SUPP (kk, :)} = 0 
3. discard 
4. Else 
5. Keep 
6. End 
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some Apriori algorithms the ARM process here knows from the user which subset of 
items forms the left hand side of the rule X and which subset of items forms the right 
hand side of the rule Y.  
The next step is to keep the rules that have satisfied both the support and confidence 
threshold, and calculate supplementary measures of interestingness, lift and the 
confidence of the inverse rule to avoid any misleading conclusion from the sole use of 
confidence. 
After, repeating the procedure above for all time stamps the next step is to create 
vectors for each rule. The element of each vector is the support value of the rule for 
every time stamp, so the first element is the support at the first time stamp, the second 
element is the support value at the second time stamp and so on. In the case where a 
rule X->Y does not satisfy the support threshold condition in some time stamps then its 
vector has zero elements at those time stamps. Those vectors are the input of the 
second part of the main process, the trend mining algorithm. 
The matrix algorithm principles were taken from the work of Yuan and Huang (2005). 
For the need of this research work a script has been created to be incorporated with the 
pre-processing and trend generation scripts. The reason for that was to have a script 
with the least interaction from the user . During the pre-processing stage the algorithm 
uses an internal language in order to recognise the attributes and their values. So it was 
decided to write a novel script for matrix algorithm which will be able to understand the 
pre-processing. The whole script was created in MATLAB. 
 
4.2.2.2 Trend mining  
 
Trend mining is implemented using mathematical prototypes on the vectors of support in 
order to show how the support for each rule changes at every time stamp and thus helps 
the visualization tool to identify how the changes on the support may be linked or not 
with changes to the values of attributes either at the left or the right hand side of the 
rule. 
The following categories of trend have been identified:  Increasing: the support increases with every time stamp, and the growth 
rate is greater than or equal to the growth rate threshold GR, which is 
defined as: Let I be a frequent item set in D1, D2, …, Dn with support S1, 
S2, ..., Sn, where n is the number of timestamps; the growth rate GR is 
then:     
 
1
1
1
1
n
i i
i i
S SGR
S
 

 
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 Decreasing: the support decreases at each time stamp but never becomes 
0.  Constant: the support either remains constant or does not change above 
or below a tolerance threshold.  Jumping: initially, the support is zero, at some point becomes non-zero, 
and then remains non-zero.  Disappearing: the support from non-zero becomes zero and stays zero for 
the rest of the time stamp.  Fluctuating: the support changes without falling into any of the other 
classes, described above.  
 
 
The table below describes how, mathematically, the trends are categorized: 
 
Table 4.1: Mathematical conditions for trend categorization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type Mathematical conditions 
Increasing 1 1, [1, 1]i
i
S i n
S
    
, GR>ρ 
Decreasing 1 1, [1, 1]i
i
S i n
S
    
 
Constant 1 1 , [1, 1]i
i
S k i n
S
     
, k : tolerance threshold 
Fluctuating 11
11
11
11 1
1 , [1, 1] 1, [1, 1] ,
1 , [1, 1] 1, [1, 1] ,
1, [1, 1] 1, [1, 1] ,
1, [1, 1] 1, [1, 1] , 1 ,
ji
i j
ji
i j
ji
i j
ji l
i j l
SS k i n and i n j i
S S
SS k i n and i n j i
S S
SS i n and i n j i
S S
SS Si n and i n j i and k l
S S S



 
         
         
        
            [1, 1] ,n l j l i   
 
Jumping : 0, [1, ] 0 [ 1, ]i ifor m n S i m and S i m n         
Disappearing : 0, [1, ] 0 [ 1, ]i ifor m n S i m and S i m n         
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4.2.3 Representation of the trends 
 
The last task of representation is to output the discovered knowledge, and this is 
achieved in two ways. One way is the generation of a text output where the outcome is 
recorded as the name of the rule and what the values of certain parameters are for 
every time stamp. These parameters are support, confidence, lift, and the criteria of 
interestingness measures, described in an earlier chapter. 
 
Another way is the creation of a colourful representation by creating groups of objects. 
The idea behind this type of representation is as follows. At the first time stamp, each 
trend’s objects represent a different group of objects. Therefore each group of objects 
consist of objects that have the same values of attributes at the first time stamp. Each 
group is allocated a unique colour. At the next time stamps, the number of objects of 
each of the initial groups present at each time stamp is examined. For example, if, 
initially, there are g different object groups {G1, G2, G3 ... Gg}, and each has the 
following number of objects {N1, N2, N3 ... Ng}, let us assume that for a rule at the M
th 
time stamp, there are K objects. Then, if any of the groups is a subset of K, the Mth 
square is filled with as many colours as there are numbers of different groups that are 
subsets. The percentage of each group is coloured with the colour of that group. For 
example, if K consists of objects of the groups G1 and G2, then the square is filled with 
the colours of groups G1 and as  
      and     , where L is the length of the square. 
With this allocation technique, colours initially for the group of patients, the user is able 
to see how objects are moving through rules in every time stamp. 
 
4.3 SOMA: An application of trend mining in diabetic 
retinopathy 
 
SOMA is the framework for the application of trend mining in the field of diabetic 
retinopathy. Diabetic retinopathy screening data are collected by The Royal Liverpool 
University Hospital (RLUH), a major centre for retinopathy research. The nature of the 
longitudinal data is of interest because it does not fit into any standard categorization of 
such data, in that the “time stamp" used is the sequential patient-consultation event 
number. The duration between consultations is also variable (Somaraki et al., 2010). 
For the temporal pattern identification process, the annual sequence was taken as the 
“time stamp”. The number of screening episodes per patient that have been recorded 
varies between one and 20, with an average of five consultations. It should also be 
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noted that in some cases, a patient did not complete an annual screening episode (in 
which case there was no record for that episode), although this did not adversely affect 
the temporal pattern mining process. In some other cases, the sequence of episodes was 
terminated because the patient “dropped” out of the screening programme (was referred 
to the Hospital Eye Service, moved away, or died). 
The data associated with a single episode, as also noted above, may actually be 
recorded over several months. In some cases, it was not clear whether a particular set of 
data entries belonged to a single episode or not. Some empirical evaluations indicated 
that the elapsed time between logging the initial screening data and (where appropriate) 
the results of biomicroscopy were less than 91 days. This was used as a working 
threshold to identify episode boundaries. For the research described here, a window of 
91 days was therefore used to collate data into a single screening episode. 
The time lapse between screening episodes is typically 12 months, although the data 
collection shows a great deal of variation resulting from practical considerations affecting 
the implementation of the screening programme (illustrated in Figure 4.2). As noted 
above, according to the nature of the retinopathy, additional episodes may occur, and 
consequently, more than one consultation can take place per year, in which case the 
second consultation was ignored. 
The initial screening data are stored in the General dataset and the next visit, which 
concerns information from eyes imaging, are stored in the Photodetails dataset, and data 
from Biomicroscopy of retina are stored in the Biomicroscopy dataset.  In order to 
combine data from all these datasets and form an episode, the time interval from 
General to Photodetails, and from Photodetails to Biomicroscopy, should be less than 91 
days. To identify the next time stamp, SOMA uses the date from General and checks 
when the next record in General took place. If the elapsed time from the next record is 
within 12 ± 6 months, then this record is the start of the next episode (Figure 4.3). All 
these are part of an internal procedure. SOMA asks the user only which attributes and 
which datasets will be used.  
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Figure 4.2: Patient distribution based on the time interval from the previous to the next episode in days. 
 
The following figure depicts a time line showing how the episodes are generated. Let’s 
say that a patient P1 has episodes with G1,G2, … ,Gn being the visits which are registered 
at General dataset with G1<G2<…<Gn, Ph1,Ph2,… ,Phn being the visits which are 
registered at Photodetails dataset with Ph1<Ph2< … <Phn and B1,B2,…,Bn being the visits 
which are registered at Biomicroscopy dataset with B1<B2<…<Bn . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Timeline of episodes creation 
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The above Figure shows the procedure that is follow from the framework to form the 
episodes and it is repeated for each patients. 
 
The data are stored in three different repositories and, in their raw form, cannot be 
formed.  The pre-processing stage within SOMA is very important because, apart from 
the form of the episodes, data are transformed in a way in which they can be understood 
from the parts that follow pre-processing. The following principles are applied:  Each attribute is allocated a unique number creating an ordered list, e.g.: 
<Age_at_Exam>::=1, <Visual_Acuity_Right_Best>::=2, 
<Visual_Acuity_Left_Best>::=3, and so on. The allocation starts from the 
General dataset, continues to the Photodetails dataset, and ends with the 
Biomicroscopy dataset.  This way of labelling the attributes allows SOMA to 
understand from which dataset to read information about an attribute.  The value of each attribute is treated according to its type. The datasets 
contain attributes that can take both continuous numerical values (e.g. the 
age of a patient) and discrete values (both numerical and categorical). For 
discrete values, the processing is straightforward, as each value is assigned a 
characteristic number. The key issue is to create bands for the continuous 
values. For each attribute that has continuous values, SOMA creates intervals 
that cover the range of values. Then, the range of each band is allocated a 
unique number. For example, the field that provides information for the age of 
the patients is transformed as follows: <Age_at_Exam>::= <0–12> | <12–
20> | <20–30> | <30–40> | <40–50> | <50–60> | <60–70> | < 70 >. 
After this categorization, SOMA will use the following norm to use this 
attribute: <1>::=<1>|<2>|<3>|<4>|<5>|<6>|<7>|<8>. On the left-hand 
side, the number denotes the attribute, and the number on the right-hand 
side denotes the value of the attribute. The range of each band is very 
important, because it will affect the frequency of appearance, in every time 
stamp, and thus determines how frequently a certain band of an attribute 
appears. For example, let us take the attribute of the age of a patient. The 
results will be different if the values are separated into two bands, below 50 
years old and above 50 years old, or if the age is separated into three bands. 
In addition, the attributes that characterize the level of diabetic retinopathy 
for the left and right eye are banded in such a way that they provide 
information on whether a patient has or does not have diabetic retinopathy, in 
the left or right eye, or both. Afterwards, these attributes are merged into a 
new attribute, “diabetic retinopathy”, which states whether a patient suffers 
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from diabetic retinopathy or not. The generation and categorization of trends 
are both based on the support count of the value of each attribute. Each value 
of an attribute represents an item, and the combination of items creates item 
sets; if the values of an attribute are scattered, the number of item sets may 
become so high that it will be practically impossible to identify useful 
knowledge, even if the support threshold were reduced to a very low level. 
This can be easily understood if we take into account the attributes with 
continuous values such as the age of a patient, which can take any value and, 
moreover, will change from time stamp to time stamp. In such a case with no 
transformation process in every time stamp, there will be as many item sets 
as the number of different ages of all patients, and in order to track them, the 
support threshold must be less than 1/N (where N is the number of patients).  Another feature of this arithmetical language is that it allocates each patient a 
unique number that is universal. A patient who can be found in all datasets is 
indicated by the same number, and this allows SOMA to identify each 
individual patient for every time stamp. 
When the time-stamped datasets (episodes) are created, the logic rules are applied so 
as to ensure that the values of attributes are correct and correspond to true medical 
situations for the present study. Also, the logic rules are applied to replace missing 
values and thus to reduce the percentage of information that is missing. The logic rules 
are a set of if clauses; the if clauses state that if a certain combination of values of 
attributes exists, then the value of a field should take a certain value. Here is an 
example: 
If < Present Treatment > ::=< diet and insulin > && < Calculated age at diagnosis > 
::=     < ≥ 30  and  <40> && < diInsTab > ::=<Don’t know> | <Null> && < 
dbPastTreat > ::= <tablets and the insulin> then <calculated diabetes type> ::= 
<diabetes type 1>. 
This rule implies that if a patient’s present treatment is diet and insulin, patient’s age 
when diagnosed with diabetes was between 30 and 40 years old, if the patient doesn’t 
know for how long was taking tablets before insulin then the diabetes type of the patient 
is diabetes type 1. 
Figure 4.4   below depicts how the algorithm searches through the datasets: the 
algorithm moves horizontally from one dataset to another in order to form an episode. 
When an episode is confirmed through logic rules, the algorithm moves vertically to the 
following records. 
Following this process, the final outcome is a number of datasets, and each represents 
one episode. In each dataset, every line represents a patient, and every column 
represents an attribute. 
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                             Figure 4.4: How framework reads data 
 
 
 
 
 
 
 
 
 
1. For i=1 to {total number of patients in general dataset}  
2. set j to i 
3. set date1 to date of visit of patient i 
4. set line1 to i 
5. set line2 to zero 
6. set line3 to zero   
7. for jj =1 to {total number of patients in photodetails} 
8. if jj is i  
9. if date1 differs from date of visit of patient jj ≤ 91 days 
10. set line2 to jj 
11. end  
12. end 
13. end 
14. for jj =1 to {total number of patients in biomicroscopy} 
15. if jj is i  
16. if date1 differs from date of visit of patient jj ≤  91days 
17. set line3 to jj 
18. end  
19. end 
20. end 
21. for ii=1 to number of attributes selected 
22. set jj to number of attribute ii 
23. if jj ≤  {total number of attributes in general} 
24. set array(ii) to General(line1,jj) 
25. end 
26. if jj >   {total number of attributes in general}  and ≤ { number of attributes 
in photodetails} 
27. set array(ii) to Photodetails(line2-{number of attributes in general}, jj) 
28. end 
29. if jj > {total number of attributes in photodetails} and ≤ {total number of 
attributes in biomicroscopy} 
30. set array(ii) to Photodetails(line2-{ total number of attributes in general} – 
{total number of attributes in   photodetails}, jj) 
31. end 
32. end  
33. End 
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At this stage, the user must specify the following parameters:  which attributes are to be examined;  the number of time stamps. 
At the next stage, Aretaeus3 software is used, which incorporates the application of rule 
mining and trend mining. It asks the user to specify the following:  in the context of association rules, which attributes are the variable attributes 
(the left side of the rule) and which are the key attributes (the right side of 
the rule);  the threshold value for both the support and the confidence.  
Next, the algorithm applies the matrix algorithm to identify item sets, which contain only 
the defined user attributes with support higher than the support threshold, and then 
checks if the rule has a greater confidence than the threshold, in at least one time 
stamp. If both thresholds have been satisfied, the implementation algorithm calculates 
the confidence of the inverse rule and the lift. 
                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
  Aretaeus (AD 130–200) was the first physician to give diabetes its proper name. In his treatise “On the 
causes and symptoms of chronic diseases Book II, he used the Greek word “diabetes” (meaning “siphon”) to 
describe the disease. He stated that “Diabetes is a remarkable affection not very frequent among men being 
a melting down of the flesh and blood into urine.” “Mellitus” was added later by others to denote the sweet 
taste of urine. “Mellitus” means “honey” in Greek. 
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The final step of the SOMA framework is the creation of a coloured representation 
showing how the patients are moving through the trends. The support count provides 
information only about the number of patients who have certain characteristics, and 
provides no information about who they are. On the other hand, keeping the identities of 
the patients anonymous is a major task in medical databases. The solution to this 
problem is to group patients in the first time stamp based on the values of the attributes 
and allocates each group a unique colour. Each trend is represented as a line with 
squares, as many as the number of time stamps. If a trend has 0 support count in a 
time stamp, the square is left white. 
At the following time stamps, SOMA examines where the patients are. Let us say that a 
trend in the 2-second time stamp has support count S2. The following conditions may 
then apply:  The patients all belong to the same group and the square will have the same 
colour as in the first time stamp.   The patients all belong to the same group, but this group appears for the first 
time at this time stamp. Then, this group is allocated a new colour and is 
considered from this point as an extra group. 
N1 patients belong to existing group A1, and N2 patients belong to existing group A2, and 
so on, such that N1+N2+...=S2. In such a case, the patients come from difference 
groups, and the square is coloured in as many colours as there are different groups. The 
percentage of each group Ni/S2 determines the area of the square, which is painted in 
the specific colour. If some of these groups have appeared for the first time, they are 
considered as new groups and are allocated a unique colour. 
The same process is followed for the rest of the time stamp until the algorithm reaches 
the last one.  
 
4.4 Validation and verification of the Framework 
 
The trend-mining method essentially performs “learning by discovery”, and hence we 
cannot train it; rather, we have to have confidence in the results it provides, that is, it 
should be validated. To perform a validation of the trend-mining framework, we 
advocate two complementary approaches: 
i)  Verification 
Verification tests whether the intermediate results and/or outputs of the framework are 
self-consistent. 
ii) Validation 
This method tests the outputs of the framework and also checks the consistency of the 
application that experts already know and expect. The methods include: 
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 confirmation of the framework that reveals known causal connections in the 
application;  confirmation of the framework that reveals known trends in the application. 
4.4.1 Verification 
 
Verification attempts to measure the extent to which a set of parameters affects the self-
consistence of trend mining framework. In this chapter, several measures are discussed 
below. In order to perform verification SOMA application is used. 
4.4.1.1 Number of time stamps 
 
The first parameter for the framework is the number of time stamps. The size of the 
dataset is determined by the number of time stamps. Also, another factor that is very 
important is the time window which determines how data recorded in different times can 
be collocated into a time stamp. 
 In SOMA for every patient, each time stamp or episode consists of collated data that 
have been recorded under different consultations. Here, a window of 91 days is used as 
the threshold to create an episode. Moreover, to move to the next episode, there is a 
window of 365 days ± 180 days.  
 
4.4.1.2 Completeness of dataset 
 
This measure refers to the degree of complexity of the datasets and how much 
information they contain. Even using logic rules at the pre-processing stage, it is not 
possible to fill all the empty values. 
The numerator of the ratio, of the support count of an item set over the total number of 
transactions of a dataset, that is used to calculate the support value, is the number of 
occurrence of an item set. The more complete a dataset is, the more information can be 
extracted from it. 
 
4.4.1.3 Rule conflict 
 
Sometimes, if a dataset is very dense (very large), there is the probability that an item 
set of “variable attributes” (the antecedent part of the rule) belongs to two or more 
different “key-variable” values (consequent). 
If X = {x1, x2, ..., xn} is an item set, the following rules are a set of conflict rules: 
XY1 
92 
 
XY2 
Where Y1 and Y2 are item sets of “key attributes”. 
In such a case, the methodology to deal with this problem will affect the final results of 
trend mining. One way to deal with the conflict rules is to discard both of them from the 
results. Another way is to perform a comparison between the conflict rules in terms of 
support and confidence across all time stamps. 
4.4.1.4 Banding of continuous attributes 
 
In the dataset, there are attributes that are continuous variables and must be banded 
within constant intervals. If an attribute that has continuous values is not banded, each 
individual value will represent an individual item, and as a result a very low support 
threshold would be required for this attribute to appear in the final result. 
Therefore, the length of the interval of the band affects the results in the context that 
when the length of a band covers a high percentage of values, its probability of 
appearing in the trend increases. Let us take an attribute, A, which is a continuous 
variable and separated into m bands: 
B1, B2, B3, ..., Bm 
which have the following percentages p1, p2, p3,..., pm. 
In order for all the bands to appear in the final results, the support threshold Sthres must 
follow the following rule: 
Sthres ≤min[p1, p2, p3, ..., pm] 
The attributes that are time-related have more effect on the results (e.g. age at 
examination). The reason for this is that the trends are time-dependent. Let’s take an 
attribute that is time-dependent and separated into bands, each of which has length m 
years within the interval [t, t + m]. 
The time from previous to next time stamp (episode) varies from 6 (0.5 year) months to 
18 months (1.5 year). 
Let’s take a case where there are N time stamps and take three options:  the time between time stamps is 0.5 year;  the time between the time stamps is 1 year; and  the time between the time stamps is 1.5 years. 
In this case:  the elapsed time T = (N – 1) * .5 years  T = (N – 1) years  the elapsed time is T = (N – 1) * 1.5. 
Let’s assume that the interval [t, t + m] has minimum value tmin. 
If tmin plus the elapsed time T gives: 
tmin + T > t + m 
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This means that between time stamp 1 and time stamp N, this attribute will change band 
from [t, t + m] to [t + m, t + 2m]. Therefore, the type and number of each trend can be 
varied because of the specific length of a band and without necessarily providing useful 
information about the data. 
4.4.1.5 Parameterization  
 
In the trend mining framework, there are four parameters whose values control the 
effectiveness of the framework:  support threshold : the minimum support required for an item set;  confidence threshold: the minimum confidence required for an association 
rule;  growth rate : the rate that shows how the support increases across all time 
stamps;  tolerance : parameter to determine a constant trend. 
All the above parameters are user-specified. 
The support threshold and confidence threshold control which rules from a dataset are 
kept and which are discarded. Also, the support threshold controls the type of trend: if 
support for a rule is above the threshold at all time stamps, the trend could be 
increasing, decreasing, or fluctuating. Otherwise it would fall into the category of 
jumping or disappearing. 
The growth-rate threshold determines if the increase in the support of a rule is sufficient 
to be characterized as an increasing trend. However, tolerance is the threshold at which, 
when the growth rate is less than the tolerance, the trend is characterized as constant. 
4.4.2 Validation 
 
Researchers have found that diabetic patients who are able to maintain appropriate 
blood sugar levels have fewer eye problems than those with poor control. Diet and 
exercise play important roles in the overall health of those with diabetes. These are 
some examples of common-sense clauses that can be justified from the trends. The 
more trends the SOMA produces (smaller support), the more clauses that can be 
“exported”. The confidence of the trend also plays an important role, as it measures the 
validity of the trend. The higher the confidence of the role, the more valid it is. 
The validation of the entire SOMA framework is based on known associations between 
the attributes that are selected. Among the attributes that have been selected, there 
should be at least one that has the role of the “key attribute”. In this research, a “key 
attribute” could be an attribute that characterizes the status of diabetic retinopathy for 
each patient. The other attributes play the role of variables, “variable attributes” whose 
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values affect the “key attribute”. At the end of the SOMA framework, the rules that are 
produced are compared with known associations, given by the experts. 
4.4.2.1 The SOMA output language 
The SOMA output language consists of keywords, which represent the attributes and 
values that represent a certain time interval or a certain situation such as the type of 
diabetes or the type of treatment. This output language is used by SOMA to process 
input data to produce the final results. The following table reveals the keywords and 
their associative values that SOMA uses to create output rules. 
Table 4.2: SOMA output language 
Attribute SOMA keyword SOMA value Interpretation 
Age at the date of 
exam 
Age_at_Exam 
1 
2 
3 
4 
5 
6 
7 
8 
<12 
12 – 20 years old 
20 – 30 years old 
30 – 40 years old 
40 – 50 years old 
50 – 60 years old 
60 – 70  years old 
>70 years old 
Age at diagnosis calculated_age_at_diagnosis 
1 
2 
3 
4 
5 
6 
7 
8 
<12 
12 – 20 years old 
20 – 30 years old 
30 – 40 years old 
40 – 50 years old 
50 – 60 years old 
60 – 70  years old 
>70 years old 
Treatment of 
diabetes 
Present_Treatment 
1 
2 
3 
4  
Diet  alone 
Diet and tablet 
Diet and insulin 
Tablets and insulin 
Type of diabetes calculated_diabetes_type 
1 
2 
3 
4 
Type 1 
Type 2 diet controlled 
Type 2 oral controlled 
Type 2 insulin required 
Duration of 
diabetes 
calculated_diabetes_duration 
1 
2 
3 
4 
5 
<5 years  
5-10 years  
10 – 15 years 
15 – 20 years 
>20 years 
95 
 
 
 
4.4.2.2   How SOMA reveals knowledge 
 
The output of SOMA framework is a combination of textual, numerical and graphical 
representation. For every association rule which meets the conditions of support 
threshold and confidence threshold SOMA provides the association rule in text format. It 
outputs the rule as pairs of attributes and the associative value, and with an arrow the 
left-hand side of the rule is separated from the right-hand side of the rule. The following 
is an example of what the textual output looks like: 
 
 
 
The SOMA output is written in the same way as for reading input data. The values of the 
attributes represent either an interval, e.g. “Age_at_Exam = 8”, meaning that the age of 
a patient at the examination is higher than 70 years old, or a certain condition, e.g. 
“calculated_diabetes_type = 4”, meaning that the type of diabetes of a patient is of type 
2, and insulin needs to be taken by the patient. 
SOMA after the associative classification process outputs in textual format information 
about the kind of trends depending on how the support of a rules varies across all time 
stamps. The kinds of trends the SOMA produces are:  Increasing  Decreasing   Jumping  Disappearing  Constant   Fluctuating 
The numerical output of SOMA concerns the support value of the rule, the minimum and 
maximum confidence, and the lift for each time stamp. Moreover, it outputs the growth 
rate of a trend if it is increasing. 
In particularly the output of the framework gives information about the rule: the support 
count of     for each time stamp, the kind of trend , the maximum and minimum 
confidence of the rule      and finally the lift of the rule. The conclusion from this 
output is that although that the rule has high confidence, the fact that lift is less than 
one lead s to the conclusion that the attributes of X are negatively correlated with the 
attributes of Y. 
 
Age_at_Exam=8  Present_Treatment=4  calculated_age_at_diagnosis=7  
calculated_diabetes_type=4  calculated_diabetes_duration=3   --> DR=0   
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If, in any time stamp, the support count is less than the support threshold, the 
confidence, lift, and support are set to 0. 
Another form of textual output that SOMA produces is how patients move from rule to 
rule at each time stamp. Here is an example: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the example above, this rule has one patient in the first time stamp and five patients 
at the second. The end user is informed that four new patients were found to have the 
characteristics of this rule. From the previous time stamp, no patient continues to exist, 
which means that this patient has a missing value, and so it is ignored by SOMA. Also, 
three patients out of five in time stamp 1 had different characteristics, which are also 
given in textual form. The # symbol is used to protect the identity of the patients. This 
type of output can help spot changes in the values of the attributes from one time stamp 
to the next. 
In cases where a rule has a high support count in every time stamp, the textual output is 
so large that it is very difficult to check the movement of the patients from time stamp 
Have the following support counts:  
1   5    
 
This trend is increasing with growth rate 5.00 
 
This rule has P(Y|X) : 
 maximum confidence : 71.4286 % 
 minimum confidence : 25.0000 % 
 
This rule lift is : 
   0.30007    0.94446  
Age_at_Exam=8  Present_Treatment=4  calculated_age_at_diagnosis=7  
calculated_diabetes_type=4  calculated_diabetes_duration=3   --> DR=0   
 From the 1 timestamp to the 2 timestamp there are more 4 patients 
 
From the previous time stamp continue 0 patients 
 
 PATIENT # at this time stamp came from the trend : 
Age_at_Exam=8  Present_Treatment=2  calculated_age_at_diagnosis=7  
calculated_diabetes_type=3  calculated_diabetes_duration=3   --> DR=0   
 PATIENT # at this time stamp came from the trend : 
Age_at_Exam=8  Present_Treatment=2  calculated_age_at_diagnosis=7  
calculated_diabetes_type=3  calculated_diabetes_duration=3   --> DR=0   
 PATIENT # at this time stamp came from the trend : 
Age_at_Exam=8  Present_Treatment=4  calculated_age_at_diagnosis=7  
calculated_diabetes_type=4  calculated_diabetes_duration=3   --> DR=1   
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to time stamp. To solve this problem, SOMA creates a graphical representation, using 
the following procedure:  Each trend is allocated a sequential number, 1, 2, 3, etc.  A mesh is created with square boxes of equal size P × T where P is the 
number of trends, and T is the number of time stamps. Each line represents a 
trend; on the left-hand side of the mesh, the trend is written, and on the 
right-hand side of the mesh, the type of trend is written.  For the first time stamp in each trend, the number of patients in that trend 
forms an individual group, each of which is allocated a unique colour, except 
white, which is allocated when the support count is zero, and black, which is 
allocated to a patient who appears for the first time in a time stamp different 
than the first.  At the following time stamps, SOMA examines the proportion of patients in 
relation to the groups formed in the first time stamp, so the box may contain 
more than one colour depending on how many different groups of patient can 
be found. 
SOMA has reserved two colours for special cases:  white: when a time stamp has no patient;  black: when in a time stamp, a patient appears but does not belong to any of 
the initial groups; this happens when patients have missing values at certain 
time stamps, and so SOMA ignores them. 
4.5 Conclusion 
 
This chapter gives a general description of the trend mining framework and also gives 
details of the application of the framework in Diabetic retinopathy, SOMA. The 
implementation of SOMA consists of 3 stages: pre-processing for cleaning the datasets 
and creating episodes, the processing stage using the matrix algorithm and the trend 
generation and the post processing which regards the categorization of trends and the 
implementation of visualization technique for the representation of trends. Finally, this 
chapter provides a framework for the verification and validation of the Trend Mining. 
Verification is based on checking how parameters of the framework affect how to 
produce the results right and on the other hand validation aims to check whether the 
results are right.
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Chapter 5 Evaluation 
5.1 Introduction 
 
This chapter describes the evaluation of research work described in the thesis which is 
centred on trend mining. The aim is to validate and verify the approach for the development 
of the advocated trend mining framework. The goal of evaluation process described here is 
to judge the usefulness of the discovered knowledge and the process of trend mining itself.  
On the one hand the evaluation of the produced rules is straightforward by using criteria 
evaluating novelty action ability unexpectedness reliability etc, on the other hand evaluating 
the processes of the framework is based on quantitative criteria which measure its 
performance.  
Trend mining validation and verification are aimed at identifying whether the trend mining 
framework:  can determine whether the intermediate results and/or outputs of the framework 
are self-consistent  produces result in the context of the domain that the data describe 
The evaluation by applying the framework to the DR data, examines if the validation and 
verification are effective as part of the framework. The evaluation is based on an approach 
embodied in the SOMA framework using the diabetic retinopathy (DR) data. This approach 
consists of three different directions:  evaluation of the verification techniques within the pre-processing stages;  evaluation of the verification techniques within the processing stages;  evaluation of the validation techniques used to determine  the quality of  the 
discovered knowledge. 
For each of those directions, a set of criteria is created. The results from the evaluation are 
measured against the specified criteria, and a scoring system is implemented in an attempt 
to measure how successful or not the evaluation is. 
 The chapter provides:  details on the evaluation setup, e.g. data used in the parameter setup and the 
type of output;  details on the criteria for measuring the results and what we want to discover;  details on outputs of the evaluation;  discussion about the results of the evaluation. 
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5.2 Verification experiments 
 
This section describes experiments in the context of testing how parameters given by the 
user such as the number of time stamps, support threshold, confidence threshold, growth 
rate threshold, and tolerance affect the amount of knowledge that is discovered as well as 
the running time, and how the number of variables affects the performance. Another set of 
experiments concerns how the intervals of bands of time variables affect the model. 
 Table 5.1 below shows the size of each temporal dataset in number of patients vs the 
number of time stamps/episodes. 
 
Table 5.1: Number of patients per number of episodes 
Number of episodes Number of patients 
2 10968 
3 6037 
4 3696 
5 2328 
6 1420 
7 887 
8 546 
9 329 
10 172 
 
The number of episodes and thus the size of the datasets determine the value of the 
support threshold that is required in each case to extract useful information for analysis. 
The size of the data set is the denominator of the ratio that determines the support value of 
the item set. 
The following tables show the conditions of the experiments. The 1st column shows the 
threshold values of support, confidence, growth rate, tolerance and the number of variables. 
The first experiments for the verification of the trend mining framework examine how the 
input parameters from the user affect the performance of the framework in the context of 
the total number of trends and the running time that is required in order to discover those 
trends. The parameters concerning these experiments are:  Support threshold  Confidence threshold  Growth rate threshold 
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 Tolerance  Number of variables 
For the experiments a dual core Pentium Intel D processor was used with clock 3.0 GHz and 
the algorithm was developed in MATLAB® 2009a. 
Tables 5.2 – 5.4 show the values of the parameters that are selected from experiment A to 
Y. in all experiments the same variables are used, but in experiments V, W, X and Y 
variables which are time related have been modified in the context of the intervals that are 
used. Each of the experiments from A to Y is repeated for several time stamps. Table 5.1 
shows the number of patients for each case.  
Tables below {5.5 – 5.28} contain the results from those experiments. There are as many 
tables as the different conditions. In each table the 1st column refers the kind of trends and 
the rest columns show the results for each time stamps. The last line shows the elapsed 
time for each time for each time excluding the moments when the user interacts with the 
algorithm in order to enter the parameters. 
From the experiments can be concluded that:  For the same conditions, in all experiments, as the number of the time stamp 
increases the elapsed time decreases because the size of datasets decreases.  For the same conditions, in all experiments, the number of trends, from the 
experiments with 2 time stamps to the experiments of 10 time stamps, becomes at 
least double which indicates that as the number of time stamps increases the 
datasets contains more information.  Comparing the experiments with the same parameters and variables but with the 
altered time intervals, experiment Q vs experiment Y, experiment G vs experiment 
X, experiment U vs experiment W and experiment T vs experiments V, it can be seen 
that in the experiments with the altered time intervals the total number of trends 
decreases and as the result the elapsed time decreases. In the experiments with the 
altered intervals Y,X,W and V the time related variables are split in only 3 intervals 
while in the Q,G,U and T experiments have been used 8 intervals. 
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Table 5.2: Experimental conditions 
 A B C D E F G H  I 
Support 
threshold 
0.05 0.05 0.05 0.01 0.01 0.01 0.005 0.005 0.005 
Confidence 
threshold 
50 70 90 50 70 90 50 70 90 
Growth rate 
Threshold 
1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 
Tolerance 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
Number of 
variables 
6 6 6 6 6 6 6 6 6 
Table 5.3: Experimental conditions 
 K L M N O P Q R 
Support 
threshold 
0.05 0.05 0.05 0.01 0.01 0.01 0.005 0.005 
Confidence 
threshold 
50 70 90 50 70 90 50 70 
Growth rate 
Threshold 
1.005 1.005 1.005 1.005 1.005 1.005 1.005 1.005 
Tolerance 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Number of 
variables 
6 6 6 6 6 6 6 6 
Table 5.4: Experimental conditions 
 S T U V W X Y 
Support 
threshold 
0.005 0.005 0.005 0.005 0.005 0.005 0.005 
Confidence 
threshold 
90 50 50 50 50 50 50 
Growth rate 
Threshold 
1.005 1.01 1.005 1.01 1.005 1.01 1.005 
Tolerance 0.0001 0.001 0.0001 0.001 0.0001 0.001 0.0001 
Number of 
variables 
6 8 8 8* 8* 6* 6* 
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The superscript (*) denotes that the bands have been altered. For each experiment, a table 
has been produced that shows the number of trends and the elapsed time.  
 
 
Table 5.5– Experiment A 
 Experiment A 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 0 0 0 0 0 0 0 0 
Decreasing 1 2 0 0 0 0 0 0 0 
Fluctuating 0 2 0 0 0 0 0 3 6 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 2 2 2 2 4 2 2 
Disappearing 3 1 3 3 3 4 4 3 3 
Total 4 5 5 5 5 6 8 8 11 
Elapsed time 
(sec) 
423.36 153.24 243.34 182.56 132.60 102.96 85.99 67.91 63.38 
 
Table 5.6 – Experiment B 
 Experiment B 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 0 0 0 0 0 0 0 0 
Decreasing 1 0 0 0 0 0 0 0 0 
Fluctuating 0 0 0 0 0 0 0 3 6 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 2 2 2 2 3 2 2 
Disappearing 3 3 3 3 3 4 4 3 3 
Total 4 3 5 5 5 6 7 8 11 
Elapsed time 
(sec) 
425.55 329.48 254.19 194.34 143.30 107.65 88.38 71.92 61.17 
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Table 5.7 – Experiment C 
 Experiment C 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 0 0 0 0 0 0 0 0 
Decreasing 0 0 0 0 0 0 0 0 0 
Fluctuating 0 0 0 0 0 0 0 2 6 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 0 0 0 0 1 0 0 
Disappearing 2 3 3 3 3 4 4 3 3 
Total 2 3 3 3 3 4 5 5 9 
Elapsed time 
(sec) 
429.90 325.56 251.61 190.70 141.87 106.73 87.05 71.21 60.87 
 
 
Table 5.8– Experiment D 
 Experiment D 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 14 7 5 1 3 1 0 0 0 
Decreasing 16 8 4 0 0 0 0 0 0 
Fluctuating 0 3 5 9 7 13 12 16 40 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 2 5 5 6 6 8 12 15 
Disappearing 0 2 6 12 14 13 12 14 13 
Total 31 22 25 27 30 33 32 42 68 
Elapsed time 
(sec) 
428.44 341.27 262.60 199.98 150.38 115.44 93.06 79.35 67.24 
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Table 2.9 - Experiment E 
 Experiment E 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 6 7 5 1 3 1 0 0 0 
Decreasing 10 8 4 0 0 0 0 0 0 
Fluctuating 0 3 5 9 7 13 12 16 40 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 3 2 5 5 6 6 8 12 15 
Disappearing 2 2 6 12 14 13 12 14 13 
Total 21 22 25 27 30 33 32 42 68 
Elapsed time 
(sec) 
431.93 334.25 261.32 199.201 150.38 115.44 93.06 79.35 67.24 
 
 
Table 5.10 - Experiment F 
 Experiment F 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 1 0 0 0 0 0 0 0 
Decreasing 5 8 4 0 0 0 0 0 0 
Fluctuating 0 1 5 5 6 9 11 14 35 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 1 1 2 2 4 6 14 
Disappearing 2 2 6 12 14 13 12 14 13 
Total 7 12 16 18 22 24 27 34 62 
Elapsed time 
(sec) 
426.19 330.24 259.41 196.54 147.45 110.75 92.25 75.74 65.97 
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Table 5.11 - Experiment G 
 Experiment G 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 14 13 8 3 3 1 0 0 0 
Decreasing 16 10 5 4 0 0 0 0 0 
Fluctuating 0 7 14 18 13 17 36 59 111 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 3 4 9 10 12 14 28 48 
Disappearing 0 2 6 6 16 19 22 18 26 
Total 31 35 37 40 42 49 72 105 185 
Elapsed time 
(sec) 
439.08 341.19 261.59 202.35 155.24 117.52 96.75 82.19 74.85 
 
 
Table 5.12 - Experiment H 
 Experiment H 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 13 13 8 3 3 1 0 0 0 
Decreasing 16 10 5 4 0 0 0 0 0 
Fluctuating 0 7 14 18 13 17 33 50 103 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 3 4 8 10 10 13 21 44 
Disappearing 0 2 6 6 16 19 22 18 25 
Total 30 35 37 39 42 47 68 89 172 
Elapsed time 
(sec) 
433.00 335.08 265.20 203.21 153.67 117.41 98.11 81.90 74.07 
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Table 5.13 - Experiment I 
 Experiment I 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 3 1 0 1 0 0 0 0 0 
Decreasing 8 10 5 4 0 0 0 0 0 
Fluctuating 0 4 11 14 11 13 29 48 103 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 2 3 2 3 6 9 19 43 
Disappearing 0 2 6 6 16 18 21 18 25 
Total 11 19 25 27 30 37 59 85 171 
Elapsed time 
(sec) 
429.41 331.61 258.32 198.70 150.22 114.81 97.66 81.27 74.09 
 
Table 5.14 - Experiment K 
 Experiment K 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 0 0 0 0 0 0 0 0 
Decreasing 1 0 0 0 0 0 0 0 0 
Fluctuating 0 0 0 0 0 0 0 3 6 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 2 2 2 2 4 2 2 
Disappearing 3 3 3 3 3 4 4 3 3 
Total 4 3 5 5 5 6 8 8 11 
Elapsed time 
(sec) 
430.21 330.40 254.54 192.67 145.01 102.54 87.07 63.08 54.19 
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Table 5.15 - Experiment L 
 Experiment L  
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing  0 0 0 0 0 0 0 0 0 
Decreasing 1 0 0 0 0 0 0 0 0 
Fluctuating  0 0 0 0 0 0 0 3 6 
Constant  0 0 0 0 0 0 0 0 0 
Jumping 0 0 2 2 2 2 3 2 2 
Disappearing 3 3 3 3 3 4 4 3 3 
Total 4 3 5 5 5 6 7 8 11 
Elapsed time 
(sec) 
422.71 324.75 249.59 185.48 143.21 106.78 87.30 71.60 60.28 
 
 
Table 5.16 - Experiment M 
 Experiment M 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 0 0 0 0 0 0 0 0 
Decreasing 0 0 0 0 0 0 0 0 0 
Fluctuating 0 0 0 0 0 0 0 2 6 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 0 0 0 0 1 0 0 
Disappearing 2 3 3 3 3 4 4 3 3 
Total 2 3 3 3 3 4 5 5 9 
Elapsed time (sec) 414.26 317.90 244.35 186.27 135.85 97.24 80.88 63.06 56.62 
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Table 5.17   - Experiment N 
 Experiment N 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 6 7 5 1 3 1 0 0 6 
Decreasing 10 8 4 0 0 0 0 0 0 
Fluctuating 0 3 5 9 7 13 12 16 40 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 3 2 5 5 6 6 8 12 15 
Disappearing 2 2 6 12 14 13 12 14 13 
Total 21 22 25 27 30 33 32 42 68 
Elapsed time 
(sec) 
417.96 320.11 249.78 186.77 140.12 103.96 88.19 69.50 63.50 
 
Table 5.18 – Experiment O 
 Experiment O 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 6 7 5 1 3 1 0 0 0 
Decreasing 10 8 4 0 0 0 0 0 0 
Fluctuating 0 3 5 9 7 13 12 15 35 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 3 2 5 5 6 6 8 11 15 
Disappearing 2 2 6 12 14 13 12 14 13 
Total 21 22 25 27 30 33 32 40 63 
Elapsed time 
(sec) 
438.04 338.09 267.29 203.23 151.90 116.02 92.83 76.96 64.89 
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Table 5.19- Experiment P 
 Experiment P 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 0 1 0 0 0 0 0 0 0 
Decreasing 5 8 4 0 0 0 0 0 0 
Fluctuating 0 1 5 5 6 9 11 14 35 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 0 1 1 2 2 4 6 14 
Disappearing 2 2 6 12 14 13 12 14 13 
Total 7 12 16 18 22 24 27 34 62 
Elapsed time 
(sec) 
411.23 312.95 244.01 183.36 136.13 100.86 83.43 69.23 62.70 
 
Table 5.20 - Experiment Q 
 Experiment Q 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 14 13 8 3 3 1 0 0 0 
Decreasing 16 10 5 4 0 0 0 0 0 
Fluctuating 0 7 14 18 13 17 36 59 111 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 3 4 9 10 12 14 28 48 
Disappearing 0 2 6 6 16 19 22 18 26 
Total 31 35 37 40 42 49 72 105 185 
Elapsed time 
(sec) 
416.64 327.64 254.87 193.39 145.55 112.94 94.17 80.68 73.10 
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Table 5.21 - Experiment R 
 Experiment R 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 13 13 8 3 3 1 0 0 0 
Decreasing 16 10 5 4 0 0 0 0 0 
Fluctuating 0 7 14 18 13 17 33 50 103 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 3 4 8 10 10 13 21 44 
Disappearing 0 2 6 6 16 19 22 18 25 
Total 30 35 37 39 42 47 68 89 172 
Elapsed time 
(sec) 
438.26 339.79 263.63 201.72 152.23 114.63 96.19 83.43 65.92 
 
 
 
 
Table 5.22 - Experiment S 
 Experiment S 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 3 1 0 1 0 0 0 0 0 
Decreasing 8 10 5 4 0 0 0 0 0 
Fluctuating 0 4 11 14 11 13 29 48 103 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 0 2 3 2 3 6 9 19 43 
Disappearing 0 2 6 6 16 18 21 18 25 
Total 11 19 25 27 30 37 59 85 171 
Elapsed time 
(sec) 
418.65 322.70 256.24 194.03 146.95 111.03 94.29 78.48 73.59 
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Table 5.23 - Experiment T 
 Experiment T 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 15 12 10 3 1 0 0 0 0 
Decreasing 17 10 6 0 0 0 0 0 0 
Fluctuating 0 6 9 16 17 26 52 71 171 
Constant 1 0 0 0 0 0 0 0 0 
Jumping 1 5 7 11 14 19 24 40 65 
Disappearing 2 6 11 18 20 16 4 0 0 
Total 36 39 43 48 52 61 80 111 236 
Elapsed time 
(sec) 
749.27 553.18 411.33 304.19 211.47 150.47 113.77 86.59 78.99 
 
Table 5.24 – Experiment U 
 Experiment U 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 15 12 10 3 1 0 0 0 0 
Decreasing 17 10 6 0 0 0 0 0 0 
Fluctuating 0 6 9 16 17 26 52 71 171 
Constant 1 0 0 0 0 0 0 0 0 
Jumping 1 5 7 11 14 19 24 40 65 
Disappearing 2 6 11 18 20 16 4 0 0 
Total 36 39 43 48 52 61 80 111 236 
Elapsed time (sec) 744.30 530.30 397.75 291.78 200.72 162.36 106.39 82.20 70.76 
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Table 5.25 - Experiment V 
 Experiment V 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 6 4 2 1 1 0 0 0 0 
Decreasing 10 8 5 3 0 0 0 0 0 
Fluctuating 0 5 10 10 15 20 24 29 76 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 2 2 4 7 10 11 17 29 41 
Disappearing 0 0 1 2 4 2 1 0 0 
Total 18 19 22 23 30 33 42 58 117 
Elapsed time 
(sec) 
324.66 251.45 193.62 156.15 121.90 102.09 81.38 71.84 64.60 
 
Table 5.26 – Experiment W 
 Experiment W 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 6 4 2 1 1 0 0 0 0 
Decreasing 10 8 5 3 0 0 0 0 0 
Fluctuating 0 5 10 10 15 20 24 29 76 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 2 2 4 7 10 11 17 29 41 
Disappearing 0 0 1 2 4 2 1 0 0 
Total 18 19 22 23 30 33 42 58 117 
Elapsed time (sec) 329.62 248.21 194.49 156.76 123.64 96.19 77.34 67.73 58.89 
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Table 5.27– Experiment X 
 Experiment X 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 4 3 4 4 1 0 0 0 0 
Decreasing 10 6 4 3 3 3 2 1 1 
Fluctuating 0 8 8 10 15 14 26 29 53 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 1 3 6 8 12 10 15 17 
Disappearing 2 0 1 1 1 1 4 5 5 
Total 17 18 20 24 28 30 42 50 76 
Elapsed time (sec) 194.29 158.08 127.14 105.11 87.16 73.74 67.89 63.42 56.85 
 
 
Table 5.28 - Experiment Y 
 Experiment Y 
 Time stamps 
 2 3 4 5 6 7 8 9 10 
Increasing 4 3 4 4 1 0 0 0 0 
Decreasing 10 6 4 3 3 3 2 1 1 
Fluctuating 0 8 8 10 15 14 26 29 53 
Constant 0 0 0 0 0 0 0 0 0 
Jumping 1 1 3 6 8 12 10 15 17 
Disappearing 2 0 1 1 1 1 4 5 5 
Total 17 18 20 24 28 30 42 50 76 
Elapsed time (sec) 195.11 157.76 133.04 111.13 92.55 78.21 70.53 63.59 57.03 
 
 
From the tables with the results (5.5 – 5.28) the following conclusions can be extracted:   for the same support threshold, as the confidence threshold increases, the 
number of rules that are discovered decreases;  for the same confidence threshold, as the support threshold decreases, the 
number of rules that are discovered increases;  for the same values of support and confidence threshold, the change in growth 
rate threshold and tolerance does not affect the amount of rules that are 
discovered; 
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 for the same confidence and support threshold and number of variables, as the 
number of time stamps increases, the elapsed time decreases;  for the same number of time stamps and variables, the elapsed time does not 
change significantly;  for the same confidence and support threshold and number of time stamps, the 
elapsed time is increased as the number of time stamps increases;  the increase in time-band intervals results in a significant decrease in the number 
of rules and the elapsed time, under the same conditions. 
 
5.3 Validation of the trend mining framework 
 
The proposed technique for validation of the trend mining framework based on using known 
relations between the attributes that describe the domain. That way the user can provide 
the attributes that describe the left and the right hand side of the rule. The validation of the 
entire SOMA framework is based on known associations between the attributes that are 
selected. 
5.3.1 Validation experiments 
 
Here, some rules are provided to show how attributes are related to diabetic retinopathy 
disease and how these rules are validated by SOMA:  Rule 1: If the duration of diabetes is longer than 15 years, it is very likely that 
this patient will suffer from diabetic retinopathy.  Rule 2: If the type of diabetes is type 1, the patient is likely to suffer from 
diabetic retinopathy.  Rule 3: If a patient is over 60 years old, has type 2 diabetes, and changes the 
treatment from insulin and oral control to insulin and tablets, this patient is likely 
to develop diabetic retinopathy.  Rule 4: If the age of a patient becomes greater than 70 years old, then it is quite 
likely that this patient will develop diabetic retinopathy. 
For rule 1, the end user should check for rules that include the attribute that SOMA 
recognizes as diabetes duration, “calculated_diabetes_duration”, and has the value 4 or 5, 
which means 15–20 years and more than 20 years, respectively. For rule 2, SOMA should 
reveal rules that include the right type of diabetes and present treatment values, as it is 
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known that patients who have diabetes type 1 require to take insulin, and so SOMA should 
also reveals this causality. 
The SOMA outputs the following rules: 
 
 
 
 
 
 
 
 
 
All of the above rules confirm that patients have a diabetes duration of 15–20 years (in 
SOMA output language calculated_diabetes_duration = 4) or longer than 20 years 
(calculated_diabetes_duration = 5). In all rules above, both supports and confidence are 
greater than the threshold, but what is really important are the high values of the lift. 
Lift is the ratio of the confidence of the rule over the support count of the item set 
appearing in the rule consequent. Sometimes, the value of the confidence of the rule may 
be misleading because the calculation of confidence ignores the support count of the item 
set appearing in the rule consequent. If lift is greater than 1, the item set appearing in the 
rule antecedent and the item set appearing in the rule consequent are positively correlated; 
if it is less than 1, they are negatively correlated; and if it is 1, they are independent. 
 
For all the above rules for all time stamps, lift is greater than 2, which means that there is a 
high positive correlation between the left- and the right-hand side of the rules. Also, from 
rules II–V, it is confirmed that in the case of a patient who suffers from diabetes type 1, 
their treatment contains insulin (Present_treatment = 3). 
Before showing how SOMA confirms rules 3 and rule 4, let us first explain what a trend-
mining algorithm should output to conclude that rules 3 and 4 are validated by SOMA. Rule 
3 describes a situation where patients have two characteristics of their condition stable, i) 
age older than 60 years old and ii) diabetes type 2, but the third characteristic which is 
treatment of diabetes changes from insulin and oral control to insulin and tablets. This 
change in the diabetes treatment results in a change in the diabetic retinopathy condition, 
from not having it to an increased likelihood of developing diabetic retinopathy. This abrupt 
change in the treatment of diabetes can be described with a jumping trend because the final 
Age_at_Exam=6  Present_Treatment=2  calculated_age_at_diagnosis=4  
calculated_diabetes_type=3  calculated_diabetes_duration=4   --> DR=1   
Age_at_Exam=4  Present_Treatment=3  calculated_age_at_diagnosis=2  
calculated_diabetes_type=1  calculated_diabetes_duration=5   --> DR=1   
Age_at_Exam=4  Present_Treatment=3  calculated_age_at_diagnosis=3  
calculated_diabetes_type=1  calculated_diabetes_duration=4   --> DR=1   
Age_at_Exam=4  Present_Treatment=3  calculated_age_at_diagnosis=2  
calculated_diabetes_type=1  calculated_diabetes_duration=5   --> DR=1   
Age_at_Exam=5  Present_Treatment=3  calculated_age_at_diagnosis=3  
calculated_diabetes_type=1  calculated_diabetes_duration=5   --> DR=1   
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condition of those patients initially does not exist but jumps sometimes. Thus, patients 
move from a trend describing the initial condition to a trend describing the final condition. 
Rule 4 describes a situation that shows how the change in the age of patients affects their 
condition of diabetic retinopathy. When the age of a patient increases above 70, the value 
of the attribute age_at_exam (age at the time of the hospital visit) changes from 6 (age 
between 60 and 70 years old) to 7 (above 70 years old). However, as time passes, the age 
of patients increases, and as a result there will be patients whose age will go to the next 
age interval. 
In SOMA, the rule 3 can be validated with the following pair for trends: 
 
 
 
 
 
 
This pair of rules confirms that for patients aged 60–70 years old (Age_at_Exam = 7), their 
treatment changes from insulin and diet control (calculated_diabetes_type = 3) to insulin 
and tablet control (calculated_diabetes_type = 4).These patients  from the disappearing 
trend appear to the jumping trend. This change can be depicted using the following coloured 
schema 5-1. The same background colour in the boxes denotes that the patients at each 
time stamp have begun from the same association, which is written in a format that the end 
user can understand and not in the language that SOMA uses to perform its tasks. At time 
stamp 7, the first association disappears and jumps the second one with 14 patients from 
the original 18 having diabetic retinopathy and a change in their treatment.
Age_at_Exam=7 Present_Treatment=3 calculated_age_at_diagnosis=5 
calculated_diabetes_type=4 calculated_diabetes_duration=4   --> DR=0   
 
Age_at_Exam=7  Present_Treatment=4  calculated_age_at_diagnosis=5  
calculated_diabetes_type=4  calculated_diabetes_duration=4  --> DR=1   
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Figure 5.1: Pair of Disappearing and Jumping trends 
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As regards rule 4 in SOMA language the following pair of decreasing and increasing 
trends can be used for validation: 
 
  
 
 
 
The first trend is decreasing because from the previous time stamp to the next, the  
number of the patients’ decreases  and for the same reason the second trend is 
increasing because the patients from the former are added to the initial number of 
patients. From the following coloured representation, this is clear because the second 
trend has two colours: the first shows the number of patients who continue from the first 
time stamp and the second shows the number of patients coming from the first trend. In 
total, the number of patients increases, which means that it is increasing trend. These 
two trends validated rule 4, which states that patients older than 70 years of age are 
likely to develop diabetic retinopathy. 
 
Age_at_Exam=7 Present_Treatment=4 calculated_age_at_diagnosis=4 
calculated_diabetes_type=4 calculated_diabetes_duration=5   --> DR=0   
 
Age_at_Exam=8 Present_Treatment=4 calculated_age_at_diagnosis=4 
calculated_diabetes_type=4 calculated_diabetes_duration=5   --> DR=1   
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Figure 5.2: Pair of decreasing and increasing trends
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5.4 Evaluation of the trend mining framework 
 
In this research work, a set of Validation and Verification criteria was used to ensure the 
quality of the discovered knowledge. To evaluate this, a case study is necessary to 
incorporate trend mining within it. The SOMA framework is used to show the 
effectiveness of trend mining with DR data, and this effectiveness is measured using a 
set of criteria incorporating various aspects of the quality of knowledge discovery and by 
showing that the results score well with respect to those criteria. 
The evaluation has three main aims: verification of the pre-processing; evaluation of the 
verification of processing; and evaluation of the validation. The evaluation of the 
verification of the pre-processing considers issues related to the pre-processing tasks 
before trend mining algorithm is applied:  noise reduction;  object distribution;  Time-stamp duration. 
The evaluation of the verification of main processing considers how interesting the rules 
are from the association mining point of view, and how changes in trends are related to 
objects. The final aim, evaluation of the validation, is related to the quality of the 
knowledge discovered. The concept behind the evaluation is to create a scoring system 
for each of the criteria. For each criterion, a set of targets is established, and for each 
target, a score is allocated. After checking the framework against all criteria, the final 
score is summed up; a higher score indicates a better performance and greater 
effectiveness of the framework. 
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5.4.1 Criteria discussion 
 
In this section, each criterion is explained and linked with the application of SOMA, and a 
discussion is provided about what the criterion aims to achieve and how this is 
associated with sets of targets:  Noise reduction: Raw data from databases are noisy with missing values, 
error values, etc. During the first stage of trend mining, data undergo 
cleansing using domain-related logic rules. The lower the percentage of 
missing values in the time-stamped datasets, the more likely information can 
be extracted from them. The aim is to achieve the greatest possible reduction 
in noise, expressed as a percentage by comparing the time-stamp datasets 
before and after use. SOMA postulates the use of specific logic rules, which 
have been set up from the physicians and determine the values of the 
attributes used.  Object distribution: This criterion evaluates at each time stamp whether an 
object has enough information in order to be included or not into the trend 
mining process. The term enough is interpreted as completeness. If an object 
has no missing information has enough information. The evaluation wants to 
establish if this happens in all time stamps .Each line of a dataset refers to a 
certain object. For any number of time-stamped datasets, every line refers to 
the same object. If, in any line, there is a missing value, this object is omitted 
from the framework processes after pre-processing. The aim of this criterion 
is to check the percentage of objects that are not ignored across all datasets. 
In this case study, the objects are the patient from the DR databases.  Time-stamp duration and interval: The time-stamp length and the interval 
between two consecutive time stamps criterion is related to both the process 
of the trend-mining framework in terms of whether data are longitudinal or 
not, but also related to the application of the domain. As explained previously, 
a time stamp may consist of a single event or may be a combination of 
multiple events associated with an object. In the case of the latter, one must 
ensure that the time interval between  multiple events and the time interval 
between time stamps are mostly uniform. In DR databases, different visits to 
medics and screeners are recorded in which different types of data are 
collected. From one dataset to the next, the interval must be no more than 91 
days so as to produce a time stamp for a patient. Additionally, for the same 
patient, the interval from one time stamp to the next must be 12±6 months. 
The target is related to the uniformity of the length of the time stamp and of 
the interval from one time stamp to another for the same patient. 
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 Interestingness of information: One of the major tasks of trend mining is to 
identify which trend is interesting or not. As described in chapter 4 a trend 
containing information of the support of a rule  is calculated. If, in any 
time stamp, the confidence of the rule  is greater than the threshold, the 
trend is accepted as interesting; otherwise, it is discarded. However, the use 
of confidence only is not adequate, and so more measures of interestingness 
are applied: lift, max confidence all confidence, cosine, and Kulczynski. These 
calculations are carried out for each time stamp. The aim is for every measure 
to exceed a threshold value for each time stamp. The more measures are 
achieved, and for more time stamps, the more interesting the rule.  Change-point detection: The change-point detection criterion evaluates the 
framework in the context of the ability of the model to identify meaningful 
changes from one condition to another for the same group of objects. The aim 
is to measure how many meaningful change points are detected. SOMA 
examines whether the change in DR status can be depicted on the 
disappearing–jumping trends concerning the same group of patients.  Quality of discovered knowledge: This criterion is simply concerned with the 
application domain of the trend mining. A set of rules describing a condition 
are used to check the quality of the knowledge. These kinds of rules have the 
form of an if-clause using the antecedent and the consequent parts of the 
discovered rules and describe a relation between them. The criterion here is 
to check whether trend mining can confirm those rules and how accurately 
that can be done. The confirmation is measured by examining if the 
framework can give either the same rule or the opposite rule and the accuracy 
is measured by examining how many attributes are included into the 
discovered rule, both antecedent and consequent. Here, the rules used 
concern how and whether certain characteristics affect DR. 
 
5.4.2 Criteria implementation 
 
This section describes how the evaluation criteria are implemented in order to measure 
the effectiveness and performance of the framework:  First criterion: the interestingness of the information. 
The main filter of the vast amount of information is the confidence threshold. If an 
association rule has a confidence greater than or equal to a threshold in any time stamp, 
then it is considered by the framework to be interesting information. However, the use of 
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confidence only is not an adequate measure for the interestingness, and so the 
framework calculates other measures, too: lift, max confidence, all confidence, cosine, 
and Kulczynski. 
 If an association rule has a high lift (more than 1), and the measures are greater 
than the threshold given for confidence, then it is assumed that this association rule is 
valid. More particularly, for each association rule, a 5×N matrix is created where N 
denotes the time stamps, where the association rule has non-zero support, and the 
figure lines denote: lift, max confidence, all confidence, Kulczynski, and cosine 
measures. If the rule has exceeded the threshold in terms of the measures, it is 
assigned 1; otherwise 0. The maximum score that a rule can have across all time stamps 
is 5×N. If S is the total score of a rule across all time stamps, the interestingness of the 
rule is given by the following ratio: 
 
 
  Second criterion: noise reduction 
For each time stamp, the number of missing values before and after the pre-processing 
is measured. If the reduction in the number of missing values is above a threshold 
(40%) and is preserved across all datasets, then the aim has been achieved, and the 
score is incremented by one or not.  Third criterion: time-stamp length and interval 
This criterion examines whether the length of the time stamp and its interval from the 
next are within a given range i) for a patient across all time stamps and ii) across the 
records within the same dataset. If the percentage of the time stamps that lie within the 
given range is above a given value, the score is accredited.  Fourth criterion: discovery of change points 
At the end of the framework, there is a colourful representation where a group of 
patients is formed, based on the patients’ characteristics at the first time stamp. 
Following each group of patients, from its unique colour, we are able to track the 
patients. We are particularly interested in tracking change points. A change point is 
defined as follows: at any time stamp T, a group of patients G is moving from rule R1 at 
time stamp T–1 to rule R2 at time stamp T. 
This change point can indicate just a change in the characteristics of the group, for 
example, a change in any variable attribute (left-hand side of the rule), or it may 
indicate that any change in left-hand side of the rule, they initially belong, may result in 
a change in “key attribute”. 
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Similarly with the second criterion, the score is accredited when a group of patients from 
a decreasing trend moves to an increasing trend. The higher the score, the better the 
system works.  Fifth criterion: object distribution 
For all time-stamped data set, each line refers to the same patient. If the line has no 
missing values across all datasets, it is considered a valid record. The total number of 
such records is calculated as a percentage against the number of all records. If the 
percentage exceeds a threshold value given by the user, the score is accredited.  Sixth criterion: Quality of discovered knowledge 
Knowledge (relations, rules, characterizations) is harvested from the experts in the 
application that they already know about, and that they expect the system should 
discover, given the data collected. The application of this criterion to the case 
study involved acquiring medical criteria such as:  If a patient suffers from cataract, it is possible to develop DR.  If a patient is diagnosed with diabetes in young age, they have an 
increased risk of suffering from DR.  If a patient suffers from type 1 diabetes, they are more likely to develop 
DR.  If a patient suffers from type 2 diabetes and is on insulin, they are more 
likely to develop DR.  If a patient suffers from type 2 diabetes for more than 20 years, they are 
more likely to develop DR.  If a patient suffers from type 1 diabetes for more than 5 years, they are 
more likely to develop DR. 
The greater the numbers of criteria from the above that are confirmed by an interesting 
trend, the higher the score the system obtains. Each time a criterion is met, the score is 
incremented by 1. 
At the end, the final score is calculated, and this is checked against the maximum score 
that could be measured in the framework evaluation. 
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5.4.3 Experimental set-up 
 
Experiments were conducted using the DR data described in chapter 4, to evaluate the 
SOMA framework. In particular, the data combine information from the General and 
Photodetails datasets. The attributes used were as follows:  age at exam  present treatment of patient  diabetes type  diabetes duration  age at diagnosis  DR in the left eye  DR in the right eye  DR. 
The last attribute is not originally included in the datasets and is synthesized by merging 
the attributes regarding the DR on either the left or right eye. The reason for this is that 
we are interested in the situation of a patient, not which eye has the disease. 
The first seven attributes from the list were chosen for two reasons:  These attributes are less noisy after the application of logic rules.  The medics believe that these attributes are very important in terms of 
trying to link DR to certain characteristics. 
The attributes have continuous and discrete values. Continuous values are the values 
from attributes that show some relation to time (age and duration). For those attributes 
(age at exam, age at diagnosis, and diabetes duration), the values are converted to 
discrete values using the following bands: 
 For age at exam and age at diagnosis, the following:    0 – 12 years old   Band 1   Value =1  12 – 20 years old   Band 2   Value =2  20 – 30 years old   Band 3   Value =3  30 – 40 years old   Band 4   Value =4  40 – 50 years old   Band 5   Value =5  50 – 60 years old   Band 6   Value =6  60 – 70 years old   Band 7   Value =7      > 70 years old   Band 8   Value =8 
For diabetes duration, the following transformation was used:      0 – 5 years    Band 1   Value =1    5 – 10 years    Band 2   Value =2 
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  10 – 15 years    Band 3   Value =3   15 – 20 years   Band 4   Value =4   > 20 years  Band 5   Value =5 
The experiment is repeated with 5 to 10 time stamps to examine short-term and long-
term changes. 
The following table shows the parameters used for all experiments: 
 
Table 5.29: Experimental Parameters 
Parameters Value 
Support threshold 0.01 % 
Confidence threshold 40 % 
Growth rate threshold 1.01 
Tolerance 0.00001 
 
The experiments were conducted using all patients who complied with the time-stamp 
rules: i) irrespective of their DR status; ii) examining those who have developed DR in 
every time stamp; and iii) those who have not developed DR in all time stamps. The 
reason for this is to examine not only how manipulation of the dataset may affect the 
results but also how evaluation measures are affected by that kind of manipulation. 
 
However, a different approach is used to evaluate the quality of discovered knowledge. 
Based on the rules used for the medical criteria, different experiments were conducted 
using only the attributes described in the rules, using all patients, and using a stricter 
confidence threshold. 
5.4.4 Experimental results and evaluation 
 
This section presents the results from the experiments with the aim to evaluate the 
trend-mining framework and SOMA in particular. As stated earlier, the datasets were 
manipulated either to contain a certain class (condition) of the disease or to pick up all 
patients. Under those conditions, Table 5.30 shows the sizes of the datasets used. 
 
 
 
 
 
 
127 
 
 
Table 5.30: Dataset size 
 Series 1 Series 2 Series 3 
Time stamps  
ALL patients 
Patients with DR in 
all time stamps 
Patients with no DR 
in all time stamps 
5  2328 51 1303 
6  1420 25 715 
7  887 10 411 
8  546 7 231 
9  329 5 135 
10  179 2 75 
 
It can be seen that the amount of information available regarding patients with DR is 
very small compared with that regarding non-DR patients or those who have developed 
DR at a certain stage of their life. Hereafter, the experiments concerning all patients will 
be referred to as series 1, experiments for patients with DR in all time stamps as series 
2, and the other category as series 3. 
 
5.4.4.1 Noise reduction 
 
Tables 5.31– 5.33 show the noise reduction as a percentage and also present the scores. 
This percentage concerns the values that have undergone cleansing successfully over the 
total number of values of a dataset in every time stamp.  
The algorithm for each time stamped dataset, calculates the number of cells which 
potentially can undergo the cleaning process. After the cleaning process the algorithm 
counts the number of cells whose values have been changed from the cleaning process. 
The ratio of the later number of cell over the former number of cells gives the 
percentage of the cleaning process. 
Tables 5.31 – 5.33 show the results. Each column in those tables represents the results 
of each experiment and each line represents the time stamp. The threshold for those 
experiments was set to 40% for each experiment and if the noise reduction is above that 
percentage the score for each experiment increases by one. For each experiment the 
maximum score is equal to the number of time stamps. The last two lines of the tables 
show the score and the maximum score for each experiment respectively. The higher 
score means more successful noise reduction. 
 
 It can be seen that the use of a threshold of 40% noise reduction is successful in series 
1 and 3 in attaining the maximum score. The results for series 2 range from 0% to 90% 
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(in terms of scoring), but if another threshold had been used, e.g. 48%, the score for all 
series would be 0. The reason for that is that the knowledge of experts which was used 
is not enough to replace the missing attributes with a value. It would be more helpful to 
replace missing values using another method, for example, using the mean value, but 
even so, such a method would have to change the support of the antecedent and 
consequently all measures of interestingness. 
 
Table 5.31: Noise reduction (%) for series 1 
 5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  42.6730 42.6962 42.6156 42.6156 42.8137 42.9370 
2nd  42.6055 42.6660 42.7444 42.7444 42.6835 42.8571 
3rd  42.6362 42.6660 42.7444 42.7444 42.6400 42.6975 
4th  42.6178 42.6559 42.6961 42.6961 42.7703 42.7773 
5th  40.9732 42.6358 42.6800 42.6800 42.9006 42.7773 
6th  N/A 41.0664 42.6317 42.6317 42.7269 42.9370 
7th  N/A N/A 41.1016 41.1016 42.8137 42.6975 
8th  N/A N/A N/A 42.6156 42.7269 42.8571 
9th N/A N/A N/A N/A 41.2505 42.6975 
10th  N/A N/A N/A N/A N/A 41.8994 
Score 5 6 7 8 9 10 
Max score 5 6 7 8 9 10 
 
Table 5.32: Noise reduction (%) for series 2 
 5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  41.1765 38.8571 40.0000 38.7755 40.0000 42.8571 
2nd  40.0560 40.0000 37.1429 38.7755 40.0000 42.8571 
3rd  39.7759 40.0000 40.0000 34.6939 40.0000 42.8571 
4th  40.6162 38.8571 40.0000 38.7755 34.2857 42.8571 
5th  38.6555 40.0000 38.5714 38.7755 40.0000 42.8571 
6th  N/A 40.0000 38.5714 36.7347 40.0000 42.8571 
7th  N/A N/A 40.0000 36.7347 37.1429 42.8571 
8th  N/A N/A N/A 38.7755 37.1429 42.8571 
9th N/A N/A N/A N/A 40.0000 35.7143 
10th  N/A N/A N/A N/A N/A 42.8571 
Score 3 4 4 0 6 9 
Max score 5 6 7 8 9 10 
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Table 5.33: Noise reduction (%) for series 3 
 
5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  42.7804 42.8571 42.7876 42.9190 42.8571 42.8571 
2nd  42.7585 42.7772 42.8571 42.7953 42.8571 42.8571 
3rd  42.7804 42.8372 42.7876 42.9190 42.8571 42.8571 
4th  42.8133 42.8172 42.8224 42.9190 42.8571 42.8571 
5th  42.7365 42.8172 42.7876 42.8571 42.8571 42.8571 
6th  N/A 42.7772 42.8224 42.9190 42.7513 42.8571 
7th  N/A N/A 42.8224 42.9190 42.8571 42.6667 
8th  N/A N/A N/A 42.9190 42.8571 42.8571 
9th N/A N/A N/A N/A 42.8571 42.8571 
10th  N/A N/A N/A N/A N/A 42.8571 
Score 5 6 7 8 9 10 
Max score 5 6 7 8 9 10 
 
Appendix 2 shows an analytical representation of the plots for noise reduction. Those 
plots are colour bars and each bar shows the percentage of values that are corrected for 
every time stamp for all experiments. 
5.4.4.2 Object distribution 
 
This measure aims to evaluate the extent to which all objects are used or not. If an 
object has a missing value, it is omitted from the framework. Tables 5.34-5.36 show the 
object distribution. At the start of an experiment the user enters the number of time 
stamps. Depending on the number of the time stamps there is a certain number of 
objects, O. Αafterwards the algorithm checks how many of the objects Ο have 
information in all time stamps. Let’s say that there’s one experiment with 5 time stamps. 
Each object, after cleaning must have values in every time stamp, if not then this object 
is ignored. 
Table 5.6 shows the number of objects O for reach experiment, for each series. Each 
number in that table is the denominator for the calculation of the ratio for the object 
distribution.  
The SOMA then for each time stamp calculates the ratio of the objects that have values 
in all time stamps over the number O. 
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Here, the threshold that is used is 90 %. Tables 5.34 – 5.36 show the distribution of 
objects. Again, experiments from series 1 and 3 have better scores than the experiments 
in series 2. This was an expected finding, since experiments from series 2 have the 
smallest scores for noise reduction. 
 
Table 5.34: Patient distribution (%) for series 1 
 
5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  93.0842 93.8732 91.4318 88.0952 85.4103 74.3017 
2nd  93.9433 93.0282 92.3337 90.1099 84.8024 81.0056 
3rd  94.1581 94.4366 93.9121 93.0403 92.0973 86.5922 
4th  93.9433 93.5915 93.4611 93.5897 93.3131 90.5028 
5th  92.6546 93.1690 92.5592 91.9414 92.4012 92.7374 
6th  N/A 92.6056 92.3337 92.6740 91.4894 91.0615 
7th  N/A N/A 91.6573 92.6740 92.0973 89.9441 
8th  N/A N/A N/A 90.4762 91.1854 91.0615 
9th N/A N/A N/A N/A 89.0578 88.8268 
10th  N/A N/A N/A N/A N/A 88.8268 
Score 5 6 7 7 6 4 
Max score 5 6 7 8 9 10 
  
Table 5.35: Patient distribution (%) for series 2 
 
5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  84.3137 84 80 85.7143 85.4103 74.3017 
2nd  84.3137 88 80 85.7143 84.8024 81.0056 
3rd  88.2353 88 90 85.7143 92.0973 86.5922 
4th  84.3137 92 80 100.0000 93.3131 90.5028 
5th  90.1961 92 80 85.7143 92.4012 92.7374 
6th  N/A 92 90 85.7143 91.4894 91.0615 
7th  N/A N/A 100 85.7143 92.0973 89.9441 
8th  N/A N/A N/A 100.0000 91.1854 91.0615 
9th N/A N/A N/A N/A 89.0578 88.8268 
10th  N/A N/A N/A N/A N/A 88.8268 
Score 1 3 4 2 6 4 
Max score 5 6 7 8 9 10 
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Table 5.36: Patient distribution (%) for series 3 
 
5 time 
stamps 
6 time 
stamps 
7 time 
stamps 
8 time 
stamps 
9 time 
stamps 
10 time 
stamps 
1st  94.4743 95.5245 93.6740 89.6104 83.7037 84.0000 
2nd  96.3162 95.9441 94.4039 92.2078 85.9259 82.6667 
3rd  95.6255 98.0420 95.8637 94.8052 94.0741 86.6667 
4th  96.3929 95.8042 96.3504 95.2381 95.5556 93.3333 
5th  95.3952 96.9231 95.1338 95.2381 94.0741 97.3333 
6th  N/A 96.0839 95.6204 94.8052 97.0370 93.3333 
7th  N/A N/A 95.3771 95.6710 94.8148 97.3333 
8th  N/A N/A N/A 93.9394 95.5556 97.3333 
9th N/A N/A N/A N/A 93.3333 94.6667 
10th  N/A N/A N/A N/A N/A 93.3333 
Score 5 6 7 7 7 7 
Max score 5 6 7 8 9 10 
 
5.4.4.3 Time-stamp distribution 
 
To evaluate the time-stamp uniformity, three rules are used:  Rule I .For each object, the average time interval and the standard deviation 
are calculated.  Rule II. For each time stamp, the average time interval and the standard 
deviation for all objects are calculated.  Rule III. The maximum time interval from General to Photodetails, 91 days, is 
divided into three intervals: 0–29 days, 30–60 days, and more than 60 days. 
For each time stamp, the percentage of patients belonging to that interval is 
calculated. The criterion is to check the uniformity of the sum of the 
percentage of patients who go from the General to Photodetails within 60 
days, and the average and standard deviation are then calculated for each 
time stamp. 
For all three rules, the ratio of the standard deviation over the average should not 
exceed a threshold value, set here to 0.15. The aim of this rule is to examine whether 
the objects need the time interval to combine information from various sources. 
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Table 5.37: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30 – 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 76.29 % 20.75 % 2.96 % 97.04 % 
2nd  time stamp 66.88 % 30.93 % 2.19 % 97.81 % 
3rd  time stamp 39.6 % 58.55 % 1.85 % 98.15 % 
4th  time stamp 46.56 % 50.64 % 2.8 % 97.2 % 
5th  time stamp 29.47 % 48.5 % 22.03 % 77.97 % 
 
Table 5.38: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 76.290% 20.750% 2.960% 97.040% 
2nd  time stamp 66.880% 30.930% 2.190% 97.810% 
3rd  time stamp 39.600% 58.550% 1.850% 98.150% 
4th  time stamp 46.560% 50.640% 2.800% 97.200% 
5th  time stamp 29.470% 48.500% 22.030% 77.970% 
 
Table  5.39: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 78.740% 18.110% 3.150% 96.850% 
2nd  time stamp 68.150% 30.010% 1.840% 98.160% 
3rd  time stamp 38.070% 59.940% 1.990% 98.010% 
4th  time stamp 43.510% 53.340% 3.150% 96.850% 
5th  time stamp 28.550% 49.730% 21.720% 78.280% 
 
Table 5.40: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 68.800% 27.460% 3.740% 96.260% 
2nd  time stamp 77.250% 20.420% 2.330% 97.670% 
3rd  time stamp 69.930% 28.590% 1.480% 98.520% 
4th  time stamp 40.990% 57.820% 1.190% 98.810% 
5th  time stamp 45.350% 52.180% 2.470% 97.530% 
6th  time stamp 26.970% 51.200% 21.830% 78.170% 
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Table 5.41: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 60.000% 36.000% 4.000% 96.000% 
2nd  time stamp 64.000% 36.000% 0.000% 100.000% 
3rd  time stamp 72.000% 28.000% 0.000% 100.000% 
4th  time stamp 48.000% 52.000% 0.000% 100.000% 
5th  time stamp 40.000% 56.000% 4.000% 96.000% 
6th  time stamp 44.000% 52.000% 4.000% 96.000% 
 
Table 5.42: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 68.800% 27.460% 3.740% 96.260% 
2nd  time stamp 77.250% 20.420% 2.330% 97.670% 
3rd  time stamp 69.930% 28.590% 1.480% 98.520% 
4th  time stamp 40.990% 57.820% 1.190% 98.810% 
5th  time stamp 45.350% 52.980% 1.670% 98.330% 
6th  time stamp 26.970% 51.200% 21.830% 78.170% 
 
Table 5.43: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30– 60 days > 60 days 
Sum of two first 
intervals 
1st  time stamp 60.880% 34.610% 4.510% 95.490% 
2nd time stamp 70.350% 26.270% 3.380% 96.620% 
3rd time stamp 79.590% 18.830% 1.580% 98.420% 
4th time stamp 71.590% 27.960% 0.450% 99.550% 
5th time stamp 38.780% 60.770% 0.450% 99.550% 
6th time stamp 42.390% 54.900% 2.710% 97.290% 
7th time stamp 23.110% 53.440% 23.450% 76.550% 
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Table 5.44: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 70.000% 10.000% 20.000% 80.000% 
2nd time stamp 60.000% 40.000% 0.000% 100.000% 
3rd  time stamp 70.000% 30.000% 0.000% 100.000% 
4th  time stamp 80.000% 20.000% 0.000% 100.000% 
5th  time stamp 50.000% 50.000% 0.000% 100.000% 
6th  time stamp 30.000% 60.000% 10.000% 90.000% 
7th time stamp 50.000% 50.000% 0.000% 100.000% 
 
 
Table 5.45: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 63.260% 33.820% 2.920% 97.080% 
2nd  time stamp 72.510% 24.820% 2.670% 97.330% 
3rd  time stamp 82.970% 15.330% 1.700% 98.300% 
4th  time stamp 73.480% 26.280% 0.240% 99.760% 
5th  time stamp 37.710% 61.800% 0.490% 99.510% 
6th  time stamp 39.420% 57.420% 3.160% 96.840% 
7th time stamp 21.900% 53.770% 24.330% 75.670% 
 
Table 5.46: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 45.790% 45.050% 9.160% 90.840% 
2nd  time stamp 63.190% 34.070% 2.740% 97.260% 
3rd  time stamp 74.180% 23.990% 1.830% 98.170% 
4th  time stamp 83.330% 15.750% 0.920% 99.080% 
5th  time stamp 72.340% 27.290% 0.370% 99.630% 
6th  time stamp 32.780% 66.850% 0.370% 99.630% 
7th time stamp 38.460% 59.160% 2.380% 97.620% 
8th time stamp 22.160% 52.010% 25.830% 74.170% 
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Table 5.47: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 57.470% 14.290% 28.240% 71.760% 
2nd  time stamp 85.710% 0.000% 14.290% 85.710% 
3rd  time stamp 42.860% 57.140% 0.000% 100.000% 
4th  time stamp 57.140% 42.860% 0.000% 100.000% 
5th  time stamp 85.710% 14.290% 0.000% 100.000% 
6th  time stamp 57.140% 42.860% 0.000% 100.000% 
7th time stamp 28.570% 71.430% 0.000% 100.000% 
8th time stamp 42.860% 57.140% 0.000% 100.000% 
 
Table 5.48: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 48.920% 42.290% 8.790% 91.210% 
2nd  time stamp 64.940% 32.030% 3.030% 96.970% 
3rd  time stamp 74.460% 23.380% 2.160% 97.840% 
4th  time stamp 84.850% 13.850% 1.300% 98.700% 
5th  time stamp 74.030% 25.970% 0.000% 100.000% 
6th  time stamp 33.330% 66.670% 0.000% 100.000% 
7th time stamp 36.360% 60.170% 3.470% 96.530% 
8th time stamp 21.650% 51.520% 26.830% 73.170% 
 
 
Table 5.49: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 38.300% 38.300% 23.400% 76.600% 
2nd  time stamp 45.590% 45.590% 8.820% 91.180% 
3rd  time stamp 65.350% 33.430% 1.220% 98.780% 
4th  time stamp 75.380% 23.400% 1.220% 98.780% 
5th  time stamp 84.800% 15.200% 0.000% 100.000% 
6th  time stamp 73.560% 26.140% 0.300% 99.700% 
7th time stamp 28.270% 71.430% 0.300% 99.700% 
8th time stamp 34.040% 52.310% 13.650% 86.350% 
9th time stamp 22.190% 52.280% 25.530% 74.470% 
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Table 5.50: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 60.000% 0.000% 40.000% 60.000% 
2nd  time stamp 60.000% 40.000% 0.000% 100.000% 
3rd  time stamp 100.000% 0.000% 0.000% 100.000% 
4th  time stamp 60.000% 40.000% 0.000% 100.000% 
5th  time stamp 40.000% 60.000% 0.000% 100.000% 
6th  time stamp 80.000% 20.000% 0.000% 100.000% 
7th time stamp 40.000% 60.000% 0.000% 100.000% 
8th time stamp 20.000% 80.000% 0.000% 100.000% 
9th time stamp 60.000% 40.000% 0.000% 100.000% 
 
Table 5.51: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 37.780% 37.780% 24.440% 75.560% 
2nd  time stamp 48.150% 42.220% 9.630% 90.370% 
3rd  time stamp 66.670% 31.850% 1.480% 98.520% 
4th  time stamp 77.040% 20.740% 2.220% 97.780% 
5th  time stamp 87.410% 12.590% 0.000% 100.000% 
6th  time stamp 74.810% 25.190% 0.000% 100.000% 
7th time stamp 26.670% 73.330% 0.000% 100.000% 
8th time stamp 31.110% 63.700% 5.190% 94.810% 
9th time stamp 22.220% 49.630% 28.150% 71.850% 
 
Table 5.52: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 46.930% 32.400% 20.670% 79.330% 
2nd  time stamp 38.550% 32.960% 28.490% 71.510% 
3rd  time stamp 49.720% 45.810% 4.470% 95.530% 
4th  time stamp 64.800% 34.640% 0.560% 99.440% 
5th  time stamp 78.210% 20.670% 1.120% 98.880% 
6th  time stamp 84.360% 15.640% 0.000% 100.000% 
7th time stamp 72.630% 26.820% 0.550% 99.450% 
8th time stamp 26.260% 73.180% 0.560% 99.440% 
9th time stamp 26.910% 65.920% 7.170% 92.830% 
10th time stamp 19.550% 51.960% 28.490% 71.510% 
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Table 5.53: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 0.000% 50.000% 50.000% 50.000% 
2nd  time stamp 50.000% 0.000% 50.000% 50.000% 
3rd  time stamp 100.000% 0.000% 0.000% 100.000% 
4th  time stamp 100.000% 0.000% 0.000% 100.000% 
5th  time stamp 50.000% 50.000% 0.000% 100.000% 
6th  time stamp 50.000% 50.000% 0.000% 100.000% 
7th time stamp 100.000% 0.000% 0.000% 100.000% 
8th time stamp 100.000% 0.000% 0.000% 100.000% 
9th time stamp 50.000% 50.000% 0.000% 100.000% 
10th time stamp 100.000% 0.000% 0.000% 100.000% 
 
Table 5.54: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 < 30 days 30– 60 days > 60 days Sum of two first 
intervals 
1st  time stamp 46.670% 32.000% 21.330% 78.670% 
2nd  time stamp 36.000% 37.330% 26.670% 73.330% 
3rd  time stamp 53.330% 40.000% 6.670% 93.330% 
4th  time stamp 69.330% 30.670% 0.000% 100.000% 
5th  time stamp 82.670% 14.640% 2.690% 97.310% 
6th  time stamp 89.330% 10.670% 0.000% 100.000% 
7th time stamp 76.000% 24.000% 0.000% 100.000% 
8th time stamp 22.670% 77.330% 0.000% 100.000% 
9th time stamp 28.000% 66.670% 5.330% 94.670% 
10th time stamp 17.330% 48.000% 34.670% 65.330% 
 
 
Tables 5.37 – 5.54 shows the results for Rule III of the time needed to combine 
information for patients with 5 to 10 time stamps for series 1, 2 and 3. In those tables,  
the 1st column shows the time stamp, the second column is the percentage of patients 
who need less than 30 days to combine information from different sources the third 
column shows the percentage of patients that need 30 to 60 days and the fourth the 
percentage of patients who need more that 60 days. 
The last column shows the percentage of patients for each time stamp who need less 
than 60 days to combine information from General and Photodetails. For those tables the 
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procedure that is followed is that for the values of the last are averaged and their 
standard deviation is calculated. If the ratio of the standard deviation over the average 
value is smaller than a threshold value, which here is set to 0.15, the test is successful 
and it is interpreted that the majority of the patients in all time stamps are examined by 
medics in less than 60 days and the score for this experiment is accredited with 1. 
However, by applying Rule I and Rule II, the outcome is that only 6 out of 2328 patients 
have a uniform time interval for linking data from different sources, and 0 out of 5 time 
stamps have uniformity over the elapsed time in days from General to Photodetails. The 
same approach is used for all experiments, and Tables 5.14–5.16 below summarize the 
scores of the 3 rules for series 1, 2, and 3. Appendix 3 provides graphs regarding the 
time intervals for all series of experiments. 
Table 5.55: Score summary for series 1; from General to Photodetails. 
 Rule I Rule II Rule III 
5 time stamps 6 / 2328 0 / 5 1 / 1 
6 time stamps 0 /1420 0 /6 1 / 1 
7 time stamps 0 / 887 0 / 7 1 / 1 
8 time stamps 0 / 546  0 / 8 1 / 1 
9 time stamps 0 / 329 0 / 9 1 / 1 
10 time stamps 0 / 179 0 /10 1 / 1 
 
Table 5.56: Score summary for series 2; from General to Photodetails 
 Rule i Rule ii Rule iii 
5 time stamps 0 / 51 0 / 5 1 / 1 
6 time stamps 0 / 25 0 /6 1 / 1 
7 time stamps 0 / 10 0 / 7 1 / 1 
8 time stamps 0 / 7  0 / 8 1 / 1 
9 time stamps 0 / 5 0 / 9 1 / 1 
10 time stamps 0 / 2 0 /10 1 / 1 
 
Table 5.57: Score summary for series 3; from General to Photodetails 
 Rule i Rule ii Rule iii 
5 time stamps 2 / 1303 0 / 5 1 / 1 
6 time stamps 0 / 715 0 /6 1 / 1 
7 time stamps 0 / 411 0 / 7 1 / 1 
8 time stamps 0 / 231  0 / 8 1 / 1 
9 time stamps 0 / 135 0 / 9 1 / 1 
10 time stamps 0 / 75 0 /10 1 / 1 
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In Tables 5.55–5.57, the first column shows whether, for the same object in every time 
stamp, the link from general to Photodetails, in terms of time interval, is uniform; the 
second column shows whether, in every time stamp, there is uniformity in objects 
regarding the link from general to Photodetails. The third column shows whether the 
majority of the objects go from general to Photodetails in a predefined time interval. 
It can be concluded, from columns 1 and 2, that:  Each object has its own time pattern from time stamp to time stamp, to link 
general to Photodetails.  In every time stamp, there is no uniformity in patients regarding the elapsed 
time from general to Photodetails. 
Column 3 shows that in all experiments, the majority of objects go from general to 
Photodetails within a time interval of 60 days. 
The following tables 5.58 – 5.75 show analytically the results for Rule III examining the 
distribution of patients from time-stamp to time-stamp. The interval of 180 to 540 days 
that intervenes between time-stamps is broken into smaller intervals , as it can been 
seen in the tables first line. 
 
Table 5.58: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.890% 7.131% 54.300% 29.300% 7.379% 92.621% 
2nd to 3rd 
time stamp 
0.902% 5.713% 48.320% 30.460% 14.605% 85.395% 
3rd to 4th 
time stamp 
0.473% 4.983% 45.790% 29.770% 18.985% 81.016% 
4th to 5th 
time stamp 
0.773% 5.069% 37.970% 31.010% 25.178% 74.822% 
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Table 5.59: Patient distribution in intervals from previous to next time stamp – Series 2 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.961% 5.882% 50.980% 33.330% 7.847% 92.153% 
2nd to 3rd 
time stamp 
0.000% 11.760% 56.860% 17.650% 13.730% 86.270% 
3rd to 4th 
time stamp 
0.000% 5.882% 47.060% 29.410% 17.648% 82.352% 
4th to 5th 
time stamp 
0.000% 3.922% 41.180% 31.370% 23.528% 76.472% 
 
Table 5.60: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.919% 8.289% 54.410% 27.860% 7.522% 92.478% 
2nd to 3rd 
time stamp 
0.537% 5.219% 46.740% 32.390% 15.114% 84.886% 
3rd to 4th 
time stamp 
0.461% 5.526% 44.900% 30.700% 18.414% 81.587% 
4th to 5th 
time stamp 
1.074% 5.679% 36.070% 31.160% 26.017% 73.983% 
 
Table 5.61: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.408% 7.606% 53.940% 26.480% 10.566% 89.434% 
2nd to 3rd 
time stamp 
0.845% 6.638% 56.340% 29.440% 6.737% 93.263% 
3rd to 4th 
time stamp 
0.916% 6.408% 49.080% 28.800% 14.797% 85.204% 
4th to 5th 
time stamp 
0.493% 5.423% 45.490% 30.350% 18.244% 81.756% 
5th to 6th 
time stamp 
0.634% 5.282% 39.370% 28.730% 25.984% 74.016% 
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Table 5.62: Patient distribution in intervals from previous to next time stamp – Series 2 
 
180-252 
days 
253-
324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
4.000% 4.000% 64.000% 16.000% 12.000% 88.000% 
2nd to 3rd 
time stamp 
0.000% 4.000% 52.000% 36.000% 8.000% 92.000% 
3rd to 4th 
time stamp 
0.000% 8.000% 64.000% 20.000% 8.000% 92.000% 
4th to 5th 
time stamp 
0.000% 0.000% 48.000% 36.000% 16.000% 84.000% 
5th to 6th 
time stamp 
0.000% 0.000% 52.000% 28.000% 20.000% 80.000% 
 
Table 5.63: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.399% 8.531% 55.240% 23.640% 11.190% 88.810% 
2nd to 3rd 
time stamp 
0.839% 6.993% 56.500% 28.530% 7.138% 92.862% 
3rd to 4th 
time stamp 
0.559% 6.434% 47.550% 30.490% 14.967% 85.033% 
4th to 5th 
time stamp 
0.420% 6.294% 43.500% 32.170% 17.616% 82.384% 
5th to 6th 
time stamp 
0.979% 6.014% 37.760% 29.230% 26.017% 73.983% 
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Table 5.64: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.127% 6.877% 59.410% 28.180% 4.406% 95.594% 
2nd to 3rd 
time stamp 
0.451% 6.877% 55.020% 27.620% 10.032% 89.968% 
3rd to 4th 
time stamp 
1.015% 6.990% 57.500% 28.520% 5.975% 94.025% 
4th to 5th 
time stamp 
0.789% 5.862% 51.070% 27.960% 14.319% 85.681% 
5th to 6th 
time stamp 
0.451% 5.186% 46.450% 31.340% 16.573% 83.427% 
6th to 7th 
time stamp 
0.902% 6.426% 38.560% 27.510% 26.602% 73.398% 
 
 
Table 5.65: Patient distribution in intervals from previous to next time stamp – Series 2 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
10.000% 10.000% 50.000% 20.000% 10.000% 90.000% 
2nd to 3rd 
time stamp 
10.000% 0.000% 60.000% 20.000% 10.000% 90.000% 
3rd to 4th 
time stamp 
0.000% 0.000% 70.000% 30.000% 0.000% 100.000% 
4th to 5th 
time stamp 
0.000% 10.000% 70.000% 20.000% 0.000% 100.000% 
5th to 6th 
time stamp 
0.000% 0.000% 60.000% 20.000% 20.000% 80.000% 
6th to 7th 
time stamp 
0.000% 0.000% 60.000% 30.000% 10.000% 90.000% 
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Table 5.66: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.217% 7.299% 58.390% 29.680% 3.414% 96.586% 
2nd to 3rd 
time stamp 
0.243% 9.002% 54.740% 25.050% 10.965% 89.035% 
3rd to 4th 
time stamp 
0.973% 7.299% 58.640% 28.470% 4.618% 95.382% 
4th to 5th 
time stamp 
0.243% 6.326% 50.850% 28.220% 14.361% 85.639% 
5th to 6th 
time stamp 
0.730% 5.596% 45.500% 32.360% 15.814% 84.186% 
6th to 7th 
time stamp 
1.460% 7.299% 37.470% 28.950% 24.821% 75.179% 
 
 
Table 5.67: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
1.282% 5.128% 68.680% 20.330% 4.580% 95.420% 
2nd to 3rd 
time stamp 
0.550% 5.861% 60.070% 30.400% 3.119% 96.881% 
3rd to 4th 
time stamp 
0.366% 7.692% 56.960% 26.370% 8.612% 91.388% 
4th to 5th 
time stamp 
0.916% 6.044% 61.360% 26.190% 5.490% 94.510% 
5th to 6th 
time stamp 
0.916% 6.044% 51.100% 27.660% 14.280% 85.720% 
6th to 7th 
time stamp 
0.366% 4.762% 46.150% 31.320% 17.402% 82.598% 
7th to 8th 
time stamp 
1.282% 7.326% 40.290% 25.460% 25.642% 74.358% 
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Table 5.68: Patient distribution in intervals from previous to next time stamp – Series 2 
 180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 180 
-468 days 
1st to 2nd time 
stamp 
0.000% 14.290% 57.140% 28.570% 0.000% 100.000% 
2nd to 3rd time 
stamp 
14.290% 14.290% 42.860% 14.290% 14.270% 85.730% 
3rd to 4th time 
stamp 
14.290% 0.000% 71.420% 14.290% 0.000% 100.000% 
4th to 5th time 
stamp 
0.000% 0.000% 71.430% 28.570% 0.000% 100.000% 
5th to 6th time 
stamp 
0.000% 14.290% 71.420% 14.290% 0.000% 100.000% 
6th to 7th time 
stamp 
0.000% 0.000% 57.140% 14.290% 28.570% 71.430% 
7th to 8th time 
stamp 
0.000% 0.000% 71.430% 28.570% 0.000% 100.000% 
 
 
Table 5.69: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
2.165% 6.061% 67.970% 18.610% 5.194% 94.806% 
2nd to 3rd 
time stamp 
0.000% 5.195% 60.610% 31.170% 3.025% 96.975% 
3rd to 4th 
time stamp 
0.433% 9.957% 58.870% 21.650% 9.090% 90.910% 
4th to 5th 
time stamp 
1.299% 4.762% 62.770% 28.570% 2.599% 97.401% 
5th to 6th 
time stamp 
0.433% 6.494% 51.520% 26.840% 14.713% 85.287% 
6th to 7th 
time stamp 
0.433% 4.329% 42.420% 36.360% 16.458% 83.542% 
7th to 8th 
time stamp 
2.165% 7.792% 39.830% 25.970% 24.243% 75.757% 
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Table 5.70: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.912% 4.863% 61.090% 28.270% 4.865% 95.135% 
2nd to 3rd 
time stamp 
0.000% 4.863% 75.080% 17.230% 2.827% 97.173% 
3rd to 4th 
time stamp 
0.912% 8.815% 60.490% 26.750% 3.033% 96.967% 
4th to 5th 
time stamp 
0.608% 7.903% 54.410% 28.270% 8.809% 91.191% 
5th to 6th 
time stamp 
1.520% 8.207% 56.230% 28.270% 5.773% 94.227% 
6th to 7th 
time stamp 
0.912% 5.471% 50.150% 27.050% 16.417% 83.583% 
7th to 8th 
time stamp 
0.304% 4.863% 46.200% 29.480% 19.153% 80.847% 
8th to 9th 
time stamp 
0.912% 7.903% 37.390% 25.230% 28.565% 71.435% 
 
 
Table 5.71: Patient distribution in intervals from previous to next time stamp – Series 2 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.000% 20.000% 60.000% 20.000% 0.000% 100.000% 
2nd to 3rd 
time stamp 
0.000% 20.000% 60.000% 20.000% 0.000% 100.000% 
3rd to 4th 
time stamp 
20.000% 20.000% 60.000% 0.000% 0.000% 100.000% 
4th to 5th 
time stamp 
0.000% 0.000% 80.000% 20.000% 0.000% 100.000% 
5th to 6th 
time stamp 
0.000% 0.000% 100.000% 0.000% 0.000% 100.000% 
6th to 7th 
time stamp 
0.000% 20.000% 80.000% 0.000% 0.000% 100.000% 
7th to 8th 
time stamp 
0.000% 0.000% 80.000% 0.000% 20.000% 80.000% 
8th to 9th 
time stamp 
0.000% 0.000% 80.000% 20.000% 0.000% 100.000% 
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Table 5.72: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.741% 4.444% 57.040% 33.330% 4.445% 95.555% 
2nd to 3rd 
time stamp 
0.000% 2.963% 75.560% 18.520% 2.957% 97.043% 
3rd to 4th 
time stamp 
0.000% 7.407% 62.220% 28.150% 2.223% 97.777% 
4th to 5th 
time stamp 
0.741% 9.630% 56.300% 27.700% 5.629% 94.371% 
5th to 6th 
time stamp 
2.222% 6.667% 57.040% 31.110% 2.961% 97.039% 
6th to 7th 
time stamp 
0.000% 5.926% 48.150% 28.890% 17.034% 82.966% 
7th to 8th 
time stamp 
0.000% 5.185% 42.220% 33.330% 19.265% 80.735% 
8th to 9th 
time stamp 
0.741% 10.370% 31.810% 28.890% 28.189% 71.811% 
 
Table 5.73: Patient distribution in intervals from previous to next time stamp – Series 1 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.000% 4.469% 56.420% 32.400% 6.711% 93.289% 
2nd to 3rd 
time stamp 
0.000% 3.911% 70.390% 24.580% 1.119% 98.881% 
3rd to 4th 
time stamp 
0.000% 5.028% 78.770% 14.530% 1.672% 98.328% 
4th to 5th 
time stamp 
0.559% 12.850% 58.100% 26.820% 1.671% 98.329% 
5th to 6th 
time stamp 
0.559% 10.610% 52.510% 26.820% 9.501% 90.499% 
6th to 7th 
time stamp 
2.235% 11.730% 57.540% 22.910% 5.585% 94.415% 
7th to 8th 
time stamp 
1.117% 6.145% 58.100% 24.020% 10.618% 89.382% 
8th to 9th 
time stamp 
0.559% 3.911% 51.960% 27.370% 16.200% 83.800% 
9th to 10th 
time stamp 
1.117% 2.821% 37.430% 25.140% 33.492% 66.508% 
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Table 5.74: Patient distribution in intervals from previous to next time stamp – Series 2 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.000% 0.000% 0.000% 50.000% 50.000% 50.000% 
2nd to 3rd 
time stamp 
0.000% 0.000% 100.000% 0.000% 0.000% 100.000% 
3rd to 4th 
time stamp 
0.000% 50.000% 50.000% 0.000% 0.000% 100.000% 
4th to 5th 
time stamp 
50.000% 50.000% 0.000% 0.000% 0.000% 100.000% 
5th to 6th 
time stamp 
0.000% 0.000% 50.000% 50.000% 0.000% 100.000% 
6th to 7th 
time stamp 
0.000% 0.000% 100.000% 0.000% 0.000% 100.000% 
7th to 8th 
time stamp 
50.000% 50.000% 0.000% 0.000% 0.000% 100.000% 
8th to 9th 
time stamp 
0.000% 0.000% 50.000% 0.000% 50.000% 50.000% 
9th to 10th 
time stamp 
0.000% 0.000% 50.000% 50.000% 0.000% 100.000% 
 
 
Table 5.75: Patient distribution in intervals from previous to next time stamp – Series 3 
 
180-252 
days 
253-324 
days 
325-396 
days 
397-468 
days 
469-540 
days 
Sum of 
180 -468 
days 
1st to 2nd 
time stamp 
0.000% 5.333% 52.000% 37.330% 5.337% 94.663% 
2nd to 3rd 
time stamp 
0.000% 5.333% 62.670% 30.670% 1.327% 98.673% 
3rd to 4th 
time stamp 
0.000% 1.333% 81.330% 14.670% 2.667% 97.333% 
4th to 5th 
time stamp 
0.000% 12.000% 53.330% 33.330% 1.340% 98.660% 
5th to 6th 
time stamp 
1.333% 12.000% 54.670% 21.330% 10.667% 89.333% 
6th to 7th 
time stamp 
4.000% 8.000% 61.330% 24.000% 2.670% 97.330% 
7th to 8th 
time stamp 
0.000% 6.667% 53.330% 30.670% 9.333% 90.667% 
8th to 9th 
time stamp 
0.000% 5.333% 49.330% 29.330% 16.007% 83.993% 
9th to 10th 
time stamp 
0.000% 9.333% 38.670% 32.000% 19.997% 80.003% 
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Tables 5.76 - 5.78 detail the scores, this time examining the time interval from time 
stamp to time stamp for each patient. 
 
 
Table 5.76: Score summary for series 1; from General to Photodetails 
 Rule I Rule II Rule III 
5 time stamps 1762 / 2328 4 / 4 1 / 1 
6 time stamps 1093 / 1420 5 / 5 1 / 1 
7 time stamps 697 / 887 5 / 6 1 / 1 
8 time stamps 0 / 546  6 / 7 1 / 1 
9 time stamps 0 / 329 6 / 8 1 / 1 
10 time stamps 0 / 179 8 /9 1 / 1 
 
Table 5.77: Score summary for series 2; from General to Photodetails 
 Rule I Rule II Rule III 
5 time stamps 41 / 51 4 / 4 1 / 1 
6 time stamps 21/25 4 / 5 1 / 1 
7 time stamps 7 / 10 3 / 6 1 / 1 
8 time stamps 4 / 7 4 / 7 1 / 1 
9 time stamps 3 / 5 6 / 8 1 / 1 
10 time stamps 0 / 2 6 /9 1 / 1 
 
Table 5.78: Score summary for series 3; from General to Photodetails 
 Rule I Rule II Rule III 
5 time stamps 968 / 1303 3 / 4 1 / 1 
6 time stamps 538 / 715 4 / 5 1 / 1 
7 time stamps 323 / 411 5 / 6 1 / 1 
8 time stamps 185 / 231 6 / 7 1 / 1 
9 time stamps 113 / 135 7 / 8 1 / 1 
10 time stamps 66 / 75 9 / 9 1 / 1 
 
Tables 5.76–5.78 show that there is uniformity in the creation of episodes not only for 
the same object in every time stamp but also from the previous to the next time stamp 
where the time interval is similar. As regards the third column in the tables above, the 
time interval from episode to episode ranges from 180 to 540 days and is broken down 
into five intervals: 180–252 days, 253–324 days, 325–396 days, 397–468 days, and 
469–540 days. It is calculated from the average of the sum of the patients that their 
time interval from time stamp to time stamp is a maximum of 468 days. The score 1/1 
shows that there is uniformity. The approach followed here is the same followed before 
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when it was examined the formation of a time stamp. The only thing that changes is the 
number of intervals. 
 
5.4.4.4 Interestingness 
 
This section presents the results of the experiments designed to evaluate the trend-
mining framework and SOMA in particular. As stated earlier, the datasets were 
manipulated either to contain a certain class (condition) of the disease or to pick up all 
patients. 
Interestingness criterion aims to identify whether:  The discovered rules are interesting   At which time stamp the discovered rules are interesting; in other words the 
criteria want to examine whether the interestingness duration is in all time stamp 
or not. 
Here interestingness should not been confused with the interestingness as a measure 
whether or the information is useful or not. The interestingness here is not used as a 
qualification criterion but as quantification. 
In large databases the amount of knowledge can be huge, hence the algorithm should be 
able to distinguish which rule is interesting or not. Using just confidence and support we 
can discover strong rules but this doesn’t mean that they are indeed interesting. 
In this thesis we are using 5 criteria to evaluate the interestingness of the discovered 
rule:  Lift  All confidence  Max confidence  Kulzusnki  Cosine. 
In chapter 2 is given details about those criteria. The following procedure is followed: 
For each of the above criteria the user sets a target which the discovered rules have to 
achieve. For lift the threshold must be above 1 which means that for any rule     X,Y 
are positively correlated. For the rest 4 criteria the threshold must be a percentage from 
0 to 100 %.  For each discovered rule,    , the 5 criteria is calculated. If the target is 
achieved the score increases by 1. So for each rule the maximum score that can be 
achieved is 5 and the minimum and then this final score is calculated as a percentage. If 
the final score expressed as a percentage, is greater than the threshold which the user 
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gives then the rule is interesting at a specific time stamp. That procedure is repeated for 
the rule     for all time stamps. 
For the experiments in this chapter, for lift the threshold is set above 1 and for the rest 4 
criteria the threshold is set to 50 %. 
The tables 5.20, 5.21 and 5.22 summarize the scores for the experiments. The line with 
the name “Total” shows the total number of trends. The following lines show the number 
of trends with the interestingness score above 50% below 50% the percentage of those 
trends and the maximum and minimum score of all trends, respectively. 
Tables5.82 to 5.84 show analytically the results for the experiments on the 
interestingness. Those tables provide the score for each of the 5 criteria for each time 
stamp, showing the number of trends that exceed the threshold, the number of trends 
that don’t exceed the threshold,  the maximum and the minimum score. 
In most case the score is ranged around 60% and this is due to the fact that the criteria 
are affected from the confidence of the inverse rule     and this can be seen from 
tables 5.82 to 5.84 and in particularly from the score of all confidence which is the mean 
of the confidences of the rule       and     and from the score of cosine which is the 
square root of the product of the confidence of a rule and its inverse. 
 
It can be seen that the amount of information available regarding patients with DR is 
very small compared with that regarding non-DR patients or those who have developed 
DR at a certain stage of their life. Hereinafter, experiments concerning all patients will be 
referred to as series 1, experiments for patients with DR in all time stamps as series 2, 
and the other category as series 3. 
The first measure of evaluation presented here is the interestingness of the rules not 
only at a certain point but in all time stamps. By applying a scoring system (described 
previously) using certain criteria apart from confidence, there is a maximum score that 
can be achieved, and the results are compared against that maximum value in Tables 
5.79 - 5.81. 
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Table 5.79: Summary of interestingness score for series 1 
       Time stamps 
Trends 5  6  7  8  9  10  
Total   423 383 338 308 259 188 
 interestingness score 
more than 50% 
228 231 214 224 197 153 
 interestingness score 
less than 50% 
195 152 124 84 62 35 
% interestingness 
score more than 50% 
53.9 60.31 63.31 72.73 76.06 81.38 
%  interestingness 
score less than 50% 
46.1 39.69 36.39 27.27 23.94 18.62 
Maximum score % 60 60 60 60 60 60 
Minimum score% 8 10 6.66 11.42 12 12.5 
 
 
 
 
Table 5.80: Summary of interestingness score for series 2 
      Time stamps 
Trends 5  6  7  8  9  10  
Total  62 40 19 16 12 6 
 interestingness score 
more than 50% 
0 1 3 1 12 6 
 interestingness score 
less than 50% 
62 39 16 15 0 0 
% interestingness 
score more than 50% 
0 2.5 15.79 6.25 100 100 
%  interestingness 
score less than 50% 
100 97.5 84.21 93.75 0 0 
Maximum score % 40 52 60 56 67.5 80 
 Minimum score % 40 40 40 40 60 80 
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Table 5.81: Summary of interestingness score for series 3 
    Time stamps 
 
Trends 
5  6  7  8  9  10  
Total   290 226 172 146 127 100 
 interestingness score 
more than 50% 
0 0 0 0 0 0 
 interestingness score 
less than 50% 
290 226 172 146 127 100 
% interestingness 
score more than 50% 
0 0 0 0 0 0 
%  interestingness 
score less than 50% 
100 100 100 100 100 100 
Maximum score % 40 40 40 40 40 47.5 
 Minimum score  % 40 40 40 40 40 40 
 
 
In all these tables, the first line shows the total line of trends under examination; the 
second line shows the number of trends for which their score exceeds 50%; and the 
third line shows the number of trends with a score below 50%. Lines 4 and 5 show, 
respectively, the percentage of trends scoring greater than and less than 50%, and the 
last two lines show the maximum and minimum scores. Each column represents an 
experiment with its number of time stamps.  
The next three tables, represent analytically the scoring for each series of experiments 
showing the results for each measure for all patients, for patients that have no DR and 
for patients with DR respectively. They present the number of occurrences which each 
criterion has exceeded, or not, a certain threshold, which is set to be equal to the 
confidence threshold, and this rule regards all confidence, max confidence, Kulczynski, 
and cosine. As regards lift, it is measured if it is greater than, equal to, or less than the 
unity. Regarding counting the number of occurrences, the trends under examination are 
those that have exceeded the confidence threshold in any time stamp. All Confidence, 
max confidence, Kulczynski, and cosine have a range of values from 0 to 100%, while lift 
is a positive real number.  
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Table 5.82: Interestingness score for series 1 
ALL Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 0 0 0 0 0 
Number of trends 
below  threshold 
1228 1177 1041 946 810 609 
Maximum value 10.22 % 10.92 % 12.26 % 13.22 % 12.69 % 18.75 % 
Minimum value 0.047 % 0.078 % 0.12% 0.20 % 0.33 % 0.60 % 
Cosine 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 0 0 0 0  0 
Number of trends 
below  threshold 
1228 1177 1041 946 810 609 
Maximum value 28.14 % 31.72 % 31.90 % 34.68 % 30.72 % 36.25 % 
Minimum value 1.13 % 1.37 % 1.54 % 2.25 % 3.37 % 4.57 % 
Max Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
1104 1065 968 879 760 573 
Number of trends 
below  threshold 
124 112 73 67 50 36 
Maximum value 100 % 100 % 100 %  100 % 100 % 100 % 
Minimum value 3.17 % 4 % 2.38 % 3.70 % 4.55 % 9.09 % 
Kulczynski 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
750 776 743 705 631 502 
Number of trends 
below  threshold 
148 401 298 241 179 107 
Maximum value 51.17 % 52.53 % 53.83 % 54.62 % 54.12 % 55.42 % 
Minimum value 1.91 % 2.23 % 1.69 % 2.76 % 3.62 % 6.71 % 
Lift 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends >1 980 923 822 773 672 524 
Number of trends =1 0 0 0 0 0 0 
Number of trends <1 300 254 219 173 138 85 
Maximum value 10.87 10.14 11.2278 11.14 10.96 13.76 
Minimum value 0.24 0.26 0.2112 0.27 0.37 0.37 
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Table 5.83: Interestingness score for series 2 
ALL Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 0 0 0 4 12 
Number of trends 
below  threshold 
139 93 47 45 30 0 
Maximum value 13.72 % 20 % 30 % 28.57 % 40 % 50 % 
Minimum value 1.96 % 4 % 10 % 14.28 % 20 % 50 % 
Cosine 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 5 36 40 34 12 
Number of trends 
below  threshold 
139 88 11 5 0 0 
Maximum value 37.04 % 44.72 % 54.77 % 53.45 % 63.24 % 70.71 % 
Minimum value 14.0 % 20 % 31.62 % 37.79 % 44.72 % 70.71 % 
Max Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
139 93 47  45 34 12 
Number of trends 
below  threshold 
0 0 0 0 0 0 
Maximum value 100 % 100 % 100 % 100 % 100 % 100 % 
Minimum value 100 % 100 % 100 % 100 % 100 % 100 % 
Kulczynski 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
139 93 47 45 34 12 
Number of trends 
below  threshold 
0 0 0 0 0 0 
Maximum value 56.86 % 60 % 65 % 64.28 % 70 % 75 % 
Minimum value 50.98 % 52 % 55 % 57.11 % 60 % 75 % 
Lift 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends >1 0 0 0 0 0 0 
Number of trends =1 139 93 47 45 34 12 
Number of trends <1 0 0 0 0 0 0 
Maximum value 1 1 1 1 1 1 
Minimum value 1 1 1 1 1 1 
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Table 5.84: Interestingness score for series 3 
ALL Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 0 0 0 0 0 
Number of trends 
below  threshold 
819 707 595 505 454 335 
Maximum value 10.36 % 11.88 % 12.65 % 15.15 % 11.85 % 22.67 % 
Minimum value 0.07 % 0.14 % 0.24 % 0.43 % 0.74 % 1.33 % 
Cosine 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
0 0 0 0 0 0 
Number of trends 
below  threshold 
819 707 595 505 454 335 
Maximum value 32.18 % 34.47 % 35.56 % 38.92 % 34.42 % 47.61 % 
Minimum value 2.77 % 3.73 % 4.93 % 6.57 % 8.50 % 11.54 % 
Max Confidence 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
819 707 595 505 454 335 
Number of trends 
below  threshold 
0 0 0 0 0 0 
Maximum value 100 % 100 % 100 % 100 % 100 % 100 % 
Minimum value 100 % 100 % 100 % 100 % 100 % 100 % 
Kulczynski 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends 
above  threshold 
819 707 595 505 454 335 
Number of trends 
below  threshold 
0 0 0 0 0 0 
Maximum value 55.18 % 55.94 % 56.32 % 57.57 % 55.92 % 50.67 % 
Minimum value 50.03 % 50.06% 50.12 % 50.21 % 50.37 % 61.33 % 
Lift 5 t.s. 6 t.s. 7 t.s. 8 t.s. 9 t.s. 10 t.s. 
Number of trends >1 0 0 0 0 0 0 
Number of trends =1 819 707 595 505 454 335 
Number of trends <1 0 0 0 0 0 0 
Maximum value 1 1 1 1 1 1 
Minimum value 1 1 1 1 1 1 
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From the tables 5.79-5.81, it can be seen that:  In all cases the maximum scoring has not been achieved. The highest scoring 
that has been achieved was 80%, and this refers to a trend from series 2 for 10 
time stamps.  In series 1 and series 3, the all confidence criterion remained below the 
threshold. Also, in the series 2 experiments for five time stamps to eight time 
stamps, the all confidence remains below the threshold. This means that only the 
  has confidence above the threshold, while the does not have 
confidence above the threshold. Practically, this can be interpreted as follows: 
characteristics are linked to DR, but DR cannot be linked to the same 
characteristics.  In series 2 and series 3, the lift is always equal to 1. This can be explained by the 
definition of lift. As mentioned earlier, lift is defined as the ratio of  over 
the product of . In those two series,  because in those datasets, 
all lines contain the same B, and .  Therefore, in cases where the 
dataset is manipulated in such a way that B has one value only, lift will always be 
equal to 1.  Therefore, the use of lift as a measure of interestingness cannot be 
reliable in such cases. 
5.4.4.5 Quality of the knowledge discovered 
 
To check the quality of knowledge discovered, specific rules were used that describe the 
relation of some attributes that exist in the databases with DR. For this reason, 
experiments were conducted using exclusively the attributes dictated by the rules. 
Moreover, the confidence threshold used in those experiments is higher than the 
confidence threshold that was used in the experiments above. At the following lines, the 
rules are presented along with the results from the experiments, which show whether 
the rules are confirmed or not:  If a patient suffers from cataracts, it is possible to develop DR: in the experiment 
with six time stamps (episodes), it has been shown that if a patient does not 
suffer from cataracts, then they are unlikely to suffer from DR. There is a 
maximum confidence of 90.64% and a minimum of 49.8%. The lift is well above 
1, with a minimum value of 1264.9. A very important finding from this 
experiment is that the inverse rule  has a minimum confidence of 87.2% 
and maximum confidence of 92.85%. 
157 
 
 The younger a patient is when diagnosed with diabetes, the more likely   this 
patient will develop DR. In the experiments with six time stamps, the following 
rule occurs: if a diabetic patient is diagnosed at the age of 60–70 years, they are 
unlikely to suffer from DR. This rule has a maximum confidence of 92.34% and a 
minimum of 53.17%, and the lift is very high, with a minimum value of 489.44%. 
However, the inverse rule has less confidence, with a minimum of 33% and 
maximum of 34%, and in this rule, the DR is not strongly linked to age of 
diabetes diagnosis.  If a patient has suffered from type 2 diabetes for more than 20 years, it is very 
likely that this patient will develop DR. An experiment with seven time stamps 
has shown the following rule: if a patient suffers from type 2 diabetes, and the 
duration of diabetes is less than 5 years, is unlikely to develop DR. This rule has a 
confidence of 84–96.4%, and the minimum lift value is 20.2. Although the inverse 
rule has a small confidence, ranging from 1.83 to 30%, it has a lift greater than 
1. Also, another rule from the same experiment is that if a patient has suffered 
from type 2 diabetes for more than 20 years, they are likely to develop DR. This 
rule has a confidence of 50–100% and minimum lift 1.1, and although the 
confidence of the inverse rule may be low, again the lift of the inverse rule is 
greater than 1, (1.4).  If a patient suffers from type 1 diabetes, they are likely to develop DR. This rule 
has been confirmed by experiments using different numbers of time stamps. In 
experiments with nine time stamps, a high value of confidence at 83.87% has 
been recorded. Both in this experiment and in others, where the maximum 
confidence reached 55%, the lift remained above 1. However, the inverse rule 
has a very low confidence (<15%) but also the lift is well above 1 with a 
minimum lift of 3.  If a patient suffers from type 2 diabetes and is on insulin treatment, this patient 
is likely to suffer from DR. This rule is confirmed by many experiments, with a 
confidence ranging from 9% to 61%, and the lift varying from 1.17 to 226.9.  If a patient suffers from type 2 diabetes, and the duration of diabetes is longer 
than 20 years then this patient is likely to develop DR. In an experiment with five 
time stamps, it has been confirmed that patient who suffers from diabetes type 2 
for more than 25 years is likely to suffer from DR. This rule has a confidence 
ranging from 75% to 100% and a lift ranging from 3.30 to 16.07. 
 
According to the clinicians of Saint Paul Eye Unit the first two clauses appear to provide 
new evidence while the other 4 fit with the accepted thinking and therefore provide 
validation to the approach described in this work. 
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5.4.5 Discussion 
 
One of the important problems in KDD is the evaluation of the discovered knowledge. In 
real-life applications, the number of discovered rules is huge, and it is difficult for the 
end user to identify interesting ones. In this thesis, evaluation concerns not the only the 
discovered knowledge from the proposed trend-mining framework, but also the 
procedure that the framework follows to discover the knowledge. Similar work has been 
proposed and described in Nohuddin (2012). In that thesis the author described an 
approach which is designed to support “end-to-end” social network data and named it 
predictive trend mining framework. The author divides the framework into two parts; 
one part is the trend discovery with the use of the FTP Apriori algorithm and in the 
second part SOM is used to group and visualise the produced trends. Finally the 
evaluation approach concentrates on the final result of the framework ignoring the 
intermediate stages.  
Geng and Hamillton (2006) used the term “interesting measures” to facilitate a general 
approach to automatically identifying interesting patterns. They used this term in three 
ways, or roles, to use their terminology. First, the measures can be used to prune 
uninteresting patterns during the mining process. Second, measures can be used to rank 
the patterns according to their interestingness, and finally they are used during post-
processing to select interesting patterns. 
 
In this research work, a similar approach is used. First, the measures are used to create 
time-stamped datasets with the least noise. Second, they are used to discover 
interesting patterns in data. Third, measures are used to rank the interestingness and 
filter the rules. Fourth, the measures are used to evaluate the interestingness of the 
discovered knowledge. 
Geng and Hamilton (2006) categorized the “interesting measures” as follows:  objective measures;  subjective measures;  semantic measures. 
Objective measures are based only on the raw data, and no knowledge about the user or 
application is required. A subjective measure takes into account both the data and the 
user of these data. To define a subjective measure, access to the user’s domain or 
background knowledge about the data is required. A semantic measure considers the 
semantics and explanations of the patterns. Because semantic measures involve domain 
knowledge from the user, Yao et al. (2006) considered them to be a special type of 
subjective measure. 
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The measures used for the evaluation of this thesis come from the categories of 
subjective and objective measures. The measures used in the pre-processing are 
subjective measures because both the creation of the time-stamped datasets and the 
development of rules for cleaning require knowledge of the domain. 
 
Measures for ARM and ranking are objective, since no knowledge of the domain is 
needed. ARM is based on the support threshold and confidence threshold, and ranking is 
achieved using the support values in every time stamp by using mathematical conditions  
and also by calculating the following properties of the rules: lift, cosine, all confidence, 
max confidence, and Kulc. Filtering, on the other hand, is subjective because the user 
uses knowledge of the domain to select the antecedent and consequent of the rule. 
 
Measures to evaluate the knowledge fall into the category of subjective measures 
because they are based on the knowledge of the domain. The measure that is used in 
this thesis to evaluate the results is based on the user’s existing knowledge and follows 
an approach similar to the work presented by Liu et al. (1997). They introduced the 
concept of general impressions. General impressions are if–then clauses that describe 
the relation between a condition variable and a class value, and reflect the user’s 
knowledge of the domain. 
 
In   Liu et al. (1997), the criterion they use to compare a discovered rule r against a set 
of general impressions G:{G1, G2, ..., GN} is that the rule r and any general impression 
from the set G must have the same consequent. In this thesis, this principle is modified 
not only by accepting a general impression with the same consequent but also by 
accepting general impressions with the opposite consequent if and only if the antecedent 
in r is also the opposite of the antecedent of a general impression. 
 
Liu et al. (1999) extended their approach to the evaluation by proposing another 
technique to rank rules according to knowledge background. Based on the user’s 
knowledge, the discovery rules can be classified into the three following categories:  An unexpected rule is a rule that is unexpected or previously unknown to the user 
if it has an unexpected condition, an unexpected consequent, or both.  A confirming rule is a rule that partially or completely matches a user’s existing 
knowledge.  An actionable rule is a rule that a user can use to do something to their 
advantage. 
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The evaluation of the knowledge discovered by the advocated trend-mining framework 
concentrates on confirming rules to validate the knowledge discovery of the framework. 
 
The rules discovered by knowledge-discovery methods must be of interest to end users 
to be considered as useful. Therefore, evaluation both of the interestingness of the rules 
and of the method used to produce those rules is an active and very important task in 
knowledge discovery, but there are no single measures that can be applied everywhere 
because KDD can be used in different application domains. Thus, the evaluation 
approach advocated is adjusted to the proposed trend-mining framework of this thesis. 
 
From the evaluation of the thesis using the SOMA framework, the following conclusions 
arise. The noise reduction barely reaches levels above 50%, mainly owing to the fact 
that in the specific example, the expert’s knowledge was used instead of a more generic 
method such as using the average value or the value that is observed more frequently. 
On the other hand, even though the percentage of noise reduction is low, the object 
distribution from time stamp to time stamp is very good, since at least 90 objects from 
the experiments are used throughout all the time stamps. As regards the interestingness 
of the produced rules, the score rarely exceeds 60% because two of the measures are 
based on the confidence of the inverse rule. On the other hand, if the dataset is 
manipulated into a specific characteristic, regarding the consequent of the rule, owing to 
the definition of confidence, some criteria are nullified. 
 
The figures in appendix 4 show colourful representations, how patients are moving from 
time stamp to time stamp and from trend to trend.  The concept behind this method is 
based on the definition of trends. As it was referred previously the trend shows how the 
support changes from time stamp to time stamp.  Thus, in each time stamp the support 
value shows the number of objects which the framework identifies as having certain 
attribute values, given by the trend. The representation passes through the following 
steps:  At the first time stamp the framework allocates with a unique colour every group 
of objects (patients in the case of SOMA).Each group fills a square with its colour. 
The number of different groups at this point is equal to the number of trends.  If 
a trend has 0 support value then it is given the white colour at the square that 
represent this trend at this time stamp.  At the next time stamp, the framework examines whether or not the group 
changes in terms of number of objects and of the trend where the objects are 
located. In other words, the framework tracks the objects and adjusts the square 
colours according to what was described earlier in chapter 4. 
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 The orientation of this mosaic of colours is :from bottom to top each line is a 
trend, at the bottom is the first trend at the top the last one; form left to right is 
every time stamp. 
The aim of this kind of representation is to help the end users to follow the trends along 
with the text outcome of the framework. 
 
Regarding the evaluation of the discovered knowledge, although the use of trend mining 
makes it possible to predict what experts expect, the confidence ranges from very low to 
very high values. Also, the inverse rule has very rarely been justified with a high 
confidence value. By contrast, lift has always shown very good values above 1. In this 
specific case using the diabetic retinopathy databases, the attributes showing diabetic 
retinopathy are rather fewer in number than the attributes showing no diabetic 
retinopathy and so it has been accepted that there are ranges in the lift and confidence 
values. 
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Chapter 6 Conclusion & Future Work 
 
In this research work it is presented a Trend Mining framework with aim to extract 
hidden trend from longitudinal datasets. The proposed trend mining mechanism is 
founded on an Association Rule Mining (ARM) approach whereby an ARM technique is 
applied to a sequence of time stamped data sets. This approach is both efficient and 
effective at finding trends. The disadvantage, given appropriate input parameters, is that 
a great many trends may be discovered; the number of identified trends can of course 
be reduced by adjusting the parameters, but at the risk of losing potentially valuable 
knowledge. 
 The application of this novel framework consists of 3 steps:  Pre-processing of the data: applying cleansing techniques to reduce noise 
and preparation of time-stamped datasets.  Main process: creation of trends.  Evaluation of the discovered knowledge. 
SOMA is the application of trend mining framework on the diabetic retinopathy datasets 
which contain data collected from St Paul’s Eye clinic of Royal University Liverpool 
Hospital. This data is itself of particular interest, in the context of trend mining, as the 
“time stamps” are defined in terms of patient visit number, as opposed to more 
traditional forms of temporal data. The data is also extremely noisy. SOMA represents 
trends as constraints on parameters over intervals that correspond to phases of a 
process. This representation is based on how expert diagnosticians verbally report their 
knowledge of trends. For this reason trend templates may be useful for knowledge 
acquisition and explanation of trends. 
SOMA monitors process data and matches them to hypotheses which include a trend 
template and a chronology of how the data fall into different stages of the trend. Our 
prototype application to growth chart monitoring produces plausible hypotheses on a real 
patient. The Aretaeus trend discovery   algorithm provides a useful mechanism for trend 
classification. 
Within this research work a generic framework has been proposed for the Validation and 
Verification of trend mining. The verification examines if the intermediate results are 
self-consistent and the validation tries to uncover known causal connections in the 
application. 
In order to evaluate the trend mining a set of criteria has been established which covers 
all stages of trend mining. Those criteria were adjusted to the application of diabetic 
retinopathy data. 
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As a result of this application it can be concluded that noise reduction based on the 
expert knowledge of the domain is not pretty much effective. Even though, the noise 
reduction didn’t exceed the 50 % the object distribution was quite good. As regards the 
interestingness of the results this is measured using max_confidence, all_confidence, 
cosine, Kulc and lift. The first 4 criteria depend not only from the confidence of the 
rule    , but also they depend on the confidence of the inverse rule    . The 
evaluation showed that using the data from the specific diabetic retinopathy databases, 
very rarely there was an inverse rule with high confidence.  
Another conclusion is that using a mosaic of colours to describe the trends, it makes the 
visualization a very difficult task because the amount of trends is huge. 
To examine the quality of the discovered knowledge, specific rules were used. Those 
rules are related with the domain of diabetic retinopathy and describe the relation of 
certain characteristics, such as diabetes type, duration, treatment etc. The trend mining 
was able to predict those rules but not always with high confidence values. Even though, 
lift values were well above 1 which shows that the attributes are highly related. 
 
6.1 Future work 
 
In order to improve the trend mining framework the following tasks are suggested for 
future studies:  The framework should be tested using different kinds of databases, for 
several large scale experiments.  Improvement of the pre-processing stage. In terms of noise reduction, a 
novel way should be implemented to deal with this task. A Bayesian 
network could be implemented to fill the missing values using the existing 
data. Thus the noise will be cleared and the datasets that will be produced 
will give more accurate results. Another challenge in the pre-processing is 
the formation of the time stamp; events, whose combination creates an 
episode, do not occur periodically, so it would be very interesting to have 
time stamps with different time interval for each stamp.  Another issue is the use of threshold values. In the work presented in this 
thesis, the framework targets knowledge with a frequency above a 
threshold. However, in some domains what is of great importance may be 
events that do not occur frequently (infrequent patterns / trends). 
Therefore it would be very challenging to make the framework work on 
events that occur rarely. 
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 Techniques to predict the interval between change points/state changes in 
records. For example to act as a guide for establishing safe disease 
screening intervals in medical records.   Techniques to identify the key attributes in longitudinal data sets that 
influence a particular classification (i.e. the features that influence patient 
progress in the context of a given disease/condition) and reduce the 
interaction with the end use on that issue, making the framework more 
autonomous.  So far the framework uses one dimension to produce trends; the time 
dimension. A field to expand the present work would be the use of more 
dimensions, where a dimension will represent a specific attribute and time 
stamps will be defined by the intervals of the values of this chosen 
attribute. For example in SOMA the user could use the attribute that 
shows the kind of treatment and assumes that different values of that 
attributes are the new stamps, the attribute-stamps. The time that so far 
was used to define an episode, with this approach could be converted into 
another attribute.  Visualization techniques. Although trend mining produces a colourful 
representation the difficulty increases when the amount of the produced 
knowledge is huge. Therefore several filters may be needed to allow the 
user ,via an interface ,to choose what should be visualized and to clear the 
amount of information based on some values like lift, confidence or the 
kind of trend.  
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Appendices 
 
Appendix 1 – Schemas for logic rules 
 
Table A1.1 Schema for DiabRetinaPhotodetails dataset 
Liverpool Diabetes Eye Study Schema Description:  
Database DIAB   
Dataset DiabRetinaPhotodetails                                                                                                                       Date: 03/03/10 
Data Label Description Data 
type 
Value  Narrative  Logic  Rules 
StudyIDNo ID number  Number Xxxxx   
NHS No 
 
ID number (key 
patient identifier 
for Study 
Tables) 
Number 10 digits   
ExamDate Date  Date/ 
Time 
dd/mm/yy    
REField1NAS Field position 
nasal field   
Ignore warehouse  
REField2UTQ Upper temporal 
quadrant 
  Ignore warehouse  
REField3LTQ Lower temporal 
quadrant 
  Ignore warehouse  
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REQual Clarity and 
focus 
  Ignore warehouse  
REHMA Haemorrhages 
and/or micro 
aneurysms  
nominal None=0, 
Quest=1, 
<2A=2, 
≥2A=3, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
RENVD New Vessels 
Disc  
nominal None=0, 
Quest=1, 
<10A=2, 
≥10A=3,  
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
RECWS8A Cotton wool 
spot 
nominal None=0, 
Quest=1, 
<six=2, 
≥six=3, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
RENVE New vessels 
elsewhere  
nominal None=0, 
Quest=1, 
<1/2DA=2, 
≥1/2DA=3, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
REVBVRVL6A Venous Beading 
and /or Venous 
nominal None=0, 
Quest=1, 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
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Reduplication 
and/or Venous 
Loop 
1Quad=2 
2Quads=3   
3Quads= 4 
 4Quads=5 
CG=90 
REFVP Fibrovascular 
proliferation 
nominal None=0, 
Quest=1, 
FPE=2,  
FPD=3,  
FPE+FPD=4,  
TRD=5, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
REIRMA Intraretinal 
microvascular 
abnormality  
nominal None=0, 
Quest=1, 
<8A=2, 
≥8A=3, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
 
REPRH VH Pre-Retinal 
Haemorrhage  
Vitreous  
Hemorrhage   
 
nominal None=0, 
Quest=1,  
PRH=2, 
VH=3,  
PRH+VH=4, 
 CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
 
RERET Retinopathy nominal None=10,  calculated from Calculated from above 8 
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level Quest=12,  
 HMA<2A=20, HMA≥2A 
and /or CWS<six=30, 
CWS≥six and/or IRMA<8A 
and/or VB/VR/VL (1 quad 
only)=40,  
IRMA≥8A and/or 
VB/VR/VL≥2 quads=50,  
FVP and/or PDR and /or 
PRP=60,  
PDR+HRC=70, 
PDR+TRD=71,  
CG-total VH=72,  
CG=90 
above 8 attributes attributes 
See appendix for full rule 
If null and LEOUTCOME8=90 
set as 90; else set as NR 
RELASER Any laser; PRP, 
focal or grid 
nominal None=0, 
Quest=1, 
PRP=2, 
Focal /Mac Grid=3, 
CG=90 
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
REMAC-EX Presence of 
macular 
exudates  
nominal None=0, 
Quest=1, 
 Present>1DD=2 , 
Circinate=3, Present.≤1DD 
and /or Laser=4,  
 If null and REOUTCOME8=90 
set as 90; else set as =NR 
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Other (non-DR) =8,  
CG=90 
RECUPDISC Cup disc ratio 
≥0.7 
nominal No=0, 
Quest=1, 
Yes=2, 
CG=90 
If yes = sign of 
glaucoma 
ignore analysis 
 
REOTHER1 None-OTHER1 nominal Yes=0 (no other disease) 
No=-1 (other disease 
present) 
CG=90 
 
This field records 
absence of other 
eye disease 
Ignore analysis 
Where REOTHER2-23 = not 0 
or empty field, then enter 0 
REOTHER2 Drusen /ARMD-
OTHER2 
nominal Yes=1 disease present) 
No =0 
ignore analysis Where null set as  0 
REOTHER3 CNVM-OTHER4 nominal Yes =2 
No=0 
ignore analysis Where null set as  0 
REOTHER4 Naevus-OTHER5 nominal Yes=3 
No=0 
ignore analysis Where null set as  0 
REOTHER5 Epiretinal 
Membrane-
stopped after 
1998 
nominal Yes=4 
No=0 
ignore analysis Where null set as  0 
REOTHER6 C/BRAO- 
stopped after 
1998 
nominal Yes=5 
No=0 
ignore analysis Where null set as  0 
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REOTHER7 CRVO-OTHER9 nominal Yes=6 
No=0 
ignore analysis Where null set as  0 
REOTHER8 BRVO-OTHER10 nominal Yes=7 
No=0 
ignore analysis Where null set as  0 
REOTHER9 Other Disc- 
stopped after 
1998 
nominal Yes=8 
No=0 
ignore analysis Where null set as  0 
REOTHER10 Rhematogenous 
RD - stopped 
after 1998 
nominal Yes=9 
No=0 
ignore analysis Where null set as  0 
REOTHER11 Vitreous 
Opacity- 
stopped after 
1998 
nominal Yes=10 
No=0 
ignore analysis Where null set as  0 
REOTHER12 Couldn’t Grade 
throughout - 
OTHER17jjk[[/ 
nominal Yes=90 
No=0 
ignore analysis Where null set as  0 
REOTHER13 Other-OTHER18 nominal Yes =11 
No = 0 
ignore analysis Where null set as  0 
REOTHER14 Age-related 
Macular 
Degeneration 
/Retinal Pigment 
Epithelial  
nominal Yes =20 
No = 0 
ignore analysis Where null set as  0 
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Change-OTHER3 
REOTHER15 OTHER6 
 
nominal 21 ignore analysis Where null set as  0 
REOTHER16 Central Retinal 
Artery Occlusion 
-OTHER7 
nominal Yes = 22 
No = 0 
ignore analysis Where null set as  0 
REOTHER17 Retinal Artery 
Occlusion -
OTHER8 
nominal Yes=23 
No=0 
ignore analysis Where null set as  0 
REOTHER18 Rhematogenous 
Retinal 
Detachment-
OTHER11 
nominal Yes=24 
No = 0 
ignore analysis Where null set as  0 
REOTHER19 Myelinated 
Nerve Fibres -
OTHER12 
nominal Yes=25 
No=0 
ignore analysis Where null set as  0 
REOTHER20 Myopic 
Degeneration-
OTHER13 
nominal Yes=26 
No=0 
ignore analysis Where null set as  0 
REOTHER21 Tited Disc-
OTHER14 
nominal Yes=27 
No=0 
ignore analysis Where null set as  0 
REOTHER22 Asteroid 
Hyalosis-
OTHER15 
nominal Yes=28 
No=0 
ignore analysis Where null set as  0 
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REOTHER23 Hollenhorst 
Plaque-
OTHER16 
nominal Yes=29 
No=0 
ignore analysis Where null set as  0 
REDISCSP Specify Disc text Comments Ignore warehouse  
REVITOPSP Vitreous Opacity  text Comments Ignore warehouse  
RESTEREO Was stereo 
photography 
performed  
 Yes/No Ignore analysis  
REMACOED Assessment of 
macular oedema 
nominal None=0,  
Quest=1, 
 present, not CSMO=2, 
Circinate=3, 
Present CSMO=4, other=8, 
CG=90 
Ignore analysis 
Only recorded if 
stereo present on 
photos.  
 
REOUTCOME1 Screen negative nominal 0 Ignore analysis  
REOUTCOME2 Screen pos –
retinopathy 
level 30 and 
above 
nominal 1 Ignore analysis  
REOUTCOME3 Screen pos- 
Maculopathy 
level 3 and 
above 
nominal 2 Ignore analysis  
REOUTCOME5 Screen pos- nominal 4 Ignore analysis  
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Disc 
REOUTCOME6 Screen pos-
diabetic other 
nominal 5 Ignore analysis  
REOUTCOME7 Non-diabetic 
STED 
nominal 6 Ignore analysis  
REOUTCOME8 Couldn’t Grade 
throughout  
nominal 90 Ignore analysis  
REOUTCOME9 No photos nominal 99 
 
Ignore analysis  
RE CALCULATED 
OUTCOME 
composite score 
for grading 
outcome for RE 
nominal screen –ve 0, 
screen +ve retinopathy 
=1, 
screen +ve maculopathy 
=2, 
screen +ve retinopathy 
and screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
This field records 
the outcome of 
the screening 
episode 
 
If  retinopathy or 
macular exudates 
is ungradable then 
eye is ungradable 
 
If either 
retinopathy or 
maculopathy 
attributes are null 
(empty) then eye 
calculated from RERET and 
REMACEX 
 
If <RERET> = 10, 12, 20 and  
<REMACEX> = 0,1,2,8 then 
set =0 
 
if <RERET> = 
30,40,50,60,70,71,72 and 
<REMACEX> =0,1,2 ,8,90,NR 
then set as =1 
 
If <RERET> = 10, 12, 
20,90,NR and  <REMACEX> 
=3,4 then set as =2 
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cannot be 
categorized for 
this field and is set 
as NR 
 
if <RERET> = 
30,40,50,60,70,71,72 and 
<REMACEX> =3,4 then set as 
=3 
 
Ungradable  
If <RERET> = 90 or 
<REMACEX> = 90 then set = 
90 
 
Null attributes 
If <RERET> = NR or  
<REMACEX> = NR then set = 
NR 
 
LEField1NAS Field position 
nasal field   
Ignore warehouse  
LEField2UTQ Upper temporal 
quadrant 
  Ignore warehouse  
LEField3LTQ Lower temporal 
quadrant 
  Ignore warehouse  
LEQual Clarity and 
focus 
  Ignore warehouse  
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LEHMA Hemorrhages 
and/or Micro 
Aneurisms  
nominal None=0, 
Quest=1, 
<2A=2, 
 ≥2A=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LENVD New vessels 
Disc  
nominal None=0, 
Quest=1, 
<10A=2, 
≥10=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LECWS8A Cotton wool 
Spot 
nominal None=0, 
Quest=1, 
<six=2, 
≥six=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LENVE New vessels 
Disc Elsewhere  
nominal None=0, 
Quest=1, 
<1/2DA=2, 
≥1/2DA(5)=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LEVB/VR/VL6A Venous Beading 
and /or Venous 
Reduplication 
and/or Venous 
nominal None=0, 
Quest=1, 
1Quad=2 
2Quads=3  ,  
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
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Loop 3Quads= 4 , 
 4Quads=5  , 
CG=90 
LEFVP Fibro vascular 
Proliferation 
nominal None=0, 
Quest=1, 
FPE=2, 
FPD=3, 
FPE+FPD=4, 
TRD=5, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LEIRMA IntraRetinal 
Micro vascular 
Anomaly  
nominal None=0, 
Quest=1, 
<8A=2, 
≥8A=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LEPRHVH Pre-Retinal 
Hemorrhage  
Vitreous  
Hemorrhage   
 
nominal None=0, 
Quest=1, 
PRH=2, 
VH=3, 
PRH+VH=4, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LERET Retinopathy 
level 
nominal None=10, 
Quest=12, 
HMA<2A=20, 
calculated from 
above 8 attributes 
Calculated from above 8 
attributes 
See appendix for full rule 
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HMA≥2,CWS<six=30, 
CWS≥six,IRMA,VB/VR/VI=
40, 
IRMA≥8,VB/VR/VL≥2 
quads=50, 
FVP,PDR±PRP=60, 
PDR+HRC=70,PDR+TRD=
71, 
CG-total VH=72, 
CG=90 
If null and LEOUTCOME8=90 
set as 90; else set as NR 
LELASER Any macular 
laser; focal or 
grid 
nominal None=0, 
Quest=1, 
PRP=2, 
Mac Grid=3, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LEMACEX Presence of 
macular 
exudates 
nominal None=0, 
Quest=1, 
Present,>1DD=2 , 
Circinate=3, 
Present.≤1DD±Laser=4, 
Other=5, 
CG=90 
 If null and LEOUTCOME8=90 
set as 90; else set as NR 
LECUPDISC Cup disc ratio 
≥0.7 
nominal No=0, 
Quest=1, 
If yes = sign of 
glaucoma 
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Yes=2, 
CG=90 
ignore analysis 
LEOTHER1 None-OTHER1 nominal 0 This field records 
absence of other 
eye disease 
Where LEOTHER2-23 = not 0 
or empty field, then enter 0 
LEOTHER2 Drusen/ARMD-
OTHER2 
nominal 1 Ignore analysis Where null set as  0 
LEOTHER3 CNVM-OTHER4 nominal 2 Ignore analysis Where null set as  0 
LEOTHER4 Naevus-OTHER5 nominal 3 Ignore analysis Where null set as  0 
LEOTHER5 Epiretinal 
Membrane- 
stopped after 
1998 
nominal  
 
4 
Ignore analysis Where null set as  0 
LEOTHER6 C/BRAO- 
stopped after 
1998 
nominal 5 Ignore analysis Where null set as  0 
LEOTHER7 CRVO-OTHER9 nominal 6 Ignore analysis Where null set as  0 
LEOTHER8 BRVO-OTHER10 nominal 7 Ignore analysis Where null set as  0 
LEOTHER9 Other Disc- 
stopped after 
1998 
nominal 8 Ignore analysis Where null set as  0 
LEOTHER10 Rhematogenous 
RD - stopped 
after 1998 
nominal 9 Ignore analysis Where null set as  0 
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LEOTHER11 Vitreous 
Opacity- 
stopped after 
1998 
nominal 10 Ignore analysis Where null set as  0 
LEOTHER12 CG- 
OTHER17 
nominal 90 Ignore analysis Where null set as  0 
LEOTHER13 Other-OTHER18 nominal 11 Ignore analysis Where null set as  0 
LEOTHER14 Age-related 
Macular 
Degeneration 
/Retinal Pigment 
Epithelial defect  
Change-OTHER3 
nominal 20 Ignore analysis Where null set as  0 
LEOTHER15 OTHER6 nominal 21 Ignore analysis Where null set as  0 
LEOTHER16 Central Retinal 
Artery 
Occlusion-
OTHER7 
nominal 22 Ignore analysis Where null set as  0 
LEOTHER17 Branch Retinal 
Artery 
Occlusion-
OTHER8 
nominal 23 Ignore analysis Where null set as  0 
LEOTHER18 Rhegmatogenou
s Retinal 
nominal 24 Ignore analysis Where null set as  0 
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Detachment -
OTHER11 
LEOTHER19 Myelinated 
Nerve Fibres -
OTHER12 
nominal 25 Ignore analysis Where null set as  0 
LEOTHER20 Myopic 
Degeneration-
OTHER13 
nominal 26 Ignore analysis Where null set as  0 
LEOTHER21 Tited Disc-
OTHER14 
nominal 27 Ignore analysis Where null set as  0 
LEOTHER22 Asteroid 
Hyalosis-
OTHER15 
nominal 28 Ignore analysis Where null set as  0 
LEOTHER23 Hollenhorst 
Plaque-
OTHER16 
nominal 29 Ignore analysis Where null set as  0 
LEDISCSP Specify Disc text Comments Ignore warehouse  
LEVITOPSP Vitreous Opacity  text Comments Ignore warehouse  
LESTEREO Was stereo 
photography 
performed  
nominal Yes/No Ignore analysis  
LEMACOED Assessment of 
macular oedema 
nominal None=0,  
Quest=1, 
 present, not CSM=2, 
Only recorded if 
stereo present on 
photos.  
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Circinate=3, 
Present CSMO=4, other=8, 
CG=90 
LEOUTCOME1 Screen negative nominal 0 Ignore analysis 
 
 
LEOUTCOME2 Screen positive 
-retinopathy 
nominal 1 Ignore analysis  
LEOUTCOME3 Screen positive- 
maculopathy 
nominal 2 Ignore analysis  
LEOUTCOME4 Screen pos 
-VA 
nominal 3 Ignore analysis  
LEOUTCOME5 Screen pos- 
disc 
nominal 4 Ignore analysis  
LEOUTCOME6 Screen pos-
diabetic other 
nominal 5 Ignore analysis  
LEOUTCOME7 Non-diabetic 
Sight 
Threatening E 
Disease  
nominal 6 Ignore analysis  
LEOUTCOME8 Couldn’t Grade 
throughout  
nominal 90 Ignore analysis  
LEOUTCOME9 No photos nominal 99 Ignore analysis  
LE CALCULATED 
OUTCOME 
composite score 
for grading 
nominal screen –ve 0, 
screen +ve retinopathy 
This field records 
the outcome of 
calculated from LERET and 
LEMACEX 
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outcome for RE =1, 
screen +ve maculopathy 
=2, 
screen +ve retinopathy 
and screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
the screening 
episode 
 
If  retinopathy or 
macular exudates 
is ungradable then 
eye is ungradable 
 
If either 
retinopathy or 
maculopathy 
attributes are null 
(empty) then eye 
cannot be 
categorized for 
this field and is set 
as NR 
 
If <LERET> = 10, 12, 20 and  
<LEMACEX> = 0,1,2,8 then 
set =0 
 
if <LERET> = 
30,40,50,60,70,71,72 and 
<LEMACEX> =0,1,2 ,8,90,NR 
then set as =1 
 
If <LERET> = 10, 12, 
20,90,NR and  <LEMACEX> 
=3,4 then set as =2 
 
if <LERET> = 
30,40,50,60,70,71,72 set = 1 
and <LEMACEX> =3,4 then set 
as =3 
 
Ungradable  
If <LERET> = 90 or  
<LEMACEX> = 90 then set = 
90 
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Null attributes 
If <LERET> = NR or  
<LEMACEX> = NR then set = 
NR 
 
BEOUTCOME1 Screen neg nominal 0 Ignore analysis  
BEOUTCOME2 Screen pos-
retinopathy 
nominal 1 Ignore analysis  
BEOUTCOME3 Screen pos-
maculopathy 
nominal 2 Ignore analysis  
BEOUTCOME4 Screen pos-VA nominal 3 Ignore analysis  
BEOUTCOME5 Screen pos- 
disc 
nominal 4 Ignore analysis  
BEOUTCOME6 Screen pos- 
Diabetic other 
nominal 5 Ignore analysis  
BEOUTCOME7 Non –diabetic 
STD 
nominal 6 Ignore analysis  
BEOUTCOME8 Couldn’t Grade 
throughout 
nominal 90 Ignore analysis  
BEOUTCOME9 No photos nominal 99 Ignore analysis  
BE CALCULATED 
OUTCOME 
composite score 
for grading 
outcome for RE 
nominal screen –ve 0, 
screen +ve retinopathy 
=1, 
screen +ve maculopathy 
This field records 
the outcome of 
the screening 
episode by patient 
calculated from RE 
CALCULATED OUTCOME and LE 
CALCULATED OUTCOME 
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=2, 
screen +ve retinopathy 
and screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
 
Highest grade in 
either eye takes 
precedence 
If maculopathy 
and retinopathy 
exist in either or 
both eyes then set 
as 3 
 
Ungradable 
Where both 
attributes = 90 set 
as 90 
Where one field = 
90: 
i) and other is 0 
set as 90 
ii) and other is 
1,2, or 3 set as 
1,2,3 respectively  
 
Null attributes 
Where both 
If < RE CALCULATED 
OUTCOME > = 0 and  < LE 
CALCULATED OUTCOME > =0 
then set = 0 
 
If (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 1) 
and (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 
0,1)  then set = 1 
 
If (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 2) 
and (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 
0,2) then set = 2 
 
If (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 1) 
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attributes = null 
set as not 
recorded (NR) 
Where one field = 
null : 
i) and other is 0 
set as NR 
ii) and other is 
1,2, or 3 set as 
1,2,3 respectively 
and (< RE CALCULATED 
OUTCOME > or < LE 
CALCULATED OUTCOME > = 2) 
then set = 3 
 
If either < RE CALCULATED 
OUTCOME > = 3 or  < LE 
CALCULATED OUTCOME > =3 
then set = 3 
 
Ungradable  
If <RE CALCULATED 
OUTCOME> = 90 and  <LE 
CALCULATED OUTCOME > = 
90 then set = 90 
 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 0) 
then set = 90 
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If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 1) 
then set = 1 
 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 2) 
then set = 2 
 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 3) 
then set = 3 
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Null attributes 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 0) 
then set = NR 
 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 1) 
then set = 1 
 
If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 2) 
then set = 2 
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If (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE 
CALCULATED OUTCOME > = 3) 
then set = 3 
 
DiabStedEye Auto generated-
by rule .Not on 
Photo form-6/98 
nominal Yes=Y, 
No=N 
Replace 
autogenerated  
with value 
calculated from 
elsewhere 
 
As in BE 
OUTCOME but 
level 40 or above 
for retinopathy 
and no account of 
presence of 
maculopathy and 
retinopathy  
calculated from < BE 
CALCULATED OUTCOME> and 
<RERET> and <LERET> 
 
If <BE CALCULATED 
OUTCOME> = 0, 90 or NR then 
set as N 
 
If <BE CALCULATED 
OUTCOME> = 2,3 then set as 
Y 
 
If <BE CALCULATED 
OUTCOME> = 1 and 
(<RERET> = 30 and <LERET> 
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= 30) then set as N else set as 
Y 
 
Action Recall nominal Yes=Y, 
No=N 
Ignore warehouse  
      
 
 Inclusive rule          
  HMA NVD CWS8A NVE VB/VR/VL6
A 
FVP IRMA PRHVH Laser 
 variables 0,1,2,
3,90,
NR 
0,1,2,
3,90,
NR 
0,1,2,3
,90,NR 
0,1,2,3,
90,NR 
0,1,2,3,4,5,
90,NR 
0,1,2,3,4,5,90
,NR 
0,1,2,3,90
,NR 
0,1,2,3,4,90,
NR 
0,1,2,3,90,
NR 
1
0 
 is not 
= 2 
or 3 
is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
1
2 
any field = 1 is not 
= 2 
or 3 
is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
2
0 
HMA =2   is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
3 HMA =2 and/or   is not  is not = is not = is not = 2,3,4 is not = 2 is not = 2,3 is not = 2,3 
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0 CWS8A =2 = 2 
or 3 
2 or 3 2,3,4 or 5 or 5 or 3 or 4 
4
0 
CWS8A = 3 and/or 
VB/VR/VL6A =2 
and/or IRMA =2  
 is not 
= 2 
or 3 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
5
0 
VB/VR/VL6A =3,4,5 
and/or IRMA =3 
 is not 
= 2 
or 3 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
6
0 
NVD =2 and/or NVE 
=2 
 and/or FVP = 2,3,4 
and/or laser = 2 
     is not = 5  is not = 2,3 
or 4 
 
7
0 
either NVD =3;  
or PRHVH =2,3,4 
and (NVD =2 and/or 
NVE =3) 
     is not = 5    
7
1 
FVP = 5 and (NVD = 
2,3 and/or NVE= 2,3 
and/or PRHVH = 
2,3,4) 
         
7
2 
PRHVH = 3,4 and all 
other attributes are 
= 90 
         
9 all attributes = 90          
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0 
 Inclusive rule          
  HMA NVD CWS8A NVE VB/VR/VL6
A 
FVP IRMA PRHVH Laser 
 variables 0,1,2,
3,90,
NR 
0,1,2,
3,90,
NR 
0,1,2,3
,90,NR 
0,1,2,3,
90,NR 
0,1,2,3,4,5,
90,NR 
0,1,2,3,4,5,90
,NR 
0,1,2,3,90
,NR 
0,1,2,3,4,90,
NR 
0,1,2,3,90,
NR 
1
0 
 is not 
= 2 
or 3 
is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
1
2 
any field = 1 is not 
= 2 
or 3 
is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
2
0 
HMA =2   is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
3
0 
HMA =2 and/or  
CWS8A =2 
 is not 
= 2 
or 3 
 is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
4
0 
CWS8A = 3 and/or 
VB/VR/VL6A =2 
and/or IRMA =2  
 is not 
= 2 
or 3 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
5
0 
VB/VR/VL6A =3,4,5 
and/or IRMA =3 
 is not 
= 2 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
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or 3 
6
0 
NVD =2 and/or NVE 
=2 
 and/or FVP = 2,3,4 
and/or laser = 2 
     is not = 5  is not = 2,3 
or 4 
 
7
0 
either NVD =3;  
or PRHVH =2,3,4 
and (NVD =2 and/or 
NVE =3) 
     is not = 5    
7
1 
FVP = 5 and (NVD = 
2,3 and/or NVE= 2,3 
and/or PRHVH = 
2,3,4) 
         
7
2 
PRHVH = 3,4 and all 
other attributes are 
= 90 
         
9
0 
all attributes = 90          
  
 
 
 
 
 
193 
 
Liverpool Diabetes Eye Study Schema Description:  
Database DIAB  
Dataset DiabEyeGeneral                                                                                                                                                                   
Version date 03/03/10 
Data Label  Description Data 
type 
Value  Unit Narrative  Logic Rules 
StudyIDNo ID number  Number Xxxxx    
NHS No ID number (key 
patient identifier 
for Study Tables) 
Number 10 digits no gaps    
Examination Date Date  Date/ 
Time 
dd/mm/yy     
Age at Exam Age integer Xxx Years   Calculated from 
<PatDOB> in  
DiabPatientDetails  and 
<Examination Date>. 
Ignore entered data 
Visual Acuity Right 
Best 
Visual acuity 
recorded on Bailey-
Lovie chart   
nominal 6/5=0,6/6=1,6/9
=2,6/12=3,6/60
=7 
<6/60=8,NPL=9 
– now uses 
Bailey Lovie 
logMAR  -0.20-+1.00 
(+2.00,+3.00,+4.00,+5.0
0) 
Where VA also exists in  
DiabBiomicroscopy  
<VARE> in  visit related 
to this episode replace 
by the data from  
DiabBiomicroscopy  
<VARE> 
Table A1.2 : Schema for General Dataset 
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Visual Acuity Left 
Best 
Visual acuity 
recorded on Bailey-
Lovie chart   
nominal 6/5=0,6/6=1,6/9
=2,6/12=3,6/60
=7 
<6/60=8,NPL=9  
logMAR -0.20-+1.00 
(+2.00,+3.00,+4.00,+5.0
0) 
Where VA also exists in  
DiabBiomicroscopy  
<VALE> in  visit related 
to this episode replace 
by the data from  
DiabBiomicroscopy  
<VARE 
See GP Regularly Do you see your 
GP regularly for 
diabetes care? 
nominal no=1,yes=2,Don’
t know=9 
 Is the patient currently 
under active review by the 
GP?  
 
If <see GP regularly> is 
yes and <lastSeeGP>  is 
within the last 12 months 
then implies under current 
GP care.  
 
If <see GP regularly> = 
yes and <lastSeeGP> is 
more than 12 months then 
implies not under current 
GP care.  
 
 
Calculated from <See 
GP Regularly> and  
<LastSeeGP> 
 
If <See GP 
Regularly>=1 and 
<Last see GP>=1 or 2 
then set <See GP 
Regularly>=2 
 
If <See GP 
Regularly>=2 and 
<Last see GP>=1 or 2 
then set <See GP 
Regularly>=2 
 
If <Last see GP>=3 
195 
 
 then set <See GP 
Regularly>=1 
 
Assignment of missing 
data rules 
if  <See GP 
Regularly>= null and 
<Last See GP>=1 or 2 
then <see GP 
regularly>=2. 
  
if  <See GP 
Regularly>= null and 
<Last See GP>=3 then 
<see GP regularly>=1. 
 
if  <See GP 
Regularly>= null and 
<Last See GP>=null 
then <see GP 
regularly>=NR 
 
Data cleansing 
completed 21.10.09 
196 
 
DMB 
Attended Diabetes 
Clinic 
Have you attended 
a hospital clinic for 
diabetes in the last 
2 years? 
nominal No=1,yes=2  Is the patient currently 
under the care of a 
diabetologist?  
 
If <att diab clinic> is no 
implies not under care of a 
diabetologist regardless of 
data in <further diab 
appt> 
 
If <att diab clinic> is yes 
and <further diab appt> = 
yes then implies under 
current diabetologist care  
 
If <att diab clinic> is yes 
and <further diab appt> is 
no then implies not under 
current diabetologist care  
 
Calculated from 
<Attended Diabetes 
Clinic> and  <Further 
diab appointment> 
 
If <Attended Diabetes 
Clinic> =1 the set <att 
diab clinic> as = 1 
 
If <Attended Diabetes 
Clinic> =2 and <further 
diab appt> = 2 then  
set <att diab clinic> =2 
 
If <Attended Diabetes 
Clinic> =2 and <further 
diab appt> =1 then set 
<att diab clinic> =1 
 
Assignment of empty 
attributes 
If <Attended Diabetes 
Clinic> = null then set  
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<Attended Diabetes 
Clinic> = NR 
 
Data cleansing 
completed 21.10.09 
DMB 
Further Diab 
Appointment 
If yes , have you 
another 
appointment to be 
seen 
nominal No=1,yes=2   If <further diab 
appointment> = null 
and <Attended Diabetes 
Clinic> = null then set 
<further diab 
appointment> = NR 
 
If <further diab 
appointment> = null 
and <Attended Diabetes 
Clinic> = 1 then set 
<further diab 
appointment> = NA 
 
If <further diab 
appointment> = null 
and <Attended Diabetes 
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Clinic> = 2 then set 
<further diab 
appointment> = NR 
 
Data cleansing 
completed 19.10.09 
DMB 
Diab Doctor Name Doctor Name text   Ignore warehouse  
Diab Hospital 
Address 
Hospital Address text   Ignore warehouse  
Attended Eye Dept 
Att<2yrs? 
Have you attended 
St. Paul eye 
Hospital or any 
other eye 
department in the 
last 2 years? 
nominal No=1,yes=2,Don’
t know=9 
 Is the patient currently 
under an ophthalmologist?  
 
If <attended eye dept> is 
no implies not under 
ophthalmic care regardless 
of data in <further eye 
appointment>  (will be 
either 1 – no or not 
applicable code) 
 
If <attended eye dept> is 
Yes, and patient has a 
further eye appt implies 
Calculated from 
<Attended Eye Dept> 
and  <Further Eye 
Appointment> 
 
If <Attended Eye Dept> 
=1 the set <Attended 
Eye Dept> as = 1 
 
If <Attended  Eye 
Dept> =2 and <Further 
Eye Appointment> = 2 
then  set <Attended Eye 
Dept> =2 
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currently under an 
ophthalmologist. 
 
If <attended eye dept> is 
Yes, and patient has no 
further eye appt implies 
not currently under an 
ophthalmologist. 
 
 
If <Attended  Eye 
Dept> =2 and <Further 
Eye Appointment > =1 
then set <Attended Eye 
Dept>=1 
 
Assignment of empty 
attributes 
If <Attended  Eye 
Dept> = null and  
<Further Eye 
Appointment > = null 
then set <Attended Eye 
Dept> = NR 
 
Data cleansing 
completed 21.10.09 
Further Eye 
Appointment 
If yes do you have 
another 
appointment to be 
seen? 
nominal No=1,yes=2,Don’
t know=9 
 Used as a support for < 
Attended Eye Dept> 
If <Further Eye 
Appointment> = null 
and <Attended Eye 
Dept> = null then set 
<Further Eye 
Appointment> = NR 
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If <Further Eye 
Appointment> = null 
and <Attended  Eye 
Dept > = 1 then set 
<Further Eye 
Appointment> = NA 
 
If <Further Eye 
Appointment> = null 
and <Attended  Eye 
Dept > = 2 then set 
<Further Eye 
Appointment>  = NR 
 
Data cleansing 
completed 19.10.09 
DMB 
diEyeDeptDocName Department  
Doctor’s name 
text   Ignore warehouse  
diEyeDeptDocAddr Department  
Doctor’s Address 
text   Ignore warehouse  
WeakEye  Have you ever 
been told that you 
nominal no=1,yes=2,null
=0 
 Ignore analysis  
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have a weak or 
lazy eye? 
WeakEyeLeft Have you ever 
been told that you 
have a weak  Eye 
left ? 
nominal Yes=1,no=0  Ignore analysis  
WeakEyeRight Have you ever 
been told that you 
have a weak eye 
right? 
nominal Yes=1,no=0  Ignore analysis  
Cataracts Have you ever 
been told that you 
have Cataract eye? 
nominal no=1,yes=2,null
=0 
 Ignore analysis  
CataractEyeLeft Have you ever 
been told that you 
have a Cataract 
left eye? 
nominal Yes=1,no=0  Ignore analysis If = null set as no = 0 
CataractEyeRight Have you ever 
been told that you 
have a Cataract 
right eye? 
nominal Yes=1,no=0  Ignore analysis If = null set as no = 0 
Glaucoma Have you ever 
been told that you 
have Glaucoma ? 
nominal no=1,yes=2,null
=0 
 Ignore analysis  
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GlaucomaEyeLeft Have you ever 
been told that you 
have a Glaucoma 
left eye?  
nominal Yes=1,no=0  Ignore analysis  
GlaucomaEyeRight Have you ever 
been told that you 
have a Glaucoma 
right eye? 
nominal Yes=1,no=0  Ignore analysis  
Other Problem Have you ever 
been told that you 
have a Other eye 
problem? 
Nominal No=1,yes=2,Don’
t know=9 
 Ignore analysis  
OtherEyeProbLeft Have you ever 
been told that you 
have Other eye 
problem left? 
Nominal Yes=1,no=0  Ignore analysis  
OtherEyeProbright Have you ever 
been told that you 
have Other eye 
problem right? 
Nominal Yes=1,no=0  Ignore analysis  
OtherEyeSpecify Describe any other 
eye problems 
text   Ignore warehouse  
Years 
Diabetic(months) 
How long have you 
been diabetic? 
integer Holds years 
Diabetic(06/98)-
months Ignore warehouse Ignore entered data 
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diYears Band 
converted into 
this field at 06/98 
Calculated diabetes 
duration 
    Duration of diabetes 
calculated for each episode 
in years 
Calculate from <age at 
exam> and <Calculated 
age at diagnosis>  
If missing data use 
<Duration: years> in 
Risk factor table. 
Calculated age at 
diagnosis 
    The age at diagnosis taken 
from the first visit with 
available data   
Used to calculate type of 
diabetes 
Calculate from 
<diAgeDiag> at first 
visit with available data 
diYearsSource How that data was 
calculated 
Nominal A=Accurate, 
D=Derived 
 
 Ignore analysis   
Years Diabetic Band  Nominal <1 yr=0, 
 1-5 yr=1, 
6-10 yr=2, 
 11-15 yr=3, 
 16-20 yr =4,  
21+ yr =5,  
Don’t know =9, 
 Banded by screener based 
on years diabetic 
 
Ignore analysis 
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fieldname 
previously 
diYears – 06/98 
 
Present Treatment 
What is your 
present treatment? 
Nominal Diet alone =1,  
diet and tablets 
=2,  
diet and insulin 
=3,  
tablets and 
insulin =4 
 
 
 Aims 
to determine whether diet, 
tablet or insulin controlled 
to determine whether 
patient has type 1 or type 
2 DM if insulin requiring 
to determine point of 
treatment change 
Used to calculate type of 
diabetes 
Where null use 
<diCurrTreat> in  
related visit  in 
DiabBiomicroscopy 
within same episode 
(≤91 days).  
Else use last available 
observation from  
DiabEyeGeneral. 
If still null set as NR. 
diInsTab If you are on 
insulin, did you 
have a period of 
time on tablets 
before starting 
insulin  
Nominal No=1, 
yes<1 year=2, 
yes ≥1year=3, 
 Don’t know=9  
– if on insulin 
was patient on 
tablets – 06/98  
 Ignore analysis 
Used to calculate type of 
diabetes 
 
Calculated Diabetes 
Type  
  Type 1 = 1 
Type 2 diet 
controlled = 2 
Type 2 oral 
 1 = <30 years old and 
currently on insulin; ≥ 30 
< 40 years old on insulin 
and <12 months tablets 
Calculated from 
<diInsTab>, <Present 
Treatment>, 
<dbPastTreatment> , 
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controlled = 3 
Type 2 insulin 
requiring = 4 
Unclassifiable =9 
Empty field = not 
recorded 
2 = ≥ 40 years old  
currently on diet control 
3 = ≥ 40 years old on oral 
control 
4 = ≥ 30  currently on 
insulin and ≥ 12 months 
tabs 
9 = <30 not on insulin; ≥ 
40 on insulin and <12 
months tablets 
<diInsTab> takes 
precedence over 
<dbPastTreatment>; not 
completed prior to 02/98 
Insulin taked precedence 
over tablets and diet 
Tablets takes precedence 
over diet 
<calculated age at 
diagnosis> 
 
Appendix 1 to 
DiabEyeGeneral schema 
sets out logic rule in full 
 
Where missing data use 
<Calculated Diabetes 
Type> from Risk 
Factors table 
LastSeeGP When did you last 
see your GP in 
your practice for 
anything(any GP 
within practice 
allowed)?  
Nominal <6/12=1, 
 6-12/12=2, 
 >12/12=3 , 
0=missing data 
 Ignore analysis 
Field required for input into 
<see GP regularly> 
Data cleansing completed 
19.10.09 DMB 
If <LastSeeGP> = null 
then set <LastSeeGP> 
= NR 
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diAgeDiag How old were you 
when your 
diabetes was 
diagnosed ? 
Integer 0=unknown, 
 else recorded in 
years 
years Ignore analysis 
Used to calculate the age 
at diagnosis 
Where there is more 
than one patient 
episode take duration 
data from earliest visit 
 
WhyVisit  Nominal No=1, 
yes=2, 
Don’t know=9 
 Ignore warehouse  
dbHPB1 Have you ever 
been told that you 
have High blood 
pressure? 
Nominal No=1,yes=2  Ignore warehouse  
dbHPB2 Have you ever 
been told that you 
have Foot Ulcers ? 
Nominal No=1,yes=2  Ignore warehouse  
dbHPB3 Have you ever 
been told that you 
have Circulatory 
problems? 
Nominal No=1,yes=2  Ignore warehouse  
dbHPB4 Have you ever 
been told that you 
have Nerve 
problems? 
Nominal No=1,yes=2  Ignore warehouse  
dbHPB5 Have you ever Nominal No=1,yes=2  Ignore warehouse  
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been told that you 
have Kidney 
problems? 
ndbOthPrb Do you have any of 
the following 
diabetic problem: 
High blood 
pressure/nerve 
problem/foot ulcers 
/kidney 
problems/circulator
y problems 
Nominal No=1,yes=2,Don’
t know=9 
 Ignore warehouse  
ndbOthPrbS Describe any other 
diabetic problems 
text   Ignore warehouse  
dbPastTreat What was the Past 
treatment? 
nominal Diet=1, diet then 
tablets  =2,Diet 
then 
insulin=3,tablets
=4,tables<yr 
then 
Insulin=5,Tablets
>1yr then 
insulin=6,tablets 
then 
 Ignore analysis 
Used to calculate type of 
diabetes 
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diet=7,insulin 
then 
tablets=8,insulin
=9,Don’t 
know=10  
diSmoke Do you smoke or 
have you smoked 
any time in the last 
10 years? 
Nominal No=1, Yes=2, 
Don’t know=9 
smoke during last 
10 years 06/98 
 Started being collected in 
1998 
Not applicable before 
01/06/1998 
if date = <01/06/1998 
set empty field = NA 
if no then set as no 
if yes set as yes 
if don’t know set as no 
if date = ≥01/06/1998 
then set empty field as 
NR 
diFamGlau Is there any family 
history of  
Glaucoma? 
Nominal No=1,yes=2,don’
t know=9-Family 
history of 
Glaucoma – 
06/98 
 Ignore warehouse  
New Patient New Patient Nominal Yes=Y, No=N  Ignore warehouse  
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Table A1.3 – Schema for DiabBiomicroscopy dataset 
Liverpool Diabetes Eye Study Schema Description:  
Database DIAB  Dataset: DiabBiomicroscopy                                                                                                                                               
Version date: 03/03/10 
Data Label Description Data type Value  Narrative  Logic Rules  
StudyIDNo ID number (key 
patient identifier 
for Study Tables)  
Number Xxxxx   
ExamDate Date  Date/ Time dd/mm/yy    
VARE Visual acuity 
recorded on 
Bailey-Lovie chart   
nominal 6/5=0,6/6=1,6/9=
2,6/12=3,6/60=7 
<6/60=8,NPL=9 – 
now uses Bailey 
Lovie 
LogMAR  
-0.20-+1.00 
(+2.00,+3.00,+4.00,
+5.00) 
Where VA exists in 
one episode in Diab 
Gen AND bio assume 
the bio VA likely to 
be more accurate 
Where VA data also exists in 
DiabEyeGeneral visit related to this 
episode, replace DiabEyeGeneral 
<Visual Acuity Right Best> with data 
from this field 
 
VALE Visual acuity 
recorded on 
Bailey-Lovie chart   
nominal 6/5=0,6/6=1,6/9=
2,6/12=3,6/60=7 
<6/60=8,NPL=9  
LogMAR  
 
-0.20-+1.00 
(+2.00,+3.00,+4.00,
+5.00) 
Where VA data also exists in 
DiabEyeGeneral visit related to this 
episode, replace DiabEyeGeneral 
<Visual Acuity Left Best> with data 
from this field 
 
B.P. Blood pressure number    
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Pulse Rate Pulse rate number  Ignore warehouse 
               
 
IOPRE Intraocular 
pressure IOP R 
Number   <21 is normal and 
>21 is abnormal 
Ignore analysis 
 
IOPLE Intraocular 
pressure IOP L 
Number  <21 is normal and 
>21 is abnormal 
Ignore analysis 
 
diYears 
 
How long have 
you been diabetic? 
Nominal <1 yr=0, 
 1-5 yr=1, 
6-10 yr=2, 
 11-15 yr=3, 
 16-20 yr =4,  
21+ yr =5,  
Don’t know =9, 
fieldname 
previously diYears – 
06/98 
Ignore analysis  
diCurrTreat 
 
What is your 
Present 
treatment? 
Nominal Diet alone =1,  
diet and tablets =2,  
diet and insulin =3,  
tablets and insulin 
=4 
Use this field to 
populate missing 
data in DiabGen.  
Some patients attend 
for bio without 
having had photo 
Where <Present Treatment> in Daib 
Gen is null or 0 use this field to 
populate if visit is ≤91 days 
previously 
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attendance  
diHospClinAtt 
 
Have you attended 
a hospital clinic for 
diabetes in the 
last 2 years? 
nominal No=1,yes=2,Don’t 
know=9 
Ignore warehouse  
diEyeDeptAtt 
 
Have you attended 
St.Paul eye 
Hospital or any 
other eye 
department in the 
last 2 years? 
nominal No=1,yes=2,Don’t 
know=9 
Ignore warehouse  
FamHistGlaucoma 
 
Is there any family 
history of  
Glaucoma? 
Nominal No=1,yes=2,don’t 
know=9-Family 
history of Glaucoma 
– 06/98 
Ignore warehouse  
CornealOpacRE 
 
Corneal 
opacity(right) 
nominal no=1,yes=2   
CornealOpacLE 
 
Corneal 
opacity(left) 
nominal no=1,yes=2   
CataractRE Cataract (Right nominal no=1,yes=2   
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 eye) 
CataractLE 
 
Cataract (Left eye) nominal no=1,yes=2   
CatRENO 
 
Cataract Nuclear 
opacity(right eye) 
nominal 1,2,3,4,5,6  If null and <CataractRE=1 then set 
as NA; else set as NR 
CatRENC 
 
Cataract Nuclear 
colour (right eye) 
nominal 1,2,3,4,5,6  If null and <CataractRE=1 then set 
as NA; else set as NR 
CatREC 
 
Cataract 
cortical(right eye) 
nominal 1,2,3,4,5,6  If null and <CataractRE=1 then set 
as NA; else set as NR 
CatREP 
 
Cataract Nuclear 
opacity(right eye) 
nominal 1,2,3,4,5,6  If null and <CataractRE=1 then set 
as NA; else set as NR 
CatLENO 
 
Cataract Nuclear 
opacity(left eye) 
nominal 1,2,3,4,5,6  If null and <CataractLE=1 then set 
as NA; else set as NR 
CatLENC 
 
Cataract Nuclear 
colour (left eye) 
nominal 1,2,3,4,5,6  If null and <CataractLE=1 then set 
as NA; else set as NR 
CatLEC 
 
Cataract 
cortical(left eye) 
nominal 1,2,3,4,5,6  If null and <CataractLE=1 then set 
as NA; else set as NR 
CatLEP 
 
Cataract Nuclear 
opacity(left eye) 
nominal 1,2,3,4,5,6  If null and <CataractLE=1 then set 
as NA; else set as NR 
Calculated 
cataract sufficient 
to interfere with 
photography 
Right eye 
  1 = yes 
2 = no 
 
calculated from 
<CatRENO>, 
<CatRENC>, 
<CatREC>, 
<CatREP> 
Cataract is sufficient to interfere with 
photography if <CatRENO> = 4, 5 
or 6; and / or <CatRENC> = 4, 5 or 
6; and / or <CatREC> = 4,5 or 6; 
and / or <CatREP> = 1,2,3,4,5 or 6. 
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Calculated 
cataract sufficient 
to interfere with 
photography 
Left eye 
  1 = yes 
2 = no 
 
calculated from 
<CatLENO>, 
<CatLENC>, 
<CatLEC>, 
<CatLEP> 
Cataract is sufficient to interfere with 
photography if <CatLENO> = 4, 5 or 
6; and / or <CatLENC> = 4, 5 or 6; 
and / or <CatLEC> = 4,5 or 6; and / 
or <CatLEP> = 1,2,3,4,5 or 6. 
VitreousOpacityRE Vitreous Opacity 
Right Eye 
nominal no=1,yes=2   
VitreousOpacityLE Vitreus Opacity 
Left Eye 
nominal no=1,yes=2   
CuppedDiscRE Clinician opinion nominal no=1, yes=2 Ignore analysis  
CuppedDiscLE Clinician opinion nominal no=1,yes=2 Ignore analysis  
PseudophakiaRE Had cataract 
removed 
IOL(Right) 
nominal no=1,yes=2 Ignore analysis  
PseudophakiaLE Had cataract 
removed IOL(left) 
nominal no=1,yes=2 Ignore analysis  
PostSynechiaeRE Posterior 
Synechiae-
adhesion between 
lens and iris 
(right) 
nominal no=1,yes=2 Ignore analysis  
PostSynechiaeLE Posterior 
Synechiae-
adhesion between 
nominal no=1,yes=2 Ignore analysis  
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lens and iris(left) 
SmallPupilRE Small Pupil e.g. 
autonomic 
neuropathy(right) 
nominal no=1,yes=2 Ignore analysis  
SmallPupilLE Small Pupil e.g. 
autonomic 
neuropathy(left) 
nominal no=1,yes=2 Ignore analysis  
OtherRE An unspecified 
reason exists(right 
eye) 
nominal no=1,yes=2 Ignore analysis  
OtherLE An unspecified 
reason exists(left 
eye) 
nominal no=1,yes=2 Ignore analysis  
OtherRESpecify Other right eye 
specify 
nominal Comments Ignore analysis  
OtherLESpecify Other left eye 
specify 
nominal Comments Ignore analysis  
ReturnRe Other reason for 
return 
nominal No = 1 
Yes = 2 
Ignore warehouse  
Return Sp Specify other 
reason for return 
text Comments Ignore warehouse  
REHMA Haemorrhages 
and/or micro 
aneurysms  
nominal None=0, 
Quest=1, 
<2A=2, 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
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≥2A=3, 
CG=90 
RENVD New Vessels Disc  nominal None=0, 
Quest=1, 
<10A=2, 
≥10A=3,  
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
RECWS8A Cotton wool spot nominal None=0, 
Quest=1, 
<six=2, 
≥six=3, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
RENVE New vessels 
elsewhere  
nominal None=0, 
Quest=1, 
<1/2DA=2, 
≥1/2DA=3, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REVBVRVL6A Venous Beading 
and /or Venous 
Reduplication 
and/or Venous 
Loop 
nominal None=0, 
Quest=1, 
1Quad=2 
2Quads=3   
3Quads= 4 
 4Quads=5 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
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REFVP Fibrovascular 
proliferation 
nominal None=0, 
Quest=1, 
FPE=2,  
FPD=3,  
FPE+FPD=4,  
TRD=5, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REIRMA Intraretinal 
microvascular 
abnormality  
nominal None=0, 
Quest=1, 
<8A=2, 
≥8A=3, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REPRH VH Pre-Retinal 
Haemorrhage  
Vitreous  
Hemorrhage   
 
nominal None=0, 
Quest=1,  
PRH=2, 
VH=3,  
PRH+VH=4, 
 CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
RERET Retinopathy level nominal None=10,  
Quest=12,  
 HMA<2A=20, 
HMA≥2A and /or 
CWS<six=30, 
CWS≥six and/or 
calculated from 
above 8 attributes 
Calculated from above 8 attributes 
See appendix for full rule 
If null and REOUTCOME8=90 set as 
90; else set as NR 
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IRMA<8A and/or 
VB/VR/VL (1 quad 
only)=40,  
IRMA≥8A and/or 
VB/VR/VL≥2 
quads=50,  
FVP and/or PDR and 
/or PRP=60,  
PDR+HRC=70, 
PDR+TRD=71,  
CG-total VH=72,  
CG=90 
RELASER Any laser; PRP, 
focal or grid 
nominal None=0, 
Quest=1, 
PRP=2, 
Focal /Mac Grid=3, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REMAC-EX Presence of 
macular exudates  
nominal None=0, 
Quest=1, 
 Present>1DD=2 , 
Circinate=3, 
Present.≤1DD and 
/or Laser=4,  
Other (non-DR) =8,  
 If null and REOUTCOME8=90 set as 
90; else set as NR 
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CG=90 
RECUPDISC Cup disc ratio 
≥0.7 
nominal No=0, 
Quest=1, 
Yes=2, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REOTHER1 None-OTHER1 nominal 0 ignore analysis Where REOTHER2-23 = not 0 or 
empty field, then enter 0 
REOTHER2 Drusen /ARMD-
OTHER2 
nominal 1 ignore analysis Where empty field set as 0 
REOTHER3 CNVM-OTHER4 nominal 2 ignore analysis Where empty field set as 0 
REOTHER4 Naevus-OTHER5 nominal 3 ignore analysis Where empty field set as 0 
REOTHER5 Epiretinal 
Membrane-
stopped 
nominal  
4 
ignore analysis Where empty field set as 0 
REOTHER6 C/BRAO-stopped nominal 5 ignore analysis Where empty field set as 0 
REOTHER7 CRVO-OTHER9 nominal 6 ignore analysis Where empty field set as 0 
REOTHER8 BRVO-OTHER10 nominal 7 ignore analysis Where empty field set as 0 
REOTHER9 Other Disc-
stopped  
nominal 8 ignore analysis Where empty field set as 0 
REOTHER10 Rhematogenous 
RD –stopped 
nominal 9 ignore analysis Where empty field set as 0 
REOTHER11 Vitreous Opacity-
stopped 
nominal 10 ignore analysis Where empty field set as 0 
REOTHER12 Couldn’t Grade nominal 90 ignore analysis Where empty field set as 0 
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throughout - 
OTHER17 
REOTHER13 Other-OTHER18 nominal 11 ignore analysis Where empty field set as 0 
REOTHER14 Age-related 
Macular 
Degeneration 
/Retinal Pigment 
Epithelial  Change-
OTHER3 
nominal 20 ignore analysis Where empty field set as 0 
REOTHER15 OTHER6 nominal 21 ignore analysis Where empty field set as 0 
REOTHER16 Central Retinal 
Artery Occlusion -
OTHER7 
nominal 22 ignore analysis Where empty field set as 0 
REOTHER17 Retinal Artery 
Occlusion -
OTHER8 
nominal 23 ignore analysis Where empty field set as 0 
REOTHER18 Rhematogenous 
Retinal 
Detachment-
OTHER11 
nominal 24 ignore analysis Where empty field set as 0 
REOTHER19 Myelinated Nerve 
Fibres -OTHER12 
nominal 25 ignore analysis Where empty field set as 0 
REOTHER20 Myopic 
Degeneration-
nominal 26 ignore analysis Where empty field set as 0 
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OTHER13 
REOTHER21 Tited Disc-
OTHER14 
nominal 27 ignore analysis Where empty field set as 0 
REOTHER22 Asteroid Hyalosis-
OTHER15 
nominal 28 ignore analysis Where empty field set as 0 
REOTHER23 Hollenhorst 
Plaque-OTHER16 
nominal 29 ignore analysis Where empty field set as 0 
REDISCSP Specify Disc text Comments Ignore analysis  
REVITOPSP Vitreous Opacity  text comments Ignore analysis  
REMACOED Assessment of 
macular oedema 
nominal None=0,  
Quest=1, 
 present, not 
CSMO=2, 
Circinate=3, 
Present CSMO=4, 
other=8, 
CG=90 
 If null and REOUTCOME8=90 set as 
90; else set as NR 
REOUTCOME1 Screen negative nominal 0 Ignore analysis  
REOUTCOME2 Screen pos –
retinopathy level 
30 and above 
nominal 1 Ignore analysis  
REOUTCOME3 Screen pos- 
Maculopathy level 
3 and above 
nominal 2 Ignore analysis  
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REOUTCOME4 Screen pos –VA nominal 3 Ignore analysis  
REOUTCOME5 Screen pos- disc nominal 4 Ignore analysis  
REOUTCOME6 Screen pos-
diabetic other 
nominal 5 Ignore analysis  
REOUTCOME7 N-diabetic STED nominal 6 Ignore analysis  
REOUTCOME8 Couldn’t Grade 
throughout  
nominal 90 Ignore analysis  
REOUTCOME9 No photos nominal 99 Ignore analysis  
RE CALCULATED 
OUTCOME 
composite score 
for grading 
outcome for RE 
nominal screen –ve 0, 
screen +ve 
retinopathy =1, 
screen +ve 
maculopathy =2, 
screen +ve 
retinopathy and 
screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
This field records the 
outcome of the 
screening episode 
 
If  retinopathy or 
macular exudates or 
macular oedema is 
ungradable then eye 
is ungradable 
 
If either retinopathy 
or maculopathy 
attributes are null 
(empty) then eye 
cannot be 
categorized for this 
calculated from RERET and 
REMACEX and REMACOED 
 
If <RERET> = 10, 12, 20 and  
<REMACEX> = 0,1,2,8 and 
<REMACOED> = 0,1,2,8 then set 
=0  
 
if <RERET> = 30,40,50,60,70,71,72 
and <REMACEX> =0,1,2 ,8,90,NR 
and <REMACOED> =0,1,2 ,8,90,NR 
then set as =1 
 
If <RERET> = 10, 12, 20,90,NR and  
(<REMACEX> =3,4 or 
<REMACOED> =3,4) then set as =2 
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field and is set as NR  
if <RERET> = 30,40,50,60,70,71,72 
and  (<REMACEX> =3,4 or 
<REMACOED> =3,4)  then set as =3 
 
Ungradable  
If <RERET> = 90 or  <REMACEX> = 
90 or <REMACOED> =90  then set 
= 90 
 
Null attributes 
If <RERET> = NR or  <REMACEX> = 
NR or <REMACOED> =NR  then set 
= NR 
 
LEHMA Hemorrhages 
and/or Micro 
Aneurisms  
nominal None=0, 
Quest=1, 
<2A=2, 
 ≥2A=3, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LENVD New vessels Disc  nominal None=0, 
Quest=1, 
<10A=2, 
≥10=3, 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
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CG=90 
LECWS8A Cotton wool Spot nominal None=0, 
Quest=1, 
<six=2, 
≥six=3, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LENVE New vessels Disc 
Elsewhere  
nominal None=0, 
Quest=1, 
<1/2DA=2, 
≥1/2DA(5)=3, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LEVB/VR/VL6A Venous Beading 
and /or Venous 
Reduplication 
and/or Venous 
Loop 
nominal None=0, 
Quest=1, 
1Quad=2 
2Quads=3  ,  
3Quads= 4 , 
 4Quads=5  , 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LEFVP Fibro vascular 
Proliferation 
nominal None=0, 
Quest=1, 
FPE=2, 
FPD=3, 
FPE+FPD=4, 
TRD=5, 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
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CG=90 
LEIRMA IntraRetinal Micro 
vascular Anomaly  
nominal None=0, 
Quest=1, 
<8A=2, 
≥8A=3, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LEPRHVH Pre-Retinal 
Hemorrhage  
Vitreous  
Hemorrhage   
 
nominal None=0, 
Quest=1, 
PRH=2, 
VH=3, 
PRH+VH=4, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LERET Retinopathy level nominal None=10, 
Quest=12, 
HMA<2A=20, 
HMA≥2,CWS<six=3
0, 
CWS≥six,IRMA,VB/
VR/VI=40, 
IRMA≥8,VB/VR/VL≥
2 quads=50, 
FVP,PDR±PRP=60, 
PDR+HRC=70,PDR
+TRD=71, 
calculated from 
above 8 attributes 
Calculated from above 8 attributes 
See appendix for full rule 
If null and LEOUTCOME8=90 set as 
90; else set as NR 
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CG-total VH=72, 
CG=90 
LELASER Any macular laser; 
focal or grid 
nominal None=0, 
Quest=1, 
PRP=2, 
Mac Grid=3, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LEMACEX Presence of 
macular exudates 
nominal None=0, 
Quest=1, 
Present,>1DD=2 , 
Circinate=3, 
Present.≤1DD±Lase
r=4, 
Other=8, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LECUPDISC Cup disc ratio 
≥0.7 
nominal No=0, 
Quest=1, 
Yes=2, 
CG=90 
If yes = sign of 
glaucoma 
 ignore analysis 
 
LEOTHER1 None-OTHER1 nominal 0 Ignore analysis 
This field records 
absence of other eye 
disease 
Where LEOTHER2-23 = not 0 or 
empty field, then enter 0 
LEOTHER2 Drusen/ARMD- nominal 1 ignore analysis Where empty field set as 0 
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OTHER2 
LEOTHER3 CNVM-OTHER4 nominal 2 ignore analysis Where empty field set as 0 
LEOTHER4 Naevus-OTHER5 nominal 3 ignore analysis Where empty field set as 0 
LEOTHER5 Epiretinal 
Membrane-
stopped 
nominal  
 
4 
ignore analysis Where empty field set as 0 
LEOTHER6 C/BRAO-stopped nominal 5 ignore analysis Where empty field set as 0 
LEOTHER7 CRVO-OTHER9 nominal 6 ignore analysis Where empty field set as 0 
LEOTHER8 BRVO-OTHER10 nominal 7 ignore analysis Where empty field set as 0 
LEOTHER9 Other Disc-
stopped  
nominal 8 ignore analysis Where empty field set as 0 
LEOTHER10 Rhematogenous 
RD –stopped 
nominal 9 ignore analysis Where empty field set as 0 
LEOTHER11 Vitreous Opacity-
stopped 
nominal 10 ignore analysis Where empty field set as 0 
LEOTHER12 CG- 
OTHER17 
nominal 90 ignore analysis Where empty field set as 0 
LEOTHER13 Other-OTHER18 nominal 11 ignore analysis Where empty field set as 0 
LEOTHER14 Age-related 
Macular 
Degeneration 
/Retinal Pigment 
Epithelial defect  
Change-OTHER3 
nominal 20 ignore analysis Where empty field set as 0 
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LEOTHER15 OTHER6 nominal 21 ignore analysis Where empty field set as 0 
LEOTHER16 Central Retinal 
Artery Occlusion-
OTHER7 
nominal 22 ignore analysis Where empty field set as 0 
LEOTHER17 Branch Retinal 
Artery Occlusion-
OTHER8 
nominal 23 ignore analysis Where empty field set as 0 
LEOTHER18 Rhegmatogenous 
Retinal 
Detachment -
OTHER11 
nominal 24 ignore analysis Where empty field set as 0 
LEOTHER19 Myelinated Nerve 
Fibres -OTHER12 
nominal 25 ignore analysis Where empty field set as 0 
LEOTHER20 Myopic 
Degeneration-
OTHER13 
nominal 26 ignore analysis Where empty field set as 0 
LEOTHER21 Tited Disc-
OTHER14 
nominal 27 ignore analysis Where empty field set as 0 
LEOTHER22 Asteroid Hyalosis-
OTHER15 
nominal 28 ignore analysis Where empty field set as 0 
LEOTHER23 Hollenhorst 
Plaque-OTHER16 
nominal 29 ignore analysis Where empty field set as 0 
LEDISCSP Specify Disc text comments Ignore warehouse  
LEVITOPSP Vitreous Opacity  text comments Ignore warehouse  
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LEMACOED Assessment of 
macular oedema 
nominal None=0,  
Quest=1, 
 present, not 
CSMO=2, 
Circinate=3, 
Present CSMO=4, 
other=8, 
CG=90 
 If null and LEOUTCOME8=90 set as 
90; else set as NR 
LE CALCULATED 
OUTCOME 
composite score 
for grading 
outcome for RE 
nominal screen –ve 0, 
screen +ve 
retinopathy =1, 
screen +ve 
maculopathy =2, 
screen +ve 
retinopathy and 
screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
This field records the 
outcome of the 
screening episode 
 
If  retinopathy or 
macular exudates or 
macular oedema is 
ungradable then eye 
is ungradable 
 
If either retinopathy 
or maculopathy 
attributes are null 
(empty) then eye 
cannot be 
categorized for this 
calculated from LERET and LEMACEX 
and LEMACOED 
 
If <LERET> = 10, 12, 20 and  
<LEMACEX> = 0,1,2,8 and 
<LEMACOED> = 0,1,2,8 then set =0  
 
if <LERET> = 30,40,50,60,70,71,72 
and <LEMACEX> =0,1,2 ,8,90,NR 
and <LEMACOED> =0,1,2 ,8,90,NR 
then set as =1 
 
If <LERET> = 10, 12, 20,90,NR and  
(<LEMACEX> =3,4 or <LEMACOED> 
=3,4) then set as =2 
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field and is set as NR if <LERET> = 30,40,50,60,70,71,72 
and  (<LEMACEX> =3,4 or 
<LEMACOED> =3,4)  then set as =3 
 
Ungradable  
If <LERET> = 90 or  <LEMACEX> = 
90 or <LEMACOED> =90  then set = 
90 
 
Null attributes 
If <LERET> = NR or  <LEMACEX> = 
NR or <LEMACOED> =NR  then set 
= NR 
 
LEOUTCOME1 Screen negative nominal 0 Ignore analysis  
LEOUTCOME2 Screen positive –
retinopathy 
nominal 1 Ignore analysis  
LEOUTCOME3 Screen positive- 
Maculopathy 
nominal 2 Ignore analysis  
LEOUTCOME4 Screen pos 
-VA 
nominal 3 Ignore analysis  
LEOUTCOME5 Screen pos- 
Disc 
nominal 4 Ignore analysis  
LEOUTCOME6 Screen pos- nominal 5 Ignore analysis  
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diabetic other 
LEOUTCOME7 Non-diabetic Sight 
Threatening E 
Disease  
nominal 6 Ignore analysis  
LEOUTCOME8 Couldn’t Grade 
throughout  
nominal 90 Ignore analysis  
LEOUTCOME9 No photos nominal 99 Ignore analysis  
BEOUTCOME1 Screen neg nominal 0 Ignore analysis  
BEOUTCOME2 Screen pos-
retinopathy 
nominal 1 Ignore analysis  
BEOUTCOME3 Screen pos-
maculopathy 
nominal 2 Ignore analysis  
BEOUTCOME4 Screen pos-VA nominal 3 Ignore analysis  
BEOUTCOME5 Screen pos- 
Disc 
nominal 4 Ignore analysis  
BEOUTCOME6 Screen pos- 
Diabetic other 
nominal 5 Ignore analysis  
BEOUTCOME7 Non –diabetic STD nominal 6 Ignore analysis  
BEOUTCOME8 Couldn’t Grade 
throughout 
nominal 90 Ignore analysis  
BEOUTCOME9 No photos nominal 99 Ignore analysis  
BE CALCULATED 
OUTCOME 
composite score 
for grading 
outcome for RE 
nominal screen –ve 0, 
screen +ve 
retinopathy =1, 
This field records the 
outcome of the 
screening episode by 
calculated from RE CALCULATED 
OUTCOME and LE CALCULATED 
OUTCOME 
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screen +ve 
maculopathy =2, 
screen +ve 
retinopathy and 
screen +ve 
maculopathy =3 
ungradable = 90 
null field = NR 
patient 
 
Highest grade in 
either eye takes 
precedence 
If maculopathy and 
retinopathy exist in 
either or both eyes 
then set as 3 
 
Ungradable 
Where both 
attributes = 90 set 
as 90 
Where one field = 
90: 
i) and other is 0 set 
as 90 
ii) and other is 1,2, 
or 3 set as 1,2,3 
respectively  
 
Null attributes 
Where both 
 
If < RE CALCULATED OUTCOME > = 
0 and  < LE CALCULATED OUTCOME 
> =0 then set = 0 
 
If (< RE CALCULATED OUTCOME > 
or < LE CALCULATED OUTCOME > = 
1) and (< RE CALCULATED 
OUTCOME > or < LE CALCULATED 
OUTCOME > = 0,1)  then set = 1 
 
If (< RE CALCULATED OUTCOME > 
or < LE CALCULATED OUTCOME > = 
2) and (< RE CALCULATED 
OUTCOME > or < LE CALCULATED 
OUTCOME > = 0,2) then set = 2 
 
If (< RE CALCULATED OUTCOME > 
or < LE CALCULATED OUTCOME > = 
1) and (< RE CALCULATED 
OUTCOME > or < LE CALCULATED 
OUTCOME > = 2) then set = 3 
 
If either < RE CALCULATED 
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attributes = null set 
as not recorded (NR) 
Where one field = 
null : 
i) and other is 0 set 
as NR 
ii) and other is 1,2, 
or 3 set as 1,2,3 
respectively 
OUTCOME > = 3 or  < LE 
CALCULATED OUTCOME > =3 then 
set = 3 
 
Ungradable  
If <RE CALCULATED OUTCOME> = 
90 and  <LE CALCULATED OUTCOME 
> = 90 then set = 90 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 0) then set = 90 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 1) then set = 1 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
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OUTCOME> or <LE CALCULATED 
OUTCOME > = 2) then set = 2 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
90) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 3) then set = 3 
 
Null attributes 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 0) then set = NR 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 1) then set = 1 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
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null) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 2) then set = 2 
 
If (<RE CALCULATED OUTCOME> or 
<LE CALCULATED OUTCOME > = 
null) and (<RE CALCULATED 
OUTCOME> or <LE CALCULATED 
OUTCOME > = 3) then set = 3 
 
DiabStedEye Auto generated-by 
rule .Not on Photo 
form-6/98 
nominal Yes=Y, 
No=N 
Replace 
autogenerated  with 
value calculated from 
elsewhere 
 
As in BE OUTCOME 
but level 40 or above 
for retinopathy and 
no account of 
presence of 
maculopathy and 
retinopathy 
calculated from < BE CALCULATED 
OUTCOME> and <RERET> and 
<LERET> 
 
If <BE CALCULATED OUTCOME> = 
0, 90 or NR then set as N 
 
If <BE CALCULATED OUTCOME> = 
2,3 then set as Y 
 
If <BE CALCULATED OUTCOME> = 1 
and (<RERET> = 30 and <LERET> 
= 30) then set as N else set as Y 
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Action1 Annual Review  1 Ignore warehouse  
Action2 Glaucoma Suspect  2 Ignore warehouse  
Action3 Retinal Clinic   3 Ignore warehouse  
Action4 General Clinic  4 Ignore warehouse  
Action5 Continued 
Ophthalmology 
F/U 
 5 Ignore warehouse  
Action6 6 month 
assessment clinic 
 6 Ignore warehouse  
Action7 W/L Laser   7 Ignore warehouse  
Action8 W/L  Cataract 
Extraction 
 8 Ignore warehouse  
Action9 For referral 
elsewhere 
 9 Ignore warehouse  
FIELDCHANGE   Y/N Ignore warehouse  
 
Logic rules for RERET and LERET (example given is RERET) 
 Inclusive rule          
  HMA NVD CWS8A NVE VB/VR/VL6
A 
FVP IRMA PRHVH Laser 
 variables 0,1,2,
3,90,
NR 
0,1,2,
3,90,
NR 
0,1,2,3
,90,NR 
0,1,2,3,
90,NR 
0,1,2,3,4,5,
90,NR 
0,1,2,3,4,5,90
,NR 
0,1,2,3,90
,NR 
0,1,2,3,4,90,
NR 
0,1,2,3,90,
NR 
1  is not is not is not is not = is not = is not = 2,3,4 is not = 2 is not = 2,3 is not = 2,3 
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0 = 2 
or 3 
= 2 
or 3 
= 2 or 
3 
2 or 3 2,3,4 or 5 or 5 or 3 or 4 
1
2 
any field = 1 is not 
= 2 
or 3 
is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
2
0 
HMA =2   is not 
= 2 
or 3 
is not 
= 2 or 
3 
is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
3
0 
HMA =2 and/or  
CWS8A =2 
 is not 
= 2 
or 3 
 is not = 
2 or 3 
is not = 
2,3,4 or 5 
is not = 2,3,4 
or 5 
is not = 2 
or 3 
is not = 2,3 
or 4 
is not = 2,3 
4
0 
CWS8A = 3 and/or 
VB/VR/VL6A =2 
and/or IRMA =2  
 is not 
= 2 
or 3 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
5
0 
VB/VR/VL6A =3,4,5 
and/or IRMA =3 
 is not 
= 2 
or 3 
 is not = 
2 or 3 
 is not = 2,3,4 
or 5 
 is not = 2,3 
or 4 
is not = 2,3 
6
0 
NVD =2 and/or NVE 
=2 
 and/or FVP = 2,3,4 
and/or laser = 2 
     is not = 5  is not = 2,3 
or 4 
 
7
0 
either NVD =3;  
or PRHVH =2,3,4 
and (NVD =2 and/or 
     is not = 5    
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NVE =3) 
7
1 
FVP = 5 and (NVD = 
2,3 and/or NVE= 2,3 
and/or PRHVH = 
2,3,4) 
         
7
2 
PRHVH = 3,4 and all 
other attributes are 
= 90 
         
9
0 
all attributes = 90          
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Appendix 2 – Noise reduction 
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Figure A2.1: Noise reduction – 5 time stamps – Series 1 
Figure A2.2: Noise reduction – 6 time stamps – Series 1 
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Figure A2.3: Noise reduction– 7 time stamps – Series 1 
Figure A2.4: Noise reduction– 8 time stamps – Series 1 
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Figure A2.5: Noise reduction– 9 time stamps – Series 1 
Figure A2.6: Noise reduction– 10 time stamps – Series 1 
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Figure A2.7: Noise reduction– 5 time stamps – Series 2 
Figure A2.8: Noise reduction– 6 time stamps – Series 2 
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Figure A2.9:Noise reduction– 7 time stamps – Series 2 
Figure A2.10:Noise reduction– 8 time stamps – Series 2 
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Figure A2.11: Noise reduction– 9 time stamps – Series 2 
Figure A2.12 :Noise reduction– 10 time stamps – Series 2 
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Figure A2.13: Noise reduction– 5 time stamps – Series 3 
Figure A2.14: Noise reduction– 6 time stamps – Series 3 
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Figure A2.16: Noise reduction– 8 time stamps – Series 3 
Figure A2.15:Noise reduction– 7 time stamps – Series 3 
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Appendix 3 – Time stamp interval distribution 
 
 
Figure A3.1: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 
Figure A3. 2: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
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Figure A3. 3: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 
 
Figure A3. 4: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
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Figure A3. 5: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 
Figure A3. 6  : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
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Figure A3. 7: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 
Figure A3. 8: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
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Figure A3. 9 : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 
Figure A3.10: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
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Figure A3. 11 : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 
Figure A3. 12: Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
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Figure A3. 13 : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
 
Figure A3. 14 : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
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Figure A3. 55  : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
 
Figure A3. 16   : Patient distribution in intervals for every time stamp, from General to Photodetails – Series 1 
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Figure A3. 17 :Patient distribution in intervals for every time stamp, from General to Photodetails – Series 2 
 
Figure A3. 18 :Patient distribution in intervals for every time stamp, from General to Photodetails – Series 3 
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Figure A3. 19 :Patient distribution in intervals from previous to next time stamp – Series 1 
 
Figure A3. 20 :Patient distribution in intervals from previous to next time stamp – Series 2 
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Figure A3. 61 :Patient distribution in intervals from previous to next time stamp – Series 3 
 
Figure A3. 22 :Patient distribution in intervals from previous to next time stamp – Series 1 
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Figure A3. 23 :Patient distribution in intervals from previous to next time stamp – Series 2 
 
Figure A3. 24 :Patient distribution in intervals from previous to next time stamp – Series 3 
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Figure A3. 25  :Patient distribution in intervals from previous to next time stamp – Series 1 
 
Figure A3. 26: Patient distribution in intervals from previous to next time stamp – Series 2 
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Figure A3. 27 : Patient distribution in intervals from previous to next time stamp – Series 3 
 
Figure A3. 28  : Patient distribution in intervals from previous to next time stamp – Series 1 
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Figure A3. 29 : Patient distribution in intervals from previous to next time stamp – Series 2 
 
Figure A3. 30: Patient distribution in intervals from previous to next time stamp – Series 3 
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Figure A3. 31: Patient distribution in intervals from previous to next time stamp – Series 1 
 
Figure A3. 32 : Patient distribution in intervals from previous to next time stamp – Series 2 
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Figure A3. 33 :Patient distribution in intervals from previous to next time stamp – Series 3 
 
Figure A3. 34 : Patient distribution in intervals from previous to next time stamp – Series 1 
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Figure A3. 35: Patient distribution in intervals from previous to next time stamp – Series 2 
 
Figure A3. 36: Patient distribution in intervals from previous to next time stamp – Series 3
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Appendix 4 – Trends representation 
 
Figure A4.1: Snapshot of mosaic representation of trends from experiment with 9 time 
stamps 
 
Figure A4.2: Snapshot of mosaic representation of trends from experiment with 8 time 
stamps
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Figure A4.3 Snapshot of mosaic representation of trends from experiment with 7 time 
stamps 
 
Figure A4.4 Snapshot of mosaic representation of trends from experiment with 7 time 
stamps
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